US20040159323A1 - Control of respiratory oxygen delivery - Google Patents

Control of respiratory oxygen delivery Download PDF

Info

Publication number
US20040159323A1
US20040159323A1 US10/695,436 US69543603A US2004159323A1 US 20040159323 A1 US20040159323 A1 US 20040159323A1 US 69543603 A US69543603 A US 69543603A US 2004159323 A1 US2004159323 A1 US 2004159323A1
Authority
US
United States
Prior art keywords
oxygen
user
valve
blood
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/695,436
Inventor
Matthew Schmidt
John Buan
Catherine Nordman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minnesota Innovative Tech and Instruments Corp MITI
Original Assignee
Minnesota Innovative Tech and Instruments Corp MITI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/900,686 external-priority patent/US6532958B1/en
Application filed by Minnesota Innovative Tech and Instruments Corp MITI filed Critical Minnesota Innovative Tech and Instruments Corp MITI
Priority to US10/695,436 priority Critical patent/US20040159323A1/en
Publication of US20040159323A1 publication Critical patent/US20040159323A1/en
Priority to US11/441,525 priority patent/US20060213519A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/1005Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • A61M16/101Preparation of respiratory gases or vapours with O2 features or with parameter measurement using an oxygen concentrator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0051Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes with alarm devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • A61M16/026Control means therefor including calculation means, e.g. using a processor specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06Respiratory or anaesthetic masks
    • A61M16/0666Nasal cannulas or tubing
    • A61M16/0672Nasal cannula assemblies for oxygen therapy
    • A61M16/0677Gas-saving devices therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0021Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0024Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with an on-off output signal, e.g. from a switch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0208Oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/03Gases in liquid phase, e.g. cryogenic liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3546Range
    • A61M2205/3561Range local, e.g. within room or hospital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics
    • A61M2230/205Blood composition characteristics partial oxygen pressure (P-O2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/63Motion, e.g. physical activity

Definitions

  • the present invention relates to the field of respiratory oxygen supply systems and methods. More particularly, the present invention provides demand delivery methods and systems that supply respiratory oxygen when the patient is inhaling.
  • Respiratory oxygen is delivered to patients in both sub-critical care situations in which oxygen is provided as a supplement to room air that may be inhaled by the patients (often referred to as “supplemental” oxygen delivery) and in critical care situations in which the gases (particularly oxygen) inspired by patients are closely controlled, possibly in connection with blood gas measurements.
  • demand delivery One approach to conserving the oxygen delivered to patients is typically referred to as “demand delivery.”
  • the demand delivery systems respond to a patient's inspiratory effort by attempting to deliver oxygen during the period of inhalation, rather than allow the oxygen to flow to the patient continuously.
  • This basic concept has been implemented.
  • respiration detection systems have been developed in connection with demand delivery systems.
  • respiration detectors include a chest belt worn by the patient that generates an electrical signal to trigger the opening of the oxygen supply valve; a hand-activated breathing device attached to a portable gas bottle via a supply hose in which users dispense the oxygen by pushing a button while holding the device next to their mouth; a mechanical chest strap/valve that functions as both an inhalation sensor and delivery device in an oxygen conserving system; and an all-pneumatic, fluidically-controlled device.
  • the present invention provides respiratory oxygen supply methods and systems.
  • the systems/methods rely on respiration sensors sensing variations in patient respiration to determine when a patient is inhaling and allow for the determination of an inhalation event after exhalation has been determined.
  • the respiration sensors may be advantageously used to detect the presence of oxygen from the oxygen supply.
  • the present invention uses a flow sensor as a respiration sensor, the system may automatically correct for variations in the signals provided by the flow sensor using a zero-flow offset signal, thereby improving the accuracy of the system.
  • the present invention provides a method of delivering respiratory oxygen to a patient by providing an oxygen delivery system including an oxygen delivery device, a respiration sensor, and an oxygen source; placing the delivery device in fluid communication with the respiration sensor and monitoring variations in respiration with the respiration sensor to determine when the patient is inhaling; placing the oxygen source in fluid communication with the delivery device; delivering oxygen to the delivery device from the oxygen source when the patient is inhaling; removing the respiration sensor from fluid communication with the delivery device when delivering oxygen to the delivery device from the oxygen source; placing the respiration sensor in fluid communication with the delivery device after delivering oxygen to the delivery device from the oxygen source; monitoring variations in respiration with the respiration sensor after delivering oxygen to the delivery device from the oxygen source to determine when the patient is exhaling; and resuming the monitoring of variations in respiration with the respiration sensor to determine that the patient is inhaling after determining that the patient has exhaled.
  • the present invention provides a method of delivering respiratory oxygen to a patient by providing an oxygen delivery system including an oxygen delivery device, a respiration sensor, and an oxygen source; placing the delivery device in fluid communication with the respiration sensor and monitoring variations in respiration with the respiration sensor to determine when the patient is inhaling; placing the oxygen source in fluid communication with the delivery device; delivering oxygen to the delivery device from the oxygen source when the patient is inhaling; removing the respiration sensor from fluid communication with the delivery device when delivering oxygen to the delivery device from the oxygen source; placing the respiration sensor in fluid communication with the delivery device after delivering oxygen to the delivery device from the oxygen source; and monitoring the respiration sensor to detect oxygen in the oxygen source.
  • the present invention provides a method of delivering respiratory oxygen to a patient by providing an oxygen delivery system including an oxygen delivery device, a flow sensor, and an oxygen source; placing the delivery device in fluid communication with the flow sensor and monitoring variations in respiration with the flow sensor to determine when the patient is inhaling; placing the oxygen source in fluid communication with the delivery device; delivering oxygen to the delivery device from the oxygen source when the patient is inhaling; removing the respiration sensor from fluid communication with the delivery device when delivering oxygen to the delivery device from the oxygen source; placing the flow sensor in fluid communication with the delivery device after delivering oxygen to the delivery device from the oxygen source; monitoring a zero-flow offset signal produced by the flow sensor when it is not in fluid communication with the delivery device; and compensating for drift in the zero-flow offset signal generated by the flow sensor based on the monitoring when the flow sensor is not in fluid communication with the delivery device.
  • the present invention provides a method of delivering respiratory oxygen to a patient by providing an oxygen delivery system including an oxygen delivery device, a bidirectional flow sensor vented to atmosphere, and an oxygen source; placing the delivery device in fluid communication with the flow sensor and monitoring variations in respiration with the flow sensor to determine when the patient is inhaling; placing the oxygen source in fluid communication with the delivery device; delivering oxygen to the delivery device from the oxygen source when the patient is inhaling; removing the flow sensor from fluid communication with the delivery device when delivering oxygen to the delivery device from the oxygen source; placing the flow sensor in fluid communication with the delivery device after delivering oxygen to the delivery device from the oxygen source; monitoring variations in respiration with the flow sensor when it is in fluid communication with the delivery device to determine when the patient is exhaling before resuming the monitoring of variations in respiration with the flow sensor to determine that the patient is inhaling; monitoring a zero-flow offset signal produced by the flow sensor when it is not in fluid communication with the delivery device; compensating for drift in the zero-flow offset signal generated by
  • the present invention provides a system for delivering respiratory oxygen to a patient including a delivery line adapted for connection to an oxygen delivery device located on a patient; a source line adapted for connection to an oxygen source; a respiration sensor; at least one valve in fluid communication with the delivery line, the source line and the respiration sensor; wherein the at least one valve places the delivery line in fluid communication with only one of the source line and the respiration sensor at any given time; means for monitoring the respiration sensor for variations in respiration of a patient; means for determining when the patient is inhaling and exhaling based on the monitoring of the respiration sensor; and means for preventing a determination that the patient is inhaling until after a determination that the patient has exhaled has been made.
  • the present invention provides a system for delivering respiratory oxygen to a patient including a delivery line adapted for connection to an oxygen delivery device located on a patient; a source line adapted for connection to an oxygen source; a respiration sensor; at least one valve in fluid communication with the delivery line, the source line and the respiration sensor; wherein the at least one valve places the delivery line in fluid communication with only one of the source line and the respiration sensor at any given time; means for monitoring the respiration sensor to detect oxygen in the source line.
  • supplemental oxygen and “supplemental respiratory oxygen” refer to oxygen delivered to patients in addition to the oxygen received by the patient through the inspiration of room or ambient air. Because room air contains some oxygen, the supplemental oxygen is provided in addition to the oxygen that would normally be inspired by the patient.
  • blood oxygen content and “blood oxygen content level” will typically be used to refer to blood oxygen saturation as commonly measured by the percentage of oxygen-saturated hemoglobin (SpO 2 ) although it can also refer to any suitable measurement for determining the level of oxygenation in a patient's blood.
  • SpO 2 oxygen-saturated hemoglobin
  • blood oxygen content can also be obtained based on data from a CO-oximeter.
  • blood oxygen content can also be obtained based on partial pressures of oxygen (PaO 2 ).
  • sub-acute care refers to care provided to patients that is not intended to treat critical conditions. Typically, sub-acute care is provided to patients in residential settings. “Residential” preferably includes, e.g., homes and long-term care facilities (such as nursing homes). Sub-acute care also includes care delivered in ambulatory situations, i.e., when the patient is engaged in normal activities outside of his or her residence, such as shopping, attending concerts or other events, traveling to appointments with health care professionals, etc.
  • the terms “continuous” and “continuously” mean that the blood oxygen content level of the patient will be measured without cessation or at intervals (fixed or variable) that are sufficiently small to provide the advantages of the invention.
  • FIG. 1 is a block diagram of one system according to the present invention.
  • FIG. 2 is a block diagram of one demand delivery module for use in a system such as that depicted in FIG. 1.
  • FIG. 3 a is a flow diagram of one method according to the present invention.
  • FIG. 3 b is a flow diagram of another method according to the present invention.
  • FIG. 4 is a flow diagram of one method of delivering supplemental oxygen based on whether the measured blood oxygen content data is valid or invalid.
  • the present invention provides demand respirating oxygen supply methods and apparatus for use in sub-acute care which maintain healthy blood oxygen saturation in patients by controlled dosing of oxygen with a measured response to the patient's actual blood oxygen content.
  • the dosing can be provided by simple on/off control over the delivery of oxygen or the amount of oxygen delivered to the patient with each inhalation can be varied in response to the patient's need as determined by a more sophisticated control scheme, such as a proportional-integral-derivative (PID) loop control algorithm, that utilizes the difference between the patient's measured blood oxygen content level and a desired or target blood oxygen content level.
  • PID proportional-integral-derivative
  • the systems and methods of the present invention are particularly directed at patients receiving supplemental oxygen in a sub-acute care environment, more preferably in a residential setting.
  • the needs and considerations of patients receiving supplemental oxygen in sub-acute care differ from those present when providing oxygen to patients in critical care environments, in which the amounts of oxygen delivered to patients are carefully controlled in connection with masks or other enclosures that do not typically allow the patents to inspire room air in uncontrolled manners.
  • the fractional amount of inspired oxygen (FIO 2 ) is typically controlled by mixing oxygen and air in a blender or other device before delivering the gas to the patient.
  • the amounts of oxygen that can be conserved by implementing the methods according to the present invention can be significant, even compared to known demand delivery systems that conserve oxygen by simply turning the supply on or off during a patient's respiration.
  • a fixed amount of oxygen can last three to seven times as long as the same amount of oxygen would last in a supplemental oxygen delivery system that does not include a simple demand delivery system.
  • Implementation of the methods according to the present invention by using a demand delivery approach with a feedback control mechanism that responds to a continuous blood oxygenation measurement could provide an oxygen savings ratio of greater than 13:1 while maintaining the patient's SaO 2 at the 90% level.
  • the present invention can allow for reductions in the size and weight of the oxygen source, thereby increasing the patient's mobility.
  • An added benefit of reducing the size and/or weight of the ambulatory systems is the potential for a better therapeutic outcome. If patients find the smaller, lighter weight systems less cosmetically unattractive they will be more likely to carry and use the systems during ambulatory activities as opposed to not using the systems. Studies have shown that the benefit of supplemental oxygen systems is significantly reduced if the systems are not used on a regular basis.
  • Another advantage of the invention, method and apparatus is a reduction in the risk of hypercapnia (carbon dioxide retention) by only providing enough oxygen to reach a predetermined blood oxygen saturation, typically about 90% as measured by a conventional two-color pulse oximeter.
  • FIG. 1 One embodiment of an automated respiratory oxygen supply system is depicted in FIG. 1 and includes a controller 10 , a demand delivery module 12 , and a blood oxygen content sensor 14 connected to the patient 16 .
  • Oxygen is supplied from an oxygen source 20 to the patient 16 by the demand delivery module 12 through, in the preferred embodiments, a supplemental oxygen delivery device 18 .
  • the preferred system may also include a user interface 32 and an alarm 38 .
  • the supplemental oxygen delivery device 18 is preferably a nasal cannula as depicted in FIG. 1, although it will be understood that the supplemental oxygen delivery device can take the form of any device designed to provide supplemental respiratory oxygen to a patient while not preventing the patient from also inspiring room or ambient air in addition to the supplemental respiratory oxygen from an oxygen source.
  • supplemental oxygen delivery devices include, but are not limited to: tracheal catheters, nasal masks designed for use with Continuous Positive Airway Pressure (CPAP) systems, vented masks that cover both the nose and the mouth but that allow inspiration of room air in uncontrolled amounts in addition to the supplemental oxygen delivered to the mask, etc.
  • CPAP Continuous Positive Airway Pressure
  • Oxygen source 20 could be an oxygen concentrator, membrane separator, high pressure cylinder or liquid oxygen dewar. This could also include any portable versions of oxygen sources 20 . Other potential sources of oxygen gas suitable for providing supplemental oxygen in sub-acute care in a residential setting and/ambulatory situations may be created in the future and should be considered as being functional with the described invention. As used below, “line” will refer to any connection made between the oxygen source, the described invention and the patient.
  • the oxygen source 20 is an oxygen concentrator, typically a continuous low-flow device, usually delivering at most 6 liters/min of 96% oxygen
  • the system may also include an oxygen storage device to accommodate the periodic higher flows that are necessary to practice the methods described below. If high flow concentrators become available, such a storage device would not be needed.
  • One controller 10 is an electronic circuit including a software programmable microcontroller as its main component. Depending on the allocation of tasks within the device a number of microcontrollers could be used as a controller 10 .
  • the controller 10 includes a serial data input port, A/D converter, LED driver capabilities and digital I/O pins.
  • a suitable controller is the PIC 16C74A microcontroller from Microchip Technology Inc. of Chandler, Ariz.
  • microcontroller Those skilled in the art will realize that a great deal of optimization may be done relative to the choice of a microcontroller(s). Specifications, such as power consumption, cost, memory size, clock speed and part availability may alter the choice for a preferred microcontroller. Furthermore, many of the functions described for the microcontroller in the preferred embodiment could be accomplished by using discrete circuits of many types. Additionally, the microcontroller and its peripheral circuitry may be replaced entirely by discrete circuitry, such as programmable logic arrays, A/D converter chips, analog comparators, etc.
  • the system also includes an oxygen content sensor 14 for monitoring the blood oxygen content of the patient 16 .
  • One suitable sensor 14 includes a sensor control module 14 a and a sensor 14 b typically mounted or attached to the patient 16 by some suitable technique.
  • the information from the oxygen content sensor 14 is fed back to the controller 10 for use in executing the methods according to the present invention. It is preferred, but not required, that the oxygen sensor 14 provide a signal to the system controller 10 in the form of a blood oxygen saturation in percent.
  • the sensor 14 preferably, but not necessarily, processes all of its data internally and the controller 10 preferably processes only error flags and numerical information as described shortly.
  • One preferred oxygen sensor 14 is a non-invasive sensor such as a two-color pulse oximeter.
  • the terms “pulse oximeter” or “oxygen sensor” will include both the optical sensor and the circuitry used to determine blood oxygen saturation levels using the optical sensor.
  • One example of a suitable pulse oximeter is a conventional two-color, OEM-II oximeter module, from Nonin Medical Inc. of Madison, Minn., that can measure the percentage of oxygen-saturated hemoglobin, SpO 2 , in the blood stream of an in vivo respiratory system.
  • the preferred embodiment of the pulse oximeter 14 uses a transmitting sensor that attaches to the user's finger. Alternative embodiments may employ sensors that attach elsewhere on the body.
  • the pulse oximeter is one preferred non-invasive oxygen sensor, it should be understood that any blood oxygen sensor, invasive or non-invasive, useful for determining blood oxygen content levels (preferably continuously) could be used in connection with the present invention. It should also be apparent to those skilled in the art that technologies on the horizon, such as an implantable, micro-electromechanical (MEMS) blood gas analyzer, may provide the blood oxygen content information needed by the system controller 10 . Furthermore, there may be improvements in pulse oximetry technology, such as the ability to determine the level of carboxyhemoglobin in the blood, that may be useful for the described invention. Use of these new blood oxygen content technologies in oxygen conservers for long-term oxygen therapy should be considered to lie within the scope of the systems and methods of the present invention provided they have the ability to provide suitable blood oxygen content measurements.
  • MEMS micro-electromechanical
  • the pulse oximeter 14 deconvolves the optical information into a blood oxygen saturation value, SpO 2 , in percent.
  • the oximeter 14 outputs a serial data stream with this information to the controller 10 for evaluation.
  • Other important information may also be included in the oximeter data stream, such as the user's pulse rate and error flags that detail the reliability of the SPO 2 and pulse rate values.
  • system controller 10 functions as the sensor control module 14 a .
  • data evaluation and error handling would be accomplished within the system controller 10 with an appropriate oxygen sensor 14 b being attached to the patient 16 .
  • Blood oxygen content measuring in connection with the present invention is described as “continuous” although it will be understood that the measurements made using, e.g., pulse oximeters and other devices, may actually be taken at discrete intervals.
  • “continuous” as used in connection with the measuring of blood oxygen content in the present invention includes measurement of the blood oxygen content levels of the patient at intervals (fixed or variable) that are sufficiently small to provide the advantages of the invention.
  • the sampling intervals will be less than about five minutes, more preferably less than about one minute, and even more preferably less than about one respiration interval (i.e., the time between the onset of two inhalations by the patient).
  • the information relating to blood oxygen content provided by the oxygen sensor 16 is then used by the system controller 10 in combination with the demand delivery module 12 to provide control over the oxygen supplied to the patient 16 from the oxygen source 20 as described in connection with the methods according to the present invention below.
  • FIG. 2 A block diagram illustrating the components of one embodiment of a demand delivery module 12 according to the present invention is depicted in FIG. 2.
  • One component in the demand delivery module 12 is an inhalation or respiration sensor 40 that monitors the respiratory activity of the patient 16 to determine variations in respiration of the patient. It is preferred that the variations in respiration allow the determination of when the patient is inhaling, although other portions of the respiratory cycle may actually be sensed. In other words, inhalation is preferably sensed, but in some cases it may be desirable to determine when inhalation is occurring based on the sensing of some other condition, activity, etc. such as chest movement, exhalation, etc.
  • the respiration sensor 40 provides a signal to a respiration sensor/valve controller 42 that, in turn, controls the valve 26 based on additional input from system controller 10 (as will be described in more detail below).
  • the respiration sensor 40 can take a variety of forms that will be known to those skilled in the art.
  • One type of suitable respiration sensor 40 monitors flow in the line used to supply oxygen to the supplemental oxygen delivery device 18 .
  • the sensor 40 in FIG. 2 monitors flow through the valve 26 interposed in the line between the supplemental oxygen delivery device 18 and the oxygen source 20 .
  • One suitable flow sensor is a Honeywell AWM2150 Microbridge Mass Airflow Sensor (available from Honeywell Corp., Minneapolis, Minn.).
  • respiration sensor 40 Another feature of the preferred respiration sensor 40 is the ability to sense bidirectional flow, i.e., flow in each direction through the sensor 40 . It is preferred that the flow generated by inhaling causes a voltage output of one polarity from the sensor 40 , while flow generated by exhaling causes an output voltage of the opposite polarity. In any event, it is preferred that the sensor 40 be capable of detecting both inspiration and expiration.
  • a pressure transducer with the appropriate sensitivity, such as a solid-state piezoresistive, capacitive or electromechanical device, could be used to generate an electrical signal in response to the breathing cycle.
  • thermistors could be used to detect changes in airflow due to respiration.
  • thermocouple placed near the nostril.
  • a flow measurement may also be possible with the use of two thermistors in an anemometer configuration. Infrared detectors, such as single element bolometers, could be used as well if they possess the speed and accuracy to distinguish variations in respiration.
  • the respiration sensor 40 provides a signal to the respiration sensor/valve controller 42 which compares the signal to a predetermined reference level.
  • the respiration sensor/valve controller 42 identifies the onset of inhalation by triggering when the sensor signal reaches the predetermined reference level.
  • the respiration sensor/valve controller 42 then provides a signal to position the spool of valve 26 so oxygen flows from supply 20 to patient 16 via supplemental oxygen delivery device 18 .
  • the spool of the valve 26 remains in this position for a period of time, the “dose time” (D), as specified by the system controller 10 . In this manner, a dose of oxygen of duration D can be provided when the patient is inhaling.
  • D dose time
  • One preferred valve 26 of the embodiment of FIG. 2 is a three-way, two-position, solenoid-actuated spool valve having three ports 26 a , 26 b , 26 c .
  • Common port 26 a is connected to the in vivo respiratory system of the patient 16 by the supplemental oxygen delivery device 18 .
  • Normally closed port 26 b is connected to the oxygen source 20 and normally open port 26 c is connected to respiration sensor 40 (with the other end of the preferred respiration sensor left open to atmosphere).
  • One preferred valve 26 is manufactured by The Lee Company, of Westbrook, Conn., Model HDI LHDA0523111H.
  • the spool of the valve 26 is positioned such that common port 26 a and normally open port 26 c are connected so that the respiration sensor 40 , supplemental oxygen delivery device 18 , and patient 16 are in fluid communication, corresponding to the OFF position of the valve 26 .
  • This allows the respiratory effort of the patient 16 to be detected by the respiration sensor 40 , through the monitoring of the flow generated in the supplemental oxygen delivery device 18 by inspiratory and expiratory efforts.
  • the spool of the valve 26 is moved so as to connect common port 26 a and normally closed port 26 b , corresponding to the ON position of the valve 26 . This, in turn, allows for flow of respiratory oxygen to the patient 16 from supply 20 through the valve 26 and the supplemental oxygen delivery device 18 .
  • the ON period for the valve 26 is preferably shorter than the inhalation period for the patient.
  • the patient may often be inhaling after the valve 26 is OFF (i.e., closed).
  • the valve 26 remain closed until the sensor 40 detects the onset of exhalation. Once exhalation is detected based on the sensor 40 , the system can then resume monitoring for the onset of inhalation, whereupon the cycle is repeated.
  • the preferred valve 26 is a 3-port valve, there is a short period after opening or closing the valve 26 , (the “bounce period”) where the sensor output voltage spikes or bounces due to oxygen leaking from the normally closed port 26 b to the normally open port 26 c while the valve spool is still moving. Once the valve 26 is fully ON or OFF and the valve spool has stopped moving, the bounce signal disappears. It is preferred that monitoring of the respiration sensor 40 be adjusted to avoid false readings due to the bounce signal after turning the valve 260 N or OFF. This adjustment can take the form of a delay in monitoring the signal provided by the sensor 40 after moving the valve 26 between the ON and OFF positions until the bounce signal has passed.
  • the bounce signal may be monitored and used advantageously.
  • the bounce signal (whether generated during ON or OFF movement of the valve spool) may be used to detect the presence of oxygen at the supply 20 . No bounce signal may indicate that no oxygen is present because of the lack of pressurized oxygen at normally closed port 26 b .
  • the bounce signal generated by turning the valve 26 to the OFF position i.e., closing port 26 b
  • the bounce signal generated by turning the valve 26 to the OFF position is used for this check because that bounce signal is typically larger and longer in duration than the bounce signal generated by turning the valve 26 to the ON position (i.e., opening port 26 b ).
  • Another advantage of the 3-port valve 26 is that sensor's zero-flow offset voltage can be checked while the valve 26 is in the ON position.
  • the measured sensor offset voltage signal (Vo) can be used to generate a correction for drift in the sensor offset voltage.
  • the signal from the respiration sensor 40 can be read and recorded for use in, e.g., a software-generated correction for zero-flow sensor offset voltage.
  • This sensor offset voltage signal is obtained from the respiration sensor 40 when the valve 26 is ON because no flow is to be expected through the respiration sensor 40 under those conditions (port 26 c is closed).
  • this offset reading is greater (in absolute value) than a predefined upper limit (VoMAX), this can be used to indicate either sensor 40 or valve 26 failure; e.g., the sensor 40 has drifted too far out of specification, the valve 26 is leaking, the valve 26 is stuck in the OFF position, etc.
  • VoMAX a predefined upper limit
  • the demand delivery module 12 described above is a subsystem that communicates to and receives communication from system controller 10 . In the described methods, it receives continually updated values of the dose time D. It will be understood, however, that those skilled in the art could design a demand delivery module 12 which is more or less dependent on the system controller 10 than is described in this embodiment. For example, it may be desirable to construct a system where respiration sensor 40 provides a signal directly to the system controller 10 with no separate respiration sensor/valve controller 42 being provided. The controller 10 would then provide a control signal to valve 26 directly as well as perform the other operations that are described as being performed by the respiration sensor/valve controller 42 .
  • valve 26 a system in which an in-line flow sensor and/or three-port, two-way valve are not required.
  • the designs may involve a plurality of valves and sensors.
  • the methods and systems of the described device operate independently from the specific configuration of hardware used for sensing variations in respiration and the specific valve configuration used to control the flow of oxygen.
  • the demand delivery module 12 described above is used to control delivery of supplemental oxygen to a patient from the source 20
  • the demand delivery module 12 and the methods of operating it as described above could find wider application.
  • they could be used in connection with critical care systems in which FiO 2 is to be controlled via the use of masks or other delivery devices used in connection with, e.g., respirators, ventilators, BIPAP (Bilevel Positive Airway Pressure) systems, etc.
  • the demand delivery module and methods of operating it are not to be limited to use in connection with systems and methods of delivering supplemental oxygen as part of a sub-acute care regime.
  • the controller 10 can use the data to control delivery of oxygen to the patient.
  • the feedback control can be implemented as a portion of software code contained in the controller 10 ; however, it could alternatively be a hard-wired controller or combination of hardware and software in other embodiments.
  • control methods There exist a variety of control methods that are of utility in the present method and invention.
  • the goal of any control method is stable operation of the controlled system about a setpoint or desired value.
  • the desired value is a blood oxygen saturation (SpO 2 ) of 90%.
  • SpO 2 blood oxygen saturation
  • One control algorithm, the ON/OFF method, is diagrammed in FIG. 3 a . This diagram assumes that the data generated by the blood oxygen content sensor is valid (validity and invalidity of that data is discussed in more detail below).
  • D non-zero value
  • the system provides oxygen when the patient is inhaling.
  • the “ON” dose time D could be very long.
  • the dose time is equal to or shorter than a typical inhalation period, in which case one or more pulses of duration D of oxygen are delivered during inhalation.
  • This ON/OFF control approach is analogous to the operation of a furnace using a mercury switch thermostat, i.e., oxygen delivery is either ON or OFF.
  • the feedback control algorithm may alternatively use a Proportional-Integral-Derivative (PID) loop as illustrated in FIG. 3 b .
  • PID Proportional-Integral-Derivative
  • Other embodiments could use algorithms based on fuzzy logic, look-up tables, P or PI loops or increment/decrement methods (oxygen delivery that increases or decreases in a preprogrammed fashion relative to setpoint and/or trend).
  • the PID algorithm is fundamentally different from the simple ON/OFF control algorithm in that it uses both the current value of the blood oxygen content and also trend information to determine whether the patient needs supplemental oxygen and, if so, how much oxygen should be delivered when the patient is inhaling.
  • a system controlled with a PID loop will, at times, deliver oxygen to the patient even if their blood oxygen content is above the desired value; or, at other times, it may not deliver oxygen even if they are below the desired value.
  • An example of when this might occur is when the patient's blood oxygen content was above the desired value, but was also dropping very quickly.
  • the PID loop would start oxygen delivery before the blood oxygen content actually fell below the desired value. (The ON/OFF method would not start oxygen delivery until after the blood oxygen content was below the desired value). This may allow a PID control method to more effectively reduce the fluctuations of the blood oxygen content about the desired value.
  • FIG. 3 b A simplified flow diagram of one such PID control system is illustrated in FIG. 3 b where the data stream of the measured blood oxygen content level sensor is assumed to be valid (validity/invalidity of that data is discussed in more detail below).
  • the system measures the patient's blood oxygen content level 110 .
  • the current information is compared with earlier data 112 to determine how much oxygen (i.e., a variable dose), based on the parameters of the PID loop 114 , should be delivered to the patient 116 .
  • the parameters of the PID loop indicate that no oxygen is to be delivered 118 , and in other instances some variable dose of oxygen will be delivered based on the parameters of the PID loop.
  • D(t) is the oxygen dose time at time t
  • K p is the loop proportional gain
  • T i is the integral time
  • T d is the derivative time
  • the integral is integrated over the range of from zero to t.
  • the preferred embodiment utilizes a first order discretization of the continuous time PID equation. This can be seen in Equation 2,
  • D(t n ) is the control signal (oxygen dose time) generated for time period t n
  • e(t n ) is the difference between the desired level of blood oxygen saturation (the setpoint) and the measured level at time t n .
  • the coefficients, A 0 , A 1 , and A 2 are given by Equations 3-5 below:
  • a 0 K p *(1 +t n /t i +t d /t n ) (3)
  • a 1 ⁇ K p *(1+2 *t d /t n ) (4)
  • K p is the loop proportional gain
  • t i is the integral time
  • t d is the derivative time
  • t n is the period of the measurement (one second if using the preferred oximeter).
  • the quantity e(t n ) is the difference between the SpO 2 value at time t n and the desired value.
  • a fixed setpoint of SpO 2 90% is used for the desired value.
  • the control algorithm will specify doses of oxygen in order to maintain the blood oxygen saturation at this level. It is thought that this saturation level may provide the necessary correction to the patient's hypoxemia, while at the same time conserving the greatest amount of oxygen. It should be apparent to those skilled in the art that the desired value (setpoint) can be changed to achieve different therapeutic and economic goals.
  • a system that uses additional physiological parameters, such as pulse rate or respiratory rate, in addition to blood oxygen content as determined by the oxygen sensor to determine a target blood oxygen level (setpoint) that changes on a rolling basis could also be implemented.
  • additional physiological parameters such as pulse rate or respiratory rate
  • the heart rate may be used to monitor the patient's activity level and therefore anticipate increased or decreased need of oxygen and adjust the setpoint accordingly.
  • Such schemes would be seeking to ameliorate the possible increased/decreased hypoxemia caused by a change in physical activity level.
  • Such changes to the setpoint should be considered to be within the spirit and scope of the present invention.
  • the transfer function coefficients A 0 , A 1 and A 2 are determined by the settings of loop proportional gain K p , the integral time t i , the derivative time t d and the time between data points t n .
  • the determination of these values will typically be accomplished through clinical monitoring of COPD patients while the system is in use.
  • the specific values of these loop parameters will depend on design goals such as loop stability, overshoot, time-to-achieve-control, and accuracy. Methods for obtaining values which provide for effective operation of the control loop will be known to those skilled in the art.
  • the control signal D(t n ) is the dose time needed to maintain the blood oxygen level at the desired value.
  • the dose time signal is provided by controller 10 to respiration sensor/valve controller 42 . It is the duration of time that valve 26 will be held in the ON or open position which permits oxygen to pass from supply 20 to patient 16 (via the supplemental oxygen delivery device 18 illustrated in FIGS. 1 and 2).
  • a dose of oxygen of duration D(t n ) is provided during inhalation (as indicated by respiration sensor 40 and sensor and valve controller 42 , described previously).
  • a system which includes a variable-flow valve could be constructed.
  • the controller 10 could specify the oxygen flow level.
  • the specified flow could, in turn, be provided for a fixed period of time at the onset of each breath, or continuously. During those times in which the patient does not require supplemental oxygen and/or is not inhaling, the flow could be restricted to a low level or to zero followed by periods in which the flow is higher (when the patient is in need of supplement oxygen and is inhaling).
  • the blood oxygen content could be controlled by providing a dose of oxygen on one or more sequential breaths and then delivering no oxygen on one or more subsequent breaths.
  • the control parameter could be described as the number of breaths during which oxygen is or is not delivered. It should be understood that those skilled in the art could construct a control scheme which uses any of these alternate methods or a combination of these methods.
  • the controller 10 also may include a minimum limit (Dmin) for the dose time. If the dose time D(t n ), as determined by Equation 2, is less than Dmin, a dose time of Dmin will be used instead. In one embodiment, Dmin will be zero. The dose time D(t n ) determined by Equation 2 will, at times, be negative. This will primarily occur when the patient's blood oxygen content is greater than the desired value. Since a negative dose time is not physically meaningful, the controller will instead substitute a dose time of Dmin. Of course, Dmin could also be greater than zero.
  • Dmin could also be greater than zero.
  • the controller 10 would also have a maximum limit (Dmax). If the dose time D(t n ), as determined by Equation 2, is greater than Dmax, a dose time of Dmax is used instead. In one embodiment, Dmax is equal to twice the default dose (described in detail below). This prevents the application of excessive amounts of oxygen and thus minimizes the patient's risk of hypercapnia (carbon-dioxide retention). Those skilled in the art will appreciate that other values of Dmax could also be used.
  • the controller 10 could include an “anti wind-up” provision. Because the dose time may have minimum and maximum limits (Dmin and Dmax, described above), it may be advantageous to include an anti wind-up provision to prevent the integral portion of the PID-calculated dose time from getting too large or too small.
  • Dmin and Dmax minimum and maximum limits
  • an anti wind-up provision to prevent the integral portion of the PID-calculated dose time from getting too large or too small.
  • the ability to respond to periods of invalid or bad data in the blood oxygen content measurements is preferably provided.
  • the delivery of oxygen moves from the closed loop control described herein to open loop control based on the criteria described herein (i.e., default values, interpolated data, etc.) and back to closed loop control when the blood oxygen measurements are again valid.
  • FIG. 4 illustrates these concepts. As shown, the system obtains a measured blood oxygen content level 120 . A decision is then made as to whether the measured blood oxygen content level data is valid or invalid 122 .
  • the system may determine whether the measured blood oxygen content level data is invalid on a point-by-point basis or it may determine whether the data stream (including a plurality of data points) is invalid as discussed below. Regardless, a decision will be made as to whether the measured blood oxygen content level data is valid. If the measured blood oxygen content level data is invalid, the system will deliver a default amount of oxygen to the patient 124 . If the measured blood oxygen content level data is valid, the system will deliver oxygen to the patient 126 according to the appropriate control algorithm (ON/OFF, PID loop, etc.).
  • the methods/systems according to the present invention will determine when the blood oxygen content data is invalid, deliver a default amount of oxygen during periods of invalid data, and then resume delivery of supplemental oxygen based on blood oxygen content when that data is again valid.
  • the ability of the systems and methods of the present invention to move from closed to open and back to closed loop control provides a robust system that can operate with a minimum of supervision from medical personnel. Those qualities are essential in any system designed for residential or ambulatory use by sub-acute patients.
  • the error flags provided by the oxygen sensor 14 in the serial data stream are combined with a numerical analysis of the SpO 2 data to create an artifact detection and handling scheme.
  • the serial data stream of the preferred pulse oximeter 14 provides one data point per second.
  • the first byte of the data point may include error flags for some problems associated with pulse oximetry. These flags are examined for the occurrence of a disconnected sensor, low or marginal perfusion, out of track oximeter and bad pulse. If any of these flags are set, the accompanying SPO 2 and heart rate data is considered bad. If the data point is determined to be bad, a timer (Timer1) is started by the controller 10 (unless it is already running based on an earlier bad data point) which then waits for the next data point. The function of Timer1 is to track the cumulative time over which consecutive bad data points are being received. Timer1 is stopped and reset to zero each time a valid or good data point is received.
  • a second error check may be performed using a statistical analysis of the data.
  • the new data point is compared to a mean value of previous data points which represents the patient's current blood oxygen content. The details of the calculation of this mean value are described below.
  • the current data point is subtracted from the mean value to generate a difference, ⁇ SpO 2 in %. (For the data-validity analysis below, if ⁇ SpO 2 is less than zero, its absolute value is used.)
  • Some alternate criteria for identifying when individual data points are invalid or bad could include, but are not limited to, identifying an invalid data point when: (a) the SpO 2 value is outside upper and/or lower limits (e.g., a lower limit of about 70% and/or an upper limit of about 98%); or (b) the heart rate is outside upper and/or lower limits (e.g., a lower limit of about 40 beats per minute and/or an upper limit of about 200 beats per minute).
  • Timer1 is stopped and set to zero (if necessary) and the new mean value of blood oxygen content is calculated with the most recent data point.
  • the new mean value is then compared to the setpoint and a dose time D is calculated as detailed above in Equations 2-5.
  • an exponentially-weighted arithmetic mean of the previous data points is used to represent the current blood oxygen content.
  • the new mean is calculated as follows:
  • ⁇ t is the time between data points (one second using the preferred oximeter)
  • a mean value that is representative of the patient's current blood oxygen content.
  • a harmonic, or geometric mean might be used. (Descriptions of these types of means can be found in “Standard Mathematical Tables” by CRC Press, 24th edition, pages 470-471.) Alternately, a “running” mean might be used. In this method, the mean of a fixed, predetermined number of the most-recent data points could be used. For example, with the preferred pulse oximeter which delivers one data point per second, one could average the preceding 10 data points, thus calculating a mean which represents the patient's blood oxygen content for the previous 10 seconds.
  • the dose time D of oxygen that is delivered to the user may depend on the validity of the data stream from the oxygen sensor. If the time over which the consecutive invalid or bad data points are received, as indicated by Timer1, exceeds a predetermined, physiologically-relevant time scale for patient desaturation (referred to as Desattime), alternative, “default” oxygen delivery procedures are employed. In one embodiment Desattime is equal to 30 seconds. The default assumption is that a patient is always in need of oxygen, unless the blood oxygen content sensor positively indicates that they are not.
  • the oxygen dose time D may remain unchanged from its current value.
  • the system will provide a dose of this duration at the onset of inhalation.
  • the system will typically continue to administer the same dose by responding to inhalation as described above. This will preferably continue until either a valid data point is received and a reevaluation can be made of the patient's condition or Timer1 exceeds Desattime.
  • the device will default to another oxygen delivery method.
  • the controller 10 will default to administering a prescription-equivalent dose of oxygen to the patient 16 from the oxygen source 20 via the demand delivery module 12 .
  • Ddefault would be shorter than a typical inhalation period, in which case the system would provide pulses of duration Ddefault synchronized with each inhalation (demand mode). This will continue until such time as the blood oxygen content data is valid and closed-loop control over oxygen delivery can start anew.
  • the valve does not necessarily open with each and every breath. It should be understood that these alternate methods of implementing a default flow still fall within the scope of the present invention.
  • the object of the default method is to provide a total flow of oxygen during this period of default operation that is no less than the physiological equivalent amount that is prescribed to the patient by the physician. (Physiological equivalence meaning the amount dispensed by other demand delivery devices to provide adequate oxygen therapy.) It should be understood that the notion of physiological equivalence as regards demand delivery devices will change over time as their effects on the physiology of COPD patients is better understood by the medical community. Current practice indicates that 35 ml delivered every other breath at the beginning of inhalation is equivalent to a continuous flow of 2 liters/minute of pure oxygen.
  • the duration of the default dose may be set by the patient's respiratory therapist using a hardware switch on the user interface 32 that is not accessible to the patient.
  • Other techniques of setting the pulse width may be possible, such as a remote controllers, push buttons, etc.
  • Timer1 exceeds Desattime, then the previous mean value of the blood oxygen saturation is reset and data acquisition starts anew. In this way, it is assumed that the old SpO 2 information is no longer valid for the patient's current physical state and that to properly administer oxygen a more current measure of the blood oxygen level is needed. Thus, by using Timer1, a period of invalid data that exceeds Desattime will always lead to the administration of oxygen to the patient. This will correct any undetected desaturation events. Moreover, the controller 10 will always use the most current, valid information regarding the patient's blood oxygen level.
  • Another method for determining whether the oxygen sensor data is valid or invalid can be based on the data stream (a plurality of data points) rather than the individual data points. For example, instead of tracking the time since the most recent valid data point or points, the system could instead determine if the data stream is valid or invalid by comparing the number of valid data points in a “look-back” window (for example, the 60 to 100 most recent data points) to a preset minimum threshold. If the number of valid data points in the look-back period is greater than or equal to the specified minimum, the data stream is considered to be valid and the calculated dose is delivered; if the number of valid data points is less than the minimum, the default dose is delivered.
  • a “look-back” window for example, the 60 to 100 most recent data points
  • the controller 10 may be used to notify the patient of a problem with the pulse oximetry via the user interface 32 and/or alarm 38 .
  • This notification may take the form of a warning light, readout, buzzer or some combination of these.
  • Those skilled in the art may also conceive of other methods of warning the user that are not detailed herein.
  • the controller 10 resumes monitoring the output of the oxygen sensor for valid data.
  • the invention makes provision for the detection of apnea, the cessation of breathing for a prolonged period of time.
  • Timer2 starts each time an inhalation is detected. If the elapsed time between breaths is greater than a predetermined time, e.g., 15 seconds, as determined by Timer2, then the alarm circuit 38 is activated by the controller 10 to signal the patient of a possible apneic event. These alarms preferably stop sounding upon detection of the next inhalation.
  • the patient could be provided with a visible and/or audible alert when their blood oxygen saturation level has been below a healthy level for a period of time—even though they have been using the above-described device.
  • This condition could be caused, e.g., by a malfunctioning of the supplemental oxygen equipment or a worsening of the patient's respiratory condition.
  • the device would increase the dose time D(t) in response to the patient's hypoxia, up to a preset upper-limit dose time Dmax. It is possible that the patient's condition could have worsened so much so that even this maximum dose is not sufficient to keep their blood oxygen saturation at a healthy level. It would be advantageous to alert the patient to this condition so they may seek appropriate medical attention. This could enable earlier detection and treatment of potentially dangerous and costly health conditions.
  • the hypoxia alarm could be implemented in software, hardware, or in a combination of software and hardware.
  • the controller 10 may already calculate a mean value of blood oxygen content from the valid blood oxygen saturation data points.
  • this hypoxia alarm mean would also be an exponentially-weighted mean because it eliminates the need to store each of the many data points that would be collected over the longer period, thereby decreasing the memory requirements.
  • controller 10 could alert the patient via alarm circuit 38 .
  • the time period for the second mean is 1 hour, and the lower limit for blood oxygen saturation is 88%; however, it should be clear that other values could be used for these parameters.
  • the patient could be provided with a visible and/or audible alert when their respiration rate has been above a healthy level for a period of time.
  • Some patients with respiratory diseases will compensate for an impaired respiratory system by maintaining a higher than normal breathing rate. These patients can sometimes maintain a healthy blood oxygen saturation, but over the long term, the increased respiration rate is also detrimental to their health.
  • the onset of a period of increased respiration rate could be caused by a malfunctioning of the supplemental oxygen equipment or a worsening of the patient's respiratory condition.
  • the device increases the dose time D(t) in response to the patient's hypoxia. It is possible that the patient's condition could have worsened, but the patient is compensating by breathing at a higher rate. As with hypoxia, it would be advantageous to alert the patient to this condition so they may seek appropriate medical attention.
  • This alarm could be implemented in software, hardware, or in a combination of software and hardware.
  • the system described above already measures the elapsed time between each breath via Timer2.
  • a mean value of the elapsed time between each breath could be calculated in a manner analogous to the mean blood oxygen levels.
  • this mean would also be an exponentially-weighted mean. It should be understood, however, that other methods of calculating a mean as described above could also be used.
  • the system could alert the patient via controller 10 and alarm circuit 38 .
  • a preset limit corresponding to the upper limit for healthy respiration rates e.g., minimum elapsed time of two seconds, corresponding to a breathing rate of 30 breaths per minute
  • the system could alert the patient via controller 10 and alarm circuit 38 .
  • the time period for calculating the mean is 1 hour
  • the lower limit for elapsed time between breaths is 2 seconds (30 breaths per minute); however, it should be clear that other values could be used for these parameters.
  • a visible and/or audible alert could be provided to the patient when their pulse rate has been above or below healthy levels for a period of time. Excessively high or low pulse rates could be an important indication that the patient needs medical treatment. It would be advantageous to alert the patient to these conditions so they may seek appropriate medical attention.
  • these alarms would be implemented in software, hardware, or in a combination of software and hardware.
  • the preferred oxygen sensor typically provides pulse rate data (in addition to blood oxygen data).
  • a mean pulse rate could be calculated in a manner analogous to the calculation of other means, described above.
  • this mean would also be an exponentially-weighted mean or, alternatively, other means or averages could be used.
  • the system could alert the patient via alarm circuit 38 .
  • preset limits e.g., less than 40 or above 180 beats per minute
  • the time period for the mean is 20 minutes
  • the lower limit for pulse rate is 40 beats per minute
  • the upper limit for pulse rate is 180 beats per minute; however, it should be clear that other values could be used for these parameters.
  • indicators that could be provided include various patient and equipment monitoring functions.
  • these indicators could be implemented in software, hardware, or in a combination of software and hardware.
  • the information provided by these indicators could be useful to the patients, respiratory therapists, physicians, etc. Some examples of indicators are described below.
  • the ON-time parameter would indicate the total amount of time that the device has been powered ON (analogous to the “hour meter” found on most oxygen concentrators), thus giving an indication of the total time the equipment was used since the ON-time parameter was last reset to zero.
  • a timer would be started by controller 10 each time the unit was turned ON.
  • controller 10 When timer reached a value of, e.g., one minute, controller 10 would increment a non-volatile memory location and reset and restart the timer. In this manner, a memory location associated with the ON-time timer would count the number of minutes the apparatus had been powered ON.
  • the memory location associated with the ON-time timer would preferably be non-volatile and, as a result, the total minute count would be retained while the unit was powered OFF. When powered ON again, counting would resume from the previously accumulated value.
  • the ON-time timer could be accessed and reset via the user interface 32 .
  • the default time monitor would preferably consist of a non-volatile memory location that would be incremented each time the timer reached one minute and the unit was in the default mode.
  • a feedback-control-time parameter could be calculated (although this parameter may be more easily obtained by subtracting the default time from the ON-time).
  • default time would preferably be accessed and reset via the user interface 32 .
  • hypoxic-time monitor would consist of a non-volatile memory location that would be incremented each time the timer reached one minute and the patient was hypoxic (and the SpO 2 data was deemed valid). As with the other monitored parameters, hypoxic-time could be accessed and reset via the user interface 32 .
  • the average-dose-time parameter could provide a useful indication of the amount of supplemental oxygen that was required to keep the patient's blood properly oxygenated. Trends in this parameter could be useful for tracking the overall efficiency of the patient's respiratory condition. For example, a measurable increase in the average-dose-time (i.e., an increase in the amount of supplemental oxygen needed) could indicated a worsening of the patient's condition, and thus provide an early warning allowing the patient to seek medical attention before their condition required a costly hospitalization.
  • two nonvolatile memory locations would be used to calculate average-dose-time: a counter and an accumulator. Each time, e.g., an inhalation was sensed, the current dose time (as indicated by controller 10 ) would be added to accumulator and the counter would be incremented. The average-dose-time could then be calculated by dividing the accumulator value by the counter value. As with the other monitored parameters, average-dose-time could be accessed and reset via the user interface 32 .

Abstract

Methods and systems for supplying respiratory oxygen to users when the users are inhaling are disclosed. The methods and systems may rely on delivery devices that are selectively placed in fluid communication with either a respiration sensor or a source of oxygen. The methods and systems may actively monitor for exhalations, as well as monitor for oxygen in the oxygen source. The respiration sensor may preferably be a flow sensor.

Description

    RELATED APPLICATIONS
  • This is a continuation of U.S. patent application Ser. No. 10/370,799, filed 20 Feb. 2003, which is a continuation of U.S. patent application Ser. No. 10/076,001, filed 14 Feb. 2002, (issued as U.S. Pat. No. 6,561,187), which is a continuation of U.S. patent application Ser. No. 09/463,614, filed 25 Jan. 2000 (with a 35 U.S.C. § 371 date of May 8, 2000, now issued as U.S. Pat. No. 6,371,114), which is a U.S. National Stage Application of PCT/US98/15490, filed 24 Jul. 1998, which claims priority to U.S. Provisional Patent Application Serial No. 60/064,578, filed 4 Nov. 1997 and which also claims priority to (and is a continuation-in-part of) U.S. patent application Ser. No. 08/900,686 filed 25 Jul. 1997, (issued as U.S. Pat. No. 6,532,958). All of the above-identified patent applications are incorporated herein by reference in their respective entireties[0001]
  • FIELD OF THE INVENTION
  • The present invention relates to the field of respiratory oxygen supply systems and methods. More particularly, the present invention provides demand delivery methods and systems that supply respiratory oxygen when the patient is inhaling. [0002]
  • BACKGROUND
  • Respiratory oxygen is delivered to patients in both sub-critical care situations in which oxygen is provided as a supplement to room air that may be inhaled by the patients (often referred to as “supplemental” oxygen delivery) and in critical care situations in which the gases (particularly oxygen) inspired by patients are closely controlled, possibly in connection with blood gas measurements. [0003]
  • Continuous oxygen delivery in sub-critical and critical care is, however, wasteful because oxygen is only needed by patients when they are inhaling and the oxygen delivered at other times is wasted. In supplemental oxygen delivery, the most significant financial cost associated with this waste is found in the increased service visits required by the oxygen provider to replenish the patient's oxygen supply, because the actual cost of the oxygen is only a small fraction of the total cost of the therapy. In critical care environments, the capacity of the oxygen delivery system must be increased to account for the oxygen delivered when the patient is exhaling. [0004]
  • One approach to conserving the oxygen delivered to patients is typically referred to as “demand delivery.” The demand delivery systems respond to a patient's inspiratory effort by attempting to deliver oxygen during the period of inhalation, rather than allow the oxygen to flow to the patient continuously. There are many ways in which this basic concept has been implemented. [0005]
  • A variety of respiration detection systems have been developed in connection with demand delivery systems. Examples of some respiration detectors include a chest belt worn by the patient that generates an electrical signal to trigger the opening of the oxygen supply valve; a hand-activated breathing device attached to a portable gas bottle via a supply hose in which users dispense the oxygen by pushing a button while holding the device next to their mouth; a mechanical chest strap/valve that functions as both an inhalation sensor and delivery device in an oxygen conserving system; and an all-pneumatic, fluidically-controlled device. [0006]
  • Other demand delivery systems use pressure sensors in the oxygen line to monitor line pressure at the nostrils. A small negative pressure, indicative of the onset of inhalation, is often relied on to trigger the release of oxygen. This type of detection scheme has become a standard method of demand delivery and is employed by most systems currently in use. [0007]
  • Yet another approach employs flow sensors to monitor patient respiration. In many of these demand delivery systems, the flow sensors are located in-line with the source of oxygen such that, in addition to monitoring patient respiration, the flow sensors also monitor the amount of oxygen passing through them during the oxygen delivery portion of the cycle. It is, however, difficult (if not impossible) to accomplish both of those functions with a single flow sensor because the flow rates that need to be sensed differ by orders of magnitude. For example, when measured using a nasal cannula, patient respiration may result in flow rates at the flow sensor of about 1 cubic centimeters per minute (cc/min) or less, while the flow rate of oxygen delivered to the patient can be up to about 15 liters per minute (l/min) or more. One significant problem is in sensing inhalation or exhalation simultaneously with the delivery of oxygen in these situations. Examples of this approach are found in U.S. Pat. No. 4,823,788 (Smith et al.) and U.S. Pat. No. 5,558,086 (Smith et al.). [0008]
  • In addition to the above-listed problems, even if the flow sensor has a dynamic range capable of sensing respiration and delivery oxygen, the systems do not allow for correction in the “drift” often associated with such sensors. In other words, over time the accuracy of the sensor may be impaired because of dynamic changes in the flow sensor during use. Because the flow sensors are always in use, monitoring either oxygen flow or respiration, adjustments are difficult if not impossible to make to correct for voltage drift. [0009]
  • Another flow sensor-based demand delivery system is described in U.S. Pat. No. 5,074,299 (Dietz) in which a flow sensor is connected to one port of a nasal cannula while oxygen is delivered through the other port of the cannula. One disadvantage to this approach is that if one side of the patient's nasal cavity is blocked due to an upper respiratory infection or cold, the system will either be unable to effectively deliver oxygen or sense respiration (depending on which port of the cannula is located on the blocked side). [0010]
  • Even if the patient is not experiencing blockage, it may be difficult for the sensor to detect exhalation if the patient is breathing through his or her mouth. The nasal respiratory flow rate is significantly reduced in such patients, and if flow sensing is occurring only through one port in the cannula, it may be too low to be accurately detected. Another disadvantage is that the system requires a more expensive and obscure dual-line cannula. [0011]
  • Regardless of whether pressure or flow sensors are used to detect respiration, shallow respiration can make respiration sensing in systems relying on pressure/flow sensors difficult or impossible because the flow volume and/or flow rate of gases associated with respiration deteriorate as the gases from inhalation or exhalation travel through the lines connecting the patient's respiratory system to the sensor. The flow volume/rate deterioration caused by the lines further reduces the flow volume/rate produced by a patient engaging in shallow respiration. As a result, the respiration sensor may be unable to detect respiration or may detect only a portion of the actual inhalation/exhalation events. [0012]
  • Another problem associated with patients experiencing rapid respiration rates is that some demand delivery systems include a time delay period to prevent sensing of the same inhalation period more than once. These systems operate on the assumption that each inhalation lasts for a predetermined minimum amount of time and the system is prevented from sensing inhalation within the delay period. Because the patient is, however, experiencing rapid respiration, the patient may actually inhale two or more times during the delay period. The effect of such a “lockout” feature is that the patient will receive oxygen during only a fraction of their inhalation events. In addition, if the respirations are rapid and the system delivers oxygen too slowly, the patient may already be exhaling by the time the system begins to deliver oxygen. [0013]
  • SUMMARY OF THE INVENTION
  • The present invention provides respiratory oxygen supply methods and systems. In some aspects, the systems/methods rely on respiration sensors sensing variations in patient respiration to determine when a patient is inhaling and allow for the determination of an inhalation event after exhalation has been determined. In other aspects, the respiration sensors may be advantageously used to detect the presence of oxygen from the oxygen supply. In still other aspects, when the present invention uses a flow sensor as a respiration sensor, the system may automatically correct for variations in the signals provided by the flow sensor using a zero-flow offset signal, thereby improving the accuracy of the system. [0014]
  • In one aspect, the present invention provides a method of delivering respiratory oxygen to a patient by providing an oxygen delivery system including an oxygen delivery device, a respiration sensor, and an oxygen source; placing the delivery device in fluid communication with the respiration sensor and monitoring variations in respiration with the respiration sensor to determine when the patient is inhaling; placing the oxygen source in fluid communication with the delivery device; delivering oxygen to the delivery device from the oxygen source when the patient is inhaling; removing the respiration sensor from fluid communication with the delivery device when delivering oxygen to the delivery device from the oxygen source; placing the respiration sensor in fluid communication with the delivery device after delivering oxygen to the delivery device from the oxygen source; monitoring variations in respiration with the respiration sensor after delivering oxygen to the delivery device from the oxygen source to determine when the patient is exhaling; and resuming the monitoring of variations in respiration with the respiration sensor to determine that the patient is inhaling after determining that the patient has exhaled. [0015]
  • In another aspect, the present invention provides a method of delivering respiratory oxygen to a patient by providing an oxygen delivery system including an oxygen delivery device, a respiration sensor, and an oxygen source; placing the delivery device in fluid communication with the respiration sensor and monitoring variations in respiration with the respiration sensor to determine when the patient is inhaling; placing the oxygen source in fluid communication with the delivery device; delivering oxygen to the delivery device from the oxygen source when the patient is inhaling; removing the respiration sensor from fluid communication with the delivery device when delivering oxygen to the delivery device from the oxygen source; placing the respiration sensor in fluid communication with the delivery device after delivering oxygen to the delivery device from the oxygen source; and monitoring the respiration sensor to detect oxygen in the oxygen source. [0016]
  • In another aspect, the present invention provides a method of delivering respiratory oxygen to a patient by providing an oxygen delivery system including an oxygen delivery device, a flow sensor, and an oxygen source; placing the delivery device in fluid communication with the flow sensor and monitoring variations in respiration with the flow sensor to determine when the patient is inhaling; placing the oxygen source in fluid communication with the delivery device; delivering oxygen to the delivery device from the oxygen source when the patient is inhaling; removing the respiration sensor from fluid communication with the delivery device when delivering oxygen to the delivery device from the oxygen source; placing the flow sensor in fluid communication with the delivery device after delivering oxygen to the delivery device from the oxygen source; monitoring a zero-flow offset signal produced by the flow sensor when it is not in fluid communication with the delivery device; and compensating for drift in the zero-flow offset signal generated by the flow sensor based on the monitoring when the flow sensor is not in fluid communication with the delivery device. [0017]
  • In another aspect, the present invention provides a method of delivering respiratory oxygen to a patient by providing an oxygen delivery system including an oxygen delivery device, a bidirectional flow sensor vented to atmosphere, and an oxygen source; placing the delivery device in fluid communication with the flow sensor and monitoring variations in respiration with the flow sensor to determine when the patient is inhaling; placing the oxygen source in fluid communication with the delivery device; delivering oxygen to the delivery device from the oxygen source when the patient is inhaling; removing the flow sensor from fluid communication with the delivery device when delivering oxygen to the delivery device from the oxygen source; placing the flow sensor in fluid communication with the delivery device after delivering oxygen to the delivery device from the oxygen source; monitoring variations in respiration with the flow sensor when it is in fluid communication with the delivery device to determine when the patient is exhaling before resuming the monitoring of variations in respiration with the flow sensor to determine that the patient is inhaling; monitoring a zero-flow offset signal produced by the flow sensor when it is not in fluid communication with the delivery device; compensating for drift in the zero-flow offset signal generated by the flow sensor based on the monitoring when the flow sensor is not in fluid communication with the delivery device; and monitoring the flow sensor to detect oxygen in the oxygen source when switching the delivery device from fluid communication with either of the oxygen source and the flow sensor. [0018]
  • In another aspect, the present invention provides a system for delivering respiratory oxygen to a patient including a delivery line adapted for connection to an oxygen delivery device located on a patient; a source line adapted for connection to an oxygen source; a respiration sensor; at least one valve in fluid communication with the delivery line, the source line and the respiration sensor; wherein the at least one valve places the delivery line in fluid communication with only one of the source line and the respiration sensor at any given time; means for monitoring the respiration sensor for variations in respiration of a patient; means for determining when the patient is inhaling and exhaling based on the monitoring of the respiration sensor; and means for preventing a determination that the patient is inhaling until after a determination that the patient has exhaled has been made. [0019]
  • In another aspect, the present invention provides a system for delivering respiratory oxygen to a patient including a delivery line adapted for connection to an oxygen delivery device located on a patient; a source line adapted for connection to an oxygen source; a respiration sensor; at least one valve in fluid communication with the delivery line, the source line and the respiration sensor; wherein the at least one valve places the delivery line in fluid communication with only one of the source line and the respiration sensor at any given time; means for monitoring the respiration sensor to detect oxygen in the source line. [0020]
  • As used in connection with the present invention, the terms “supplemental oxygen” and “supplemental respiratory oxygen” refer to oxygen delivered to patients in addition to the oxygen received by the patient through the inspiration of room or ambient air. Because room air contains some oxygen, the supplemental oxygen is provided in addition to the oxygen that would normally be inspired by the patient. [0021]
  • As used in connection with the present invention, the term “blood oxygen content” and “blood oxygen content level” will typically be used to refer to blood oxygen saturation as commonly measured by the percentage of oxygen-saturated hemoglobin (SpO[0022] 2) although it can also refer to any suitable measurement for determining the level of oxygenation in a patient's blood. For example, it will be understood that blood oxygen content can also be obtained based on data from a CO-oximeter. Furthermore, blood oxygen content, can also be obtained based on partial pressures of oxygen (PaO2).
  • As used in connection with the present invention, the term “sub-acute care” refers to care provided to patients that is not intended to treat critical conditions. Typically, sub-acute care is provided to patients in residential settings. “Residential” preferably includes, e.g., homes and long-term care facilities (such as nursing homes). Sub-acute care also includes care delivered in ambulatory situations, i.e., when the patient is engaged in normal activities outside of his or her residence, such as shopping, attending concerts or other events, traveling to appointments with health care professionals, etc. [0023]
  • As used in connection with the present invention, the terms “continuous” and “continuously” (when referring to the measuring of blood oxygen content levels) mean that the blood oxygen content level of the patient will be measured without cessation or at intervals (fixed or variable) that are sufficiently small to provide the advantages of the invention. [0024]
  • These and other features and advantages of the present invention will be apparent upon review of the detailed description of the invention and accompanying drawings.[0025]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a block diagram of one system according to the present invention. [0026]
  • FIG. 2 is a block diagram of one demand delivery module for use in a system such as that depicted in FIG. 1. [0027]
  • FIG. 3[0028] a is a flow diagram of one method according to the present invention.
  • FIG. 3[0029] b is a flow diagram of another method according to the present invention.
  • FIG. 4 is a flow diagram of one method of delivering supplemental oxygen based on whether the measured blood oxygen content data is valid or invalid.[0030]
  • DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS OF THE INVENTION
  • As described above, the present invention provides demand respirating oxygen supply methods and apparatus for use in sub-acute care which maintain healthy blood oxygen saturation in patients by controlled dosing of oxygen with a measured response to the patient's actual blood oxygen content. The dosing can be provided by simple on/off control over the delivery of oxygen or the amount of oxygen delivered to the patient with each inhalation can be varied in response to the patient's need as determined by a more sophisticated control scheme, such as a proportional-integral-derivative (PID) loop control algorithm, that utilizes the difference between the patient's measured blood oxygen content level and a desired or target blood oxygen content level. [0031]
  • The systems and methods of the present invention are particularly directed at patients receiving supplemental oxygen in a sub-acute care environment, more preferably in a residential setting. The needs and considerations of patients receiving supplemental oxygen in sub-acute care differ from those present when providing oxygen to patients in critical care environments, in which the amounts of oxygen delivered to patients are carefully controlled in connection with masks or other enclosures that do not typically allow the patents to inspire room air in uncontrolled manners. In those situations, the fractional amount of inspired oxygen (FIO[0032] 2) is typically controlled by mixing oxygen and air in a blender or other device before delivering the gas to the patient.
  • Among the advantages of the present invention are the significant conservation of oxygen provided by delivering only the amount of oxygen needed to maintain a healthy blood oxygen content and the ability to address therapeutic problems associated with demand delivery systems by providing the correct amount of oxygen to the patient to reduce uncontrolled hypoxic events. [0033]
  • The amounts of oxygen that can be conserved by implementing the methods according to the present invention can be significant, even compared to known demand delivery systems that conserve oxygen by simply turning the supply on or off during a patient's respiration. Studies have reported oxygen savings ratios of from 3:1 to 7:1 for known simple demand delivery systems. In other words, a fixed amount of oxygen can last three to seven times as long as the same amount of oxygen would last in a supplemental oxygen delivery system that does not include a simple demand delivery system. Implementation of the methods according to the present invention by using a demand delivery approach with a feedback control mechanism that responds to a continuous blood oxygenation measurement could provide an oxygen savings ratio of greater than 13:1 while maintaining the patient's SaO[0034] 2 at the 90% level.
  • Other advantages of the methods and apparatus according to the present invention are the ability to integrate the invention with any sub-acute care supplemental oxygen supply system, including both ambulatory and stationary sources. For unlimited volume sources, such as oxygen concentrators and membrane separators, the invention will reduce their size and energy consumption for a given level of therapy. For fixed volume gas sources, such as liquid and high pressure gas, the invention will extend the lifetime of the oxygen supply, thereby significantly decreasing the cost of providing that treatment. [0035]
  • If the system is ambulatory, the present invention can allow for reductions in the size and weight of the oxygen source, thereby increasing the patient's mobility. An added benefit of reducing the size and/or weight of the ambulatory systems is the potential for a better therapeutic outcome. If patients find the smaller, lighter weight systems less cosmetically unattractive they will be more likely to carry and use the systems during ambulatory activities as opposed to not using the systems. Studies have shown that the benefit of supplemental oxygen systems is significantly reduced if the systems are not used on a regular basis. [0036]
  • Another advantage of the invention, method and apparatus, is a reduction in the risk of hypercapnia (carbon dioxide retention) by only providing enough oxygen to reach a predetermined blood oxygen saturation, typically about 90% as measured by a conventional two-color pulse oximeter. [0037]
  • One embodiment of an automated respiratory oxygen supply system is depicted in FIG. 1 and includes a [0038] controller 10, a demand delivery module 12, and a blood oxygen content sensor 14 connected to the patient 16. Oxygen is supplied from an oxygen source 20 to the patient 16 by the demand delivery module 12 through, in the preferred embodiments, a supplemental oxygen delivery device 18. The preferred system may also include a user interface 32 and an alarm 38.
  • The supplemental [0039] oxygen delivery device 18 is preferably a nasal cannula as depicted in FIG. 1, although it will be understood that the supplemental oxygen delivery device can take the form of any device designed to provide supplemental respiratory oxygen to a patient while not preventing the patient from also inspiring room or ambient air in addition to the supplemental respiratory oxygen from an oxygen source. Examples of other supplemental oxygen delivery devices include, but are not limited to: tracheal catheters, nasal masks designed for use with Continuous Positive Airway Pressure (CPAP) systems, vented masks that cover both the nose and the mouth but that allow inspiration of room air in uncontrolled amounts in addition to the supplemental oxygen delivered to the mask, etc.
  • [0040] Oxygen source 20 could be an oxygen concentrator, membrane separator, high pressure cylinder or liquid oxygen dewar. This could also include any portable versions of oxygen sources 20. Other potential sources of oxygen gas suitable for providing supplemental oxygen in sub-acute care in a residential setting and/ambulatory situations may be created in the future and should be considered as being functional with the described invention. As used below, “line” will refer to any connection made between the oxygen source, the described invention and the patient.
  • If the [0041] oxygen source 20 is an oxygen concentrator, typically a continuous low-flow device, usually delivering at most 6 liters/min of 96% oxygen, the system may also include an oxygen storage device to accommodate the periodic higher flows that are necessary to practice the methods described below. If high flow concentrators become available, such a storage device would not be needed.
  • One [0042] controller 10 is an electronic circuit including a software programmable microcontroller as its main component. Depending on the allocation of tasks within the device a number of microcontrollers could be used as a controller 10. In one embodiment, the controller 10 includes a serial data input port, A/D converter, LED driver capabilities and digital I/O pins. One example of a suitable controller is the PIC 16C74A microcontroller from Microchip Technology Inc. of Chandler, Ariz.
  • Those skilled in the art will realize that a great deal of optimization may be done relative to the choice of a microcontroller(s). Specifications, such as power consumption, cost, memory size, clock speed and part availability may alter the choice for a preferred microcontroller. Furthermore, many of the functions described for the microcontroller in the preferred embodiment could be accomplished by using discrete circuits of many types. Additionally, the microcontroller and its peripheral circuitry may be replaced entirely by discrete circuitry, such as programmable logic arrays, A/D converter chips, analog comparators, etc. [0043]
  • The system also includes an [0044] oxygen content sensor 14 for monitoring the blood oxygen content of the patient 16. One suitable sensor 14 includes a sensor control module 14 a and a sensor 14 b typically mounted or attached to the patient 16 by some suitable technique. The information from the oxygen content sensor 14 is fed back to the controller 10 for use in executing the methods according to the present invention. It is preferred, but not required, that the oxygen sensor 14 provide a signal to the system controller 10 in the form of a blood oxygen saturation in percent. The sensor 14 preferably, but not necessarily, processes all of its data internally and the controller 10 preferably processes only error flags and numerical information as described shortly.
  • One [0045] preferred oxygen sensor 14 is a non-invasive sensor such as a two-color pulse oximeter. As used herein, the terms “pulse oximeter” or “oxygen sensor” will include both the optical sensor and the circuitry used to determine blood oxygen saturation levels using the optical sensor. One example of a suitable pulse oximeter is a conventional two-color, OEM-II oximeter module, from Nonin Medical Inc. of Plymouth, Minn., that can measure the percentage of oxygen-saturated hemoglobin, SpO2, in the blood stream of an in vivo respiratory system. The preferred embodiment of the pulse oximeter 14 uses a transmitting sensor that attaches to the user's finger. Alternative embodiments may employ sensors that attach elsewhere on the body.
  • While the pulse oximeter is one preferred non-invasive oxygen sensor, it should be understood that any blood oxygen sensor, invasive or non-invasive, useful for determining blood oxygen content levels (preferably continuously) could be used in connection with the present invention. It should also be apparent to those skilled in the art that technologies on the horizon, such as an implantable, micro-electromechanical (MEMS) blood gas analyzer, may provide the blood oxygen content information needed by the [0046] system controller 10. Furthermore, there may be improvements in pulse oximetry technology, such as the ability to determine the level of carboxyhemoglobin in the blood, that may be useful for the described invention. Use of these new blood oxygen content technologies in oxygen conservers for long-term oxygen therapy should be considered to lie within the scope of the systems and methods of the present invention provided they have the ability to provide suitable blood oxygen content measurements.
  • In one embodiment, the [0047] pulse oximeter 14 deconvolves the optical information into a blood oxygen saturation value, SpO2, in percent. The oximeter 14 outputs a serial data stream with this information to the controller 10 for evaluation. Other important information may also be included in the oximeter data stream, such as the user's pulse rate and error flags that detail the reliability of the SPO2 and pulse rate values.
  • It will be recognized by those skilled in the art that an alternative embodiment may be provided in which the [0048] system controller 10 functions as the sensor control module 14 a. As a result, data evaluation and error handling would be accomplished within the system controller 10 with an appropriate oxygen sensor 14 b being attached to the patient 16.
  • Blood oxygen content measuring in connection with the present invention is described as “continuous” although it will be understood that the measurements made using, e.g., pulse oximeters and other devices, may actually be taken at discrete intervals. As discussed above, “continuous” as used in connection with the measuring of blood oxygen content in the present invention includes measurement of the blood oxygen content levels of the patient at intervals (fixed or variable) that are sufficiently small to provide the advantages of the invention. Preferably the sampling intervals will be less than about five minutes, more preferably less than about one minute, and even more preferably less than about one respiration interval (i.e., the time between the onset of two inhalations by the patient). [0049]
  • The information relating to blood oxygen content provided by the [0050] oxygen sensor 16 is then used by the system controller 10 in combination with the demand delivery module 12 to provide control over the oxygen supplied to the patient 16 from the oxygen source 20 as described in connection with the methods according to the present invention below.
  • A block diagram illustrating the components of one embodiment of a [0051] demand delivery module 12 according to the present invention is depicted in FIG. 2. One component in the demand delivery module 12 is an inhalation or respiration sensor 40 that monitors the respiratory activity of the patient 16 to determine variations in respiration of the patient. It is preferred that the variations in respiration allow the determination of when the patient is inhaling, although other portions of the respiratory cycle may actually be sensed. In other words, inhalation is preferably sensed, but in some cases it may be desirable to determine when inhalation is occurring based on the sensing of some other condition, activity, etc. such as chest movement, exhalation, etc.
  • In one embodiment, the [0052] respiration sensor 40 provides a signal to a respiration sensor/valve controller 42 that, in turn, controls the valve 26 based on additional input from system controller 10 (as will be described in more detail below).
  • The [0053] respiration sensor 40 can take a variety of forms that will be known to those skilled in the art. One type of suitable respiration sensor 40 monitors flow in the line used to supply oxygen to the supplemental oxygen delivery device 18. The sensor 40 in FIG. 2 monitors flow through the valve 26 interposed in the line between the supplemental oxygen delivery device 18 and the oxygen source 20. One suitable flow sensor is a Honeywell AWM2150 Microbridge Mass Airflow Sensor (available from Honeywell Corp., Minneapolis, Minn.).
  • Another feature of the [0054] preferred respiration sensor 40 is the ability to sense bidirectional flow, i.e., flow in each direction through the sensor 40. It is preferred that the flow generated by inhaling causes a voltage output of one polarity from the sensor 40, while flow generated by exhaling causes an output voltage of the opposite polarity. In any event, it is preferred that the sensor 40 be capable of detecting both inspiration and expiration.
  • In addition to the preferred flow sensor, it should be understood that other types of sensors may be utilized to detect variations in respiration, preferably inhalation and exhalation. Those skilled in the art will recognize that pressure transducers, thermistors or infrared detectors may all be used to sense inhalation. In one example, a pressure transducer with the appropriate sensitivity, such as a solid-state piezoresistive, capacitive or electromechanical device, could be used to generate an electrical signal in response to the breathing cycle. In another example, thermistors could be used to detect changes in airflow due to respiration. If the thermistor was sufficiently sensitive, one may be able to ascertain the onset of inhalation by monitoring the temperature of a thermistor (or thermocouple) placed near the nostril. A flow measurement may also be possible with the use of two thermistors in an anemometer configuration. Infrared detectors, such as single element bolometers, could be used as well if they possess the speed and accuracy to distinguish variations in respiration. [0055]
  • The [0056] respiration sensor 40 provides a signal to the respiration sensor/valve controller 42 which compares the signal to a predetermined reference level. The respiration sensor/valve controller 42 identifies the onset of inhalation by triggering when the sensor signal reaches the predetermined reference level. The respiration sensor/valve controller 42 then provides a signal to position the spool of valve 26 so oxygen flows from supply 20 to patient 16 via supplemental oxygen delivery device 18. The spool of the valve 26 remains in this position for a period of time, the “dose time” (D), as specified by the system controller 10. In this manner, a dose of oxygen of duration D can be provided when the patient is inhaling.
  • One [0057] preferred valve 26 of the embodiment of FIG. 2 is a three-way, two-position, solenoid-actuated spool valve having three ports 26 a, 26 b, 26 c. Common port 26 a is connected to the in vivo respiratory system of the patient 16 by the supplemental oxygen delivery device 18. Normally closed port 26 b is connected to the oxygen source 20 and normally open port 26 c is connected to respiration sensor 40 (with the other end of the preferred respiration sensor left open to atmosphere). One preferred valve 26 is manufactured by The Lee Company, of Westbrook, Conn., Model HDI LHDA0523111H.
  • When oxygen is not being supplied to the [0058] patient 16, the spool of the valve 26 is positioned such that common port 26 a and normally open port 26 c are connected so that the respiration sensor 40, supplemental oxygen delivery device 18, and patient 16 are in fluid communication, corresponding to the OFF position of the valve 26. This allows the respiratory effort of the patient 16 to be detected by the respiration sensor 40, through the monitoring of the flow generated in the supplemental oxygen delivery device 18 by inspiratory and expiratory efforts.
  • To supply oxygen to the [0059] patient 16, the spool of the valve 26 is moved so as to connect common port 26 a and normally closed port 26 b, corresponding to the ON position of the valve 26. This, in turn, allows for flow of respiratory oxygen to the patient 16 from supply 20 through the valve 26 and the supplemental oxygen delivery device 18.
  • The ON period for the [0060] valve 26, corresponding to the dosage period as discussed below, is preferably shorter than the inhalation period for the patient. As a result, the patient may often be inhaling after the valve 26 is OFF (i.e., closed). To reduce or prevent multiple openings of the valve 26 during a single inhalation, it is preferred that the valve 26 remain closed until the sensor 40 detects the onset of exhalation. Once exhalation is detected based on the sensor 40, the system can then resume monitoring for the onset of inhalation, whereupon the cycle is repeated.
  • Because the [0061] preferred valve 26 is a 3-port valve, there is a short period after opening or closing the valve 26, (the “bounce period”) where the sensor output voltage spikes or bounces due to oxygen leaking from the normally closed port 26 b to the normally open port 26 c while the valve spool is still moving. Once the valve 26 is fully ON or OFF and the valve spool has stopped moving, the bounce signal disappears. It is preferred that monitoring of the respiration sensor 40 be adjusted to avoid false readings due to the bounce signal after turning the valve 260N or OFF. This adjustment can take the form of a delay in monitoring the signal provided by the sensor 40 after moving the valve 26 between the ON and OFF positions until the bounce signal has passed.
  • In some systems, the bounce signal may be monitored and used advantageously. The bounce signal (whether generated during ON or OFF movement of the valve spool) may be used to detect the presence of oxygen at the [0062] supply 20. No bounce signal may indicate that no oxygen is present because of the lack of pressurized oxygen at normally closed port 26 b. In the preferred embodiment, the bounce signal generated by turning the valve 26 to the OFF position (i.e., closing port 26 b) is used for this check because that bounce signal is typically larger and longer in duration than the bounce signal generated by turning the valve 26 to the ON position (i.e., opening port 26 b).
  • Another advantage of the 3-[0063] port valve 26 is that sensor's zero-flow offset voltage can be checked while the valve 26 is in the ON position. The measured sensor offset voltage signal (Vo) can be used to generate a correction for drift in the sensor offset voltage. After the valve 26 has been ON longer than the valve-ON bounce period, the signal from the respiration sensor 40 can be read and recorded for use in, e.g., a software-generated correction for zero-flow sensor offset voltage. This sensor offset voltage signal is obtained from the respiration sensor 40 when the valve 26 is ON because no flow is to be expected through the respiration sensor 40 under those conditions (port 26 c is closed). In addition, if this offset reading is greater (in absolute value) than a predefined upper limit (VoMAX), this can be used to indicate either sensor 40 or valve 26 failure; e.g., the sensor 40 has drifted too far out of specification, the valve 26 is leaking, the valve 26 is stuck in the OFF position, etc.
  • The [0064] demand delivery module 12 described above is a subsystem that communicates to and receives communication from system controller 10. In the described methods, it receives continually updated values of the dose time D. It will be understood, however, that those skilled in the art could design a demand delivery module 12 which is more or less dependent on the system controller 10 than is described in this embodiment. For example, it may be desirable to construct a system where respiration sensor 40 provides a signal directly to the system controller 10 with no separate respiration sensor/valve controller 42 being provided. The controller 10 would then provide a control signal to valve 26 directly as well as perform the other operations that are described as being performed by the respiration sensor/valve controller 42.
  • Moreover, it should be understood that alternative designs for the connections of the [0065] valve 26, respiration sensor 40, oxygen source 20, and patient 16 may be envisioned by the those skilled in the art. It would be possible to design a system in which an in-line flow sensor and/or three-port, two-way valve are not required. For example, the designs may involve a plurality of valves and sensors. It should be understood that the methods and systems of the described device operate independently from the specific configuration of hardware used for sensing variations in respiration and the specific valve configuration used to control the flow of oxygen.
  • Although the [0066] demand delivery module 12 described above is used to control delivery of supplemental oxygen to a patient from the source 20, the demand delivery module 12 and the methods of operating it as described above could find wider application. For example, they could be used in connection with critical care systems in which FiO2 is to be controlled via the use of masks or other delivery devices used in connection with, e.g., respirators, ventilators, BIPAP (Bilevel Positive Airway Pressure) systems, etc. As a result, the demand delivery module and methods of operating it are not to be limited to use in connection with systems and methods of delivering supplemental oxygen as part of a sub-acute care regime.
  • As long as the data stream from the blood [0067] oxygen content sensor 14 is valid (as described in detail below), the controller 10 can use the data to control delivery of oxygen to the patient. The feedback control can be implemented as a portion of software code contained in the controller 10; however, it could alternatively be a hard-wired controller or combination of hardware and software in other embodiments.
  • There exist a variety of control methods that are of utility in the present method and invention. The goal of any control method is stable operation of the controlled system about a setpoint or desired value. In the preferred embodiment, the desired value is a blood oxygen saturation (SpO[0068] 2) of 90%. One control algorithm, the ON/OFF method, is diagrammed in FIG. 3a. This diagram assumes that the data generated by the blood oxygen content sensor is valid (validity and invalidity of that data is discussed in more detail below).
  • The system measures the patient's blood [0069] oxygen content level 100. With that information, a decision 102 is made. When the measured blood oxygen content level is not below the desired value no oxygen is delivered 104. When the measured blood oxygen content level is below the desired value, oxygen is delivered 106. For example, when the measured blood oxygen content level is not below the desired value, controller 10 sets a dose time of zero (D=0), thereby preventing the delivery of supplemental oxygen. Alternatively, the system may otherwise restrict the flow of oxygen by, e.g., reducing its flow to a very low value in an attempt to conserve the supplemental oxygen source. The reduction in flow can be accomplished using a variable flow valve or by introducing a flow restrictor into the system between the source 20 and the patient 16. When the measured blood oxygen content falls below the desired value, controller 10 delivers supplemental oxygen to the patient 16 by, e.g., setting a non-zero value (D>0) for the dose time or otherwise increasing the flow of oxygen to the patient.
  • As long as the measured blood oxygen content level remains below the desired value, the system provides oxygen when the patient is inhaling. In one relatively simple implementation, the “ON” dose time D could be very long. Preferably, however, the dose time is equal to or shorter than a typical inhalation period, in which case one or more pulses of duration D of oxygen are delivered during inhalation. This ON/OFF control approach is analogous to the operation of a furnace using a mercury switch thermostat, i.e., oxygen delivery is either ON or OFF. [0070]
  • The feedback control algorithm may alternatively use a Proportional-Integral-Derivative (PID) loop as illustrated in FIG. 3[0071] b. Other embodiments could use algorithms based on fuzzy logic, look-up tables, P or PI loops or increment/decrement methods (oxygen delivery that increases or decreases in a preprogrammed fashion relative to setpoint and/or trend). The PID algorithm is fundamentally different from the simple ON/OFF control algorithm in that it uses both the current value of the blood oxygen content and also trend information to determine whether the patient needs supplemental oxygen and, if so, how much oxygen should be delivered when the patient is inhaling. Because of the use of trend information, a system controlled with a PID loop will, at times, deliver oxygen to the patient even if their blood oxygen content is above the desired value; or, at other times, it may not deliver oxygen even if they are below the desired value. An example of when this might occur is when the patient's blood oxygen content was above the desired value, but was also dropping very quickly. In this case, the PID loop would start oxygen delivery before the blood oxygen content actually fell below the desired value. (The ON/OFF method would not start oxygen delivery until after the blood oxygen content was below the desired value). This may allow a PID control method to more effectively reduce the fluctuations of the blood oxygen content about the desired value.
  • A simplified flow diagram of one such PID control system is illustrated in FIG. 3[0072] b where the data stream of the measured blood oxygen content level sensor is assumed to be valid (validity/invalidity of that data is discussed in more detail below). The system measures the patient's blood oxygen content level 110. The current information is compared with earlier data 112 to determine how much oxygen (i.e., a variable dose), based on the parameters of the PID loop 114, should be delivered to the patient 116. In some instances, the parameters of the PID loop indicate that no oxygen is to be delivered 118, and in other instances some variable dose of oxygen will be delivered based on the parameters of the PID loop.
  • The preferred systems for implementing the methods of the present invention use a digital controller. As a result, discretization of the following continuous-time PID control equation must be performed: [0073]
  • D(t)=K p *[e(t)+(1/T i)*∫e(t′)dt′+(T d)*de/dt]  (1)
  • where D(t) is the oxygen dose time at time t, K[0074] p is the loop proportional gain, Ti is the integral time, Td is the derivative time, and where the integral is integrated over the range of from zero to t. The preferred embodiment utilizes a first order discretization of the continuous time PID equation. This can be seen in Equation 2,
  • D(t n)=D(t n−1)+A 0 e(t n)+A 1 e(t n−1)+A 2 e(t n−2)  (2)
  • where D(t[0075] n) is the control signal (oxygen dose time) generated for time period tn, e(tn) is the difference between the desired level of blood oxygen saturation (the setpoint) and the measured level at time tn. The coefficients, A0, A1, and A2 are given by Equations 3-5 below:
  • A 0 =K p*(1+t n /t i +t d /t n)  (3)
  • A 1 =−K p*(1+2*t d /t n)  (4)
  • A 2 =K p*(t d /t n)  (5)
  • where K[0076] p is the loop proportional gain, ti is the integral time, td is the derivative time and tn is the period of the measurement (one second if using the preferred oximeter).
  • As mentioned, the quantity e(t[0077] n) is the difference between the SpO2 value at time tn and the desired value. In one embodiment, a fixed setpoint of SpO2=90% is used for the desired value. The control algorithm will specify doses of oxygen in order to maintain the blood oxygen saturation at this level. It is thought that this saturation level may provide the necessary correction to the patient's hypoxemia, while at the same time conserving the greatest amount of oxygen. It should be apparent to those skilled in the art that the desired value (setpoint) can be changed to achieve different therapeutic and economic goals.
  • Moreover, a system that uses additional physiological parameters, such as pulse rate or respiratory rate, in addition to blood oxygen content as determined by the oxygen sensor to determine a target blood oxygen level (setpoint) that changes on a rolling basis could also be implemented. For example, one may use the heart rate to monitor the patient's activity level and therefore anticipate increased or decreased need of oxygen and adjust the setpoint accordingly. Such schemes would be seeking to ameliorate the possible increased/decreased hypoxemia caused by a change in physical activity level. Such changes to the setpoint should be considered to be within the spirit and scope of the present invention. [0078]
  • Referring now to Equations 3-5 above, the transfer function coefficients A[0079] 0, A1 and A2 are determined by the settings of loop proportional gain Kp, the integral time ti, the derivative time td and the time between data points tn. The determination of these values will typically be accomplished through clinical monitoring of COPD patients while the system is in use. The specific values of these loop parameters will depend on design goals such as loop stability, overshoot, time-to-achieve-control, and accuracy. Methods for obtaining values which provide for effective operation of the control loop will be known to those skilled in the art.
  • In one method, the control signal D(t[0080] n) is the dose time needed to maintain the blood oxygen level at the desired value. The dose time signal is provided by controller 10 to respiration sensor/valve controller 42. It is the duration of time that valve 26 will be held in the ON or open position which permits oxygen to pass from supply 20 to patient 16 (via the supplemental oxygen delivery device 18 illustrated in FIGS. 1 and 2). A dose of oxygen of duration D(tn) is provided during inhalation (as indicated by respiration sensor 40 and sensor and valve controller 42, described previously).
  • It should be understood that other methods besides varying the dose time could also be employed to control the patient's blood oxygen content. For example, a system which includes a variable-flow valve (as opposed to the preferred open/closed valve) could be constructed. In such a system, the [0081] controller 10 could specify the oxygen flow level. The specified flow could, in turn, be provided for a fixed period of time at the onset of each breath, or continuously. During those times in which the patient does not require supplemental oxygen and/or is not inhaling, the flow could be restricted to a low level or to zero followed by periods in which the flow is higher (when the patient is in need of supplement oxygen and is inhaling).
  • Alternately, the blood oxygen content could be controlled by providing a dose of oxygen on one or more sequential breaths and then delivering no oxygen on one or more subsequent breaths. In this method, the control parameter could be described as the number of breaths during which oxygen is or is not delivered. It should be understood that those skilled in the art could construct a control scheme which uses any of these alternate methods or a combination of these methods. [0082]
  • The [0083] controller 10 also may include a minimum limit (Dmin) for the dose time. If the dose time D(tn), as determined by Equation 2, is less than Dmin, a dose time of Dmin will be used instead. In one embodiment, Dmin will be zero. The dose time D(tn) determined by Equation 2 will, at times, be negative. This will primarily occur when the patient's blood oxygen content is greater than the desired value. Since a negative dose time is not physically meaningful, the controller will instead substitute a dose time of Dmin. Of course, Dmin could also be greater than zero.
  • Similarly, in one embodiment the [0084] controller 10 would also have a maximum limit (Dmax). If the dose time D(tn), as determined by Equation 2, is greater than Dmax, a dose time of Dmax is used instead. In one embodiment, Dmax is equal to twice the default dose (described in detail below). This prevents the application of excessive amounts of oxygen and thus minimizes the patient's risk of hypercapnia (carbon-dioxide retention). Those skilled in the art will appreciate that other values of Dmax could also be used.
  • In another embodiment, the [0085] controller 10 could include an “anti wind-up” provision. Because the dose time may have minimum and maximum limits (Dmin and Dmax, described above), it may be advantageous to include an anti wind-up provision to prevent the integral portion of the PID-calculated dose time from getting too large or too small. One way this could be implemented is as follows: If the previous PID-calculated dose time D(tn−1) (from Equations 2-7) is less than Dmin or greater than Dmax, the integral term from Equation 3 is deleted (i.e., Equation 3 is replaced with Equation 3a, below):
  • A 0 =K p*(1+t d /t n)  (3a)
  • In systems and methods according to the present invention, the ability to respond to periods of invalid or bad data in the blood oxygen content measurements is preferably provided. In the preferred methods and systems, the delivery of oxygen moves from the closed loop control described herein to open loop control based on the criteria described herein (i.e., default values, interpolated data, etc.) and back to closed loop control when the blood oxygen measurements are again valid. FIG. 4 illustrates these concepts. As shown, the system obtains a measured blood [0086] oxygen content level 120. A decision is then made as to whether the measured blood oxygen content level data is valid or invalid 122. The system may determine whether the measured blood oxygen content level data is invalid on a point-by-point basis or it may determine whether the data stream (including a plurality of data points) is invalid as discussed below. Regardless, a decision will be made as to whether the measured blood oxygen content level data is valid. If the measured blood oxygen content level data is invalid, the system will deliver a default amount of oxygen to the patient 124. If the measured blood oxygen content level data is valid, the system will deliver oxygen to the patient 126 according to the appropriate control algorithm (ON/OFF, PID loop, etc.).
  • In other words, the methods/systems according to the present invention will determine when the blood oxygen content data is invalid, deliver a default amount of oxygen during periods of invalid data, and then resume delivery of supplemental oxygen based on blood oxygen content when that data is again valid. The ability of the systems and methods of the present invention to move from closed to open and back to closed loop control provides a robust system that can operate with a minimum of supervision from medical personnel. Those qualities are essential in any system designed for residential or ambulatory use by sub-acute patients. [0087]
  • The following description illustrates some preferred methods for accomplishing these features, but it should be understood that in its essence the present invention provides for that movement from closed loop control to open loop control and back to closed loop control based on the presence of valid or invalid blood oxygen content measurements. [0088]
  • In one embodiment, before the measured blood oxygen saturation reading (SpO[0089] 2) is used for determining the dose time D of oxygen to be delivered to the patient 16 from the oxygen source 20, various error handling and artifact detection procedures are followed to prevent erroneous over- or under-dosing of oxygen to the patient. In one embodiment of the present invention, the error flags provided by the oxygen sensor 14 in the serial data stream are combined with a numerical analysis of the SpO2 data to create an artifact detection and handling scheme.
  • The serial data stream of the preferred [0090] pulse oximeter 14 provides one data point per second. Each data point includes three bytes of information, as follows:
    1st byte = Status Bit 7 = Always set to “1”
    Bit 6 = Sensor disconnected, set if true
    Bit 5 = out of track, set if true
    Bit 4 = low perfusion, set if true
    Bit 3 = marginal perfusion, set if true
    Bit 2 = bad pulse, set if true
    Bit
    1 = heart rate bit 8
    Bit 0 = heart rate bit 7
    2nd byte = Heart Rate (511 = bad data) Bit “7” is always set to “0”
    Heart Rate Data = Bits 0-6
    Plus bits 0 & 1 of status byte to provide 9 bits
    of resolution
    3rd byte = SpO2 (127 = bad data)
  • The first byte of the data point may include error flags for some problems associated with pulse oximetry. These flags are examined for the occurrence of a disconnected sensor, low or marginal perfusion, out of track oximeter and bad pulse. If any of these flags are set, the accompanying SPO[0091] 2 and heart rate data is considered bad. If the data point is determined to be bad, a timer (Timer1) is started by the controller 10 (unless it is already running based on an earlier bad data point) which then waits for the next data point. The function of Timer1 is to track the cumulative time over which consecutive bad data points are being received. Timer1 is stopped and reset to zero each time a valid or good data point is received.
  • If, however, none of the flags is set, a second error check may be performed using a statistical analysis of the data. The new data point is compared to a mean value of previous data points which represents the patient's current blood oxygen content. The details of the calculation of this mean value are described below. The current data point is subtracted from the mean value to generate a difference, ΔSpO[0092] 2 in %. (For the data-validity analysis below, if ΔSpO2 is less than zero, its absolute value is used.)
  • If the absolute value of ΔSpO[0093] 2>4% and Timer1 equals zero (i.e., the last data point was valid), then the current data point is determined to be invalid. Since the time between data points in the serial data stream will be about one second, a change larger than 4 percent in the SpO02 in such a short time would be physiologically impossible. If the data point is determined to be invalid using this procedure, the data is ignored, Timer1 is started and controller 10 waits for the next data point.
  • If, however, the absolute value of ΔSpO[0094] 2>4% and Timer1 does not equal zero, then additional evaluation may be performed. The observed rate of oxygen desaturation in humans can approach 20%/minute or about 3% every 10 seconds. If Timer1 is less than 10 seconds and the absolute value of ΔSpO2>4%, then the data is considered to be invalid. If Timer1 is greater than 10 seconds, but less than 20 seconds then the acceptance criteria is absolute value of ΔSpO2 less than 8% for the data to be valid. If Timer1 is greater than 20 seconds, but less than 30 seconds then the acceptance criteria is absolute value of ΔSpO2 less than 12%. If Timer1 is greater than 30 seconds, then oxygen is delivered using the default method which is described in detail below. It should, of course, be understood that, in the above analysis, the specific values of 4%, 8%, and 12%, and the specific times of 10, 20 and 30 seconds could be replaced with different values.
  • Some alternate criteria for identifying when individual data points are invalid or bad could include, but are not limited to, identifying an invalid data point when: (a) the SpO[0095] 2 value is outside upper and/or lower limits (e.g., a lower limit of about 70% and/or an upper limit of about 98%); or (b) the heart rate is outside upper and/or lower limits (e.g., a lower limit of about 40 beats per minute and/or an upper limit of about 200 beats per minute).
  • If the data point passes all the tests, Timer1 is stopped and set to zero (if necessary) and the new mean value of blood oxygen content is calculated with the most recent data point. The new mean value is then compared to the setpoint and a dose time D is calculated as detailed above in Equations 2-5. [0096]
  • In one embodiment, an exponentially-weighted arithmetic mean of the previous data points is used to represent the current blood oxygen content. The new mean is calculated as follows: [0097]
  • new mean=(current data point)*W1+(previous mean)*W2  (6)
  • where [0098]
  • W1=1−exp (−Δt/T)W2=exp (−Δt/T)  (7)
  • Here Δt is the time between data points (one second using the preferred oximeter), and T is a parameter which represents an appropriate time scale for the averaging. If an appropriate value of T is chosen, the exponentially-weighted mean will smooth out normal point-to-point “noise” fluctuations in the pulse oximeter data without masking the real trends related to the patient's blood oxygen content. (A typical value would be T=10 seconds, although other values could be used.) [0099]
  • Other methods could also be used to determine a mean value that is representative of the patient's current blood oxygen content. For example, a harmonic, or geometric mean might be used. (Descriptions of these types of means can be found in “Standard Mathematical Tables” by CRC Press, 24th edition, pages 470-471.) Alternately, a “running” mean might be used. In this method, the mean of a fixed, predetermined number of the most-recent data points could be used. For example, with the preferred pulse oximeter which delivers one data point per second, one could average the preceding [0100] 10 data points, thus calculating a mean which represents the patient's blood oxygen content for the previous 10 seconds.
  • In one embodiment, the dose time D of oxygen that is delivered to the user may depend on the validity of the data stream from the oxygen sensor. If the time over which the consecutive invalid or bad data points are received, as indicated by Timer1, exceeds a predetermined, physiologically-relevant time scale for patient desaturation (referred to as Desattime), alternative, “default” oxygen delivery procedures are employed. In one embodiment Desattime is equal to 30 seconds. The default assumption is that a patient is always in need of oxygen, unless the blood oxygen content sensor positively indicates that they are not. [0101]
  • If the current oxygen sensor data point is invalid, but Timer1 is less than Desattime, the oxygen dose time D may remain unchanged from its current value. The system will provide a dose of this duration at the onset of inhalation. The process of gathering and evaluating blood oxygen saturation data then continues. Prior to the onset of invalid data, the system was either administering oxygen to correct a deficiency or the patient was in no need of oxygen. Thus, in this embodiment it is assumed that the patient's oxygen needs have not changed during this short time of invalid data and the status quo is maintained. If the patient was receiving no oxygen prior to the invalid data (e.g., dose time D=0), the system will not administer any oxygen. If, however, the patient was receiving oxygen (e.g., D>0), the system will typically continue to administer the same dose by responding to inhalation as described above. This will preferably continue until either a valid data point is received and a reevaluation can be made of the patient's condition or Timer1 exceeds Desattime. [0102]
  • If the oxygen sensor data points continue to be invalid and Timer1 exceeds Desattime, then the device will default to another oxygen delivery method. In the default method, the [0103] controller 10 will default to administering a prescription-equivalent dose of oxygen to the patient 16 from the oxygen source 20 via the demand delivery module 12. This default dose of oxygen could take many forms: In one embodiment, the default could be a continuous flow of oxygen. To implement this, the system could output a very large dose time to hold valve 26 in the ON position which allows oxygen to flow from source 20 to patient 16. Alternately, in the preferred embodiment, the default mode would provide a short dose of oxygen (of duration D=Ddefault) at the onset of inhalation for almost every breath. In this preferred embodiment, Ddefault would be shorter than a typical inhalation period, in which case the system would provide pulses of duration Ddefault synchronized with each inhalation (demand mode). This will continue until such time as the blood oxygen content data is valid and closed-loop control over oxygen delivery can start anew.
  • It is possible to envision additional alternate methods of default flow. In one such alternate embodiment, the valve does not necessarily open with each and every breath. It should be understood that these alternate methods of implementing a default flow still fall within the scope of the present invention. The object of the default method is to provide a total flow of oxygen during this period of default operation that is no less than the physiological equivalent amount that is prescribed to the patient by the physician. (Physiological equivalence meaning the amount dispensed by other demand delivery devices to provide adequate oxygen therapy.) It should be understood that the notion of physiological equivalence as regards demand delivery devices will change over time as their effects on the physiology of COPD patients is better understood by the medical community. Current practice indicates that 35 ml delivered every other breath at the beginning of inhalation is equivalent to a continuous flow of 2 liters/minute of pure oxygen. [0104]
  • In one embodiment of the invention, the duration of the default dose (Ddefault) may be set by the patient's respiratory therapist using a hardware switch on the [0105] user interface 32 that is not accessible to the patient. Other techniques of setting the pulse width may be possible, such as a remote controllers, push buttons, etc.
  • Also, in one embodiment, if Timer1 exceeds Desattime, then the previous mean value of the blood oxygen saturation is reset and data acquisition starts anew. In this way, it is assumed that the old SpO[0106] 2 information is no longer valid for the patient's current physical state and that to properly administer oxygen a more current measure of the blood oxygen level is needed. Thus, by using Timer1, a period of invalid data that exceeds Desattime will always lead to the administration of oxygen to the patient. This will correct any undetected desaturation events. Moreover, the controller 10 will always use the most current, valid information regarding the patient's blood oxygen level.
  • It should also be understood that other methods for recognizing and handling erroneous data points from the oxygen sensor could be devised. Those skilled in the art could create different algorithms for handling invalid data points, such as replacement of invalid data points with interpolated values based on the recent trend in the blood oxygen saturation. Alternative methods of identifying and rejecting invalid data points should be considered to be within the scope of the present method and system. [0107]
  • Another method for determining whether the oxygen sensor data is valid or invalid can be based on the data stream (a plurality of data points) rather than the individual data points. For example, instead of tracking the time since the most recent valid data point or points, the system could instead determine if the data stream is valid or invalid by comparing the number of valid data points in a “look-back” window (for example, the 60 to 100 most recent data points) to a preset minimum threshold. If the number of valid data points in the look-back period is greater than or equal to the specified minimum, the data stream is considered to be valid and the calculated dose is delivered; if the number of valid data points is less than the minimum, the default dose is delivered. [0108]
  • Those skilled in the art will understand that a wide range of possibilities for oxygen delivery in default mode beyond those that have been described here could be used. Although they are not described in detail herein, they should be considered as falling within the scope of the methods according to the present invention. [0109]
  • If invalid data is a problem, the [0110] controller 10 may be used to notify the patient of a problem with the pulse oximetry via the user interface 32 and/or alarm 38. This notification may take the form of a warning light, readout, buzzer or some combination of these. Those skilled in the art may also conceive of other methods of warning the user that are not detailed herein. After the warnings have been issued and default demand flow mode entered, the controller 10 resumes monitoring the output of the oxygen sensor for valid data.
  • Along with monitoring the breathing cycle for oxygen delivery, the invention makes provision for the detection of apnea, the cessation of breathing for a prolonged period of time. Timer2 starts each time an inhalation is detected. If the elapsed time between breaths is greater than a predetermined time, e.g., 15 seconds, as determined by Timer2, then the [0111] alarm circuit 38 is activated by the controller 10 to signal the patient of a possible apneic event. These alarms preferably stop sounding upon detection of the next inhalation.
  • Other alarms and indicators that can be included in the systems and methods of the present invention include hypoxia alarms, high respiration rate alarms, high/low pulse rate alarms, and patient monitoring indicators. These alarms and/or indicators can be used to warn the patient that their supplemental oxygen equipment is not operating properly, they are not using it properly, or they are having other problems and need to seek medical treatment. [0112]
  • In the case of an hypoxia alarm, the patient could be provided with a visible and/or audible alert when their blood oxygen saturation level has been below a healthy level for a period of time—even though they have been using the above-described device. This condition could be caused, e.g., by a malfunctioning of the supplemental oxygen equipment or a worsening of the patient's respiratory condition. In normal operation of the preferred embodiment as described above, the device would increase the dose time D(t) in response to the patient's hypoxia, up to a preset upper-limit dose time Dmax. It is possible that the patient's condition could have worsened so much so that even this maximum dose is not sufficient to keep their blood oxygen saturation at a healthy level. It would be advantageous to alert the patient to this condition so they may seek appropriate medical attention. This could enable earlier detection and treatment of potentially dangerous and costly health conditions. [0113]
  • The hypoxia alarm could be implemented in software, hardware, or in a combination of software and hardware. In the methods described above, the [0114] controller 10 may already calculate a mean value of blood oxygen content from the valid blood oxygen saturation data points. In the preferred embodiment, the mean value that is already calculated is an exponentially-weighted arithmetic mean with a typical time constant T=10 seconds. This mean represents the average blood oxygen saturation for the previous 10 seconds. For the hypoxia alarm, a second mean value of blood oxygen saturation, for a longer period (e.g. T=1 hour) could be calculated in an analogous manner. In the preferred embodiment, this hypoxia alarm mean would also be an exponentially-weighted mean because it eliminates the need to store each of the many data points that would be collected over the longer period, thereby decreasing the memory requirements.
  • It should be understood, however, that other methods of calculating a mean as discussed above could also be used. When the second mean falls below a preset limit representing the lower limit for healthy blood oxygen levels (e.g., 88%), [0115] controller 10 could alert the patient via alarm circuit 38. In the preferred embodiment, the time period for the second mean is 1 hour, and the lower limit for blood oxygen saturation is 88%; however, it should be clear that other values could be used for these parameters.
  • In the case of a high respiration rate alarm, the patient could be provided with a visible and/or audible alert when their respiration rate has been above a healthy level for a period of time. Some patients with respiratory diseases will compensate for an impaired respiratory system by maintaining a higher than normal breathing rate. These patients can sometimes maintain a healthy blood oxygen saturation, but over the long term, the increased respiration rate is also detrimental to their health. The onset of a period of increased respiration rate could be caused by a malfunctioning of the supplemental oxygen equipment or a worsening of the patient's respiratory condition. [0116]
  • In normal operation of the preferred embodiment as described above, the device increases the dose time D(t) in response to the patient's hypoxia. It is possible that the patient's condition could have worsened, but the patient is compensating by breathing at a higher rate. As with hypoxia, it would be advantageous to alert the patient to this condition so they may seek appropriate medical attention. [0117]
  • This alarm could be implemented in software, hardware, or in a combination of software and hardware. The system described above already measures the elapsed time between each breath via Timer2. For the high-respiration rate alarm, a mean value of the elapsed time between each breath could be calculated in a manner analogous to the mean blood oxygen levels. In the preferred embodiment, this mean would also be an exponentially-weighted mean. It should be understood, however, that other methods of calculating a mean as described above could also be used. When the mean elapsed time between breaths falls below a preset limit corresponding to the upper limit for healthy respiration rates (e.g., minimum elapsed time of two seconds, corresponding to a breathing rate of 30 breaths per minute), the system could alert the patient via [0118] controller 10 and alarm circuit 38. In the preferred embodiment, the time period for calculating the mean is 1 hour, and the lower limit for elapsed time between breaths is 2 seconds (30 breaths per minute); however, it should be clear that other values could be used for these parameters.
  • In the case of a high/low pulse rate alarm, a visible and/or audible alert could be provided to the patient when their pulse rate has been above or below healthy levels for a period of time. Excessively high or low pulse rates could be an important indication that the patient needs medical treatment. It would be advantageous to alert the patient to these conditions so they may seek appropriate medical attention. [0119]
  • In the preferred embodiment, these alarms would be implemented in software, hardware, or in a combination of software and hardware. The preferred oxygen sensor typically provides pulse rate data (in addition to blood oxygen data). A mean pulse rate could be calculated in a manner analogous to the calculation of other means, described above. As with the other alarms, in the preferred embodiment, this mean would also be an exponentially-weighted mean or, alternatively, other means or averages could be used. [0120]
  • When the mean pulse rate falls above or below preset limits (e.g., less than 40 or above 180 beats per minute), the system could alert the patient via [0121] alarm circuit 38. In the preferred embodiment, the time period for the mean is 20 minutes, the lower limit for pulse rate is 40 beats per minute, and the upper limit for pulse rate is 180 beats per minute; however, it should be clear that other values could be used for these parameters.
  • Among the indicators that could be provided include various patient and equipment monitoring functions. In the preferred embodiment, these indicators could be implemented in software, hardware, or in a combination of software and hardware. The information provided by these indicators could be useful to the patients, respiratory therapists, physicians, etc. Some examples of indicators are described below. [0122]
  • One indicator that could be useful is an “ON-time” indicator. An important factor in treating patients that require supplemental oxygen is monitoring their compliance with their oxygen prescription. Some patients will not use their oxygen equipment as much as they should. Medical studies have shown that most patients must use their supplemental oxygen equipment at least 18 hours per day in order to receive significant benefits from it. The ON-time parameter would indicate the total amount of time that the device has been powered ON (analogous to the “hour meter” found on most oxygen concentrators), thus giving an indication of the total time the equipment was used since the ON-time parameter was last reset to zero. In the preferred embodiment, a timer would be started by [0123] controller 10 each time the unit was turned ON. When timer reached a value of, e.g., one minute, controller 10 would increment a non-volatile memory location and reset and restart the timer. In this manner, a memory location associated with the ON-time timer would count the number of minutes the apparatus had been powered ON. The memory location associated with the ON-time timer would preferably be non-volatile and, as a result, the total minute count would be retained while the unit was powered OFF. When powered ON again, counting would resume from the previously accumulated value. In the preferred embodiment, the ON-time timer could be accessed and reset via the user interface 32.
  • It may also be useful to track the total number of times each alarm condition has occurred. In the preferred embodiment, a separate non-volatile memory location would be used to count the number of times each alarm condition had occurred. Each time an alarm condition occurred, the associated memory location would be incremented. In addition to the three alarms described above, the preferred embodiment could also count the number of apnea alarms. The various alarm-count parameters could be accessed and reset, e.g., via the [0124] user interface 32.
  • It may also be useful to keep track of the total amount of time the unit was in “default” mode as described above. In a manner similar to tracking ON-time, the default time monitor would preferably consist of a non-volatile memory location that would be incremented each time the timer reached one minute and the unit was in the default mode. In a similar manner, a feedback-control-time parameter could be calculated (although this parameter may be more easily obtained by subtracting the default time from the ON-time). As with the other monitored parameters, default time would preferably be accessed and reset via the [0125] user interface 32.
  • It may also be useful to keep track of the total number of times the apparatus entered the “default” mode. In the preferred embodiment, a separate non-volatile memory location would be used to count the number of times the default delivery condition had occurred. Each time the apparatus entered the default delivery mode, the associated memory location would be incremented. The default count parameter would preferably be accessed and reset via the [0126] user interface 32.
  • It may also be useful to keep track of the total amount of time the patient was hypoxic (e.g., SpO[0127] 2<88%). In a manner similar to tracking the ON-time, the hypoxic-time monitor would consist of a non-volatile memory location that would be incremented each time the timer reached one minute and the patient was hypoxic (and the SpO2 data was deemed valid). As with the other monitored parameters, hypoxic-time could be accessed and reset via the user interface 32.
  • It may also be useful to keep track of the average duration of the pulses of oxygen that are provided at each inhalation (i.e., the average dose time). The average-dose-time parameter could provide a useful indication of the amount of supplemental oxygen that was required to keep the patient's blood properly oxygenated. Trends in this parameter could be useful for tracking the overall efficiency of the patient's respiratory condition. For example, a measurable increase in the average-dose-time (i.e., an increase in the amount of supplemental oxygen needed) could indicated a worsening of the patient's condition, and thus provide an early warning allowing the patient to seek medical attention before their condition required a costly hospitalization. [0128]
  • In the preferred embodiment, two nonvolatile memory locations would be used to calculate average-dose-time: a counter and an accumulator. Each time, e.g., an inhalation was sensed, the current dose time (as indicated by controller [0129] 10) would be added to accumulator and the counter would be incremented. The average-dose-time could then be calculated by dividing the accumulator value by the counter value. As with the other monitored parameters, average-dose-time could be accessed and reset via the user interface 32.
  • In addition to those parameters specifically recited herein, other useful parameters may also be generated. For example, average SpO[0130] 2 (the patient's average blood oxygen saturation); average respiration rate; average heart rate; etc. Monitoring of these parameters could also be implemented in software, hardware, or in a combination of software and hardware.
  • Various methods and systems for conserving supplemental oxygen delivery to a sub-acute patient based on continuous blood oxygen content measurements and inhalation have been described above. Many changes, alterations and variations of the subject invention will become apparent to those skilled in the art after consideration of this specification and the accompanying figures and diagrams of the preferred embodiments. For example, the values chosen for, e.g., ΔSpO[0131] 2, Timer1, Timer2, etc., are intended to be exemplary of some preferred values and should not limit the scope of the invention unless the values are explicitly recited in the claims. All such changes, modifications, variations, etc. are deemed to be covered by the claims which follow.

Claims (80)

1. A portable oxygen delivery control apparatus for controlling a flow of oxygen to a user in an open-loop breathing system including an oxygen supply and a delivery apparatus for delivering supplemental oxygen to a user comprising:
an oximeter arranged to measure a blood-oxygen saturation level of a user and provide an output signal indicative of said blood-oxygen saturation level;
a valve, a first port of said valve adapted to be connected to said oxygen supply and a second port adapted to be connected to said delivery apparatus, said valve having a first position permitting oxygen to flow from said supply to said delivery apparatus, and a second position preventing oxygen from flowing from said supply to said delivery apparatus;
a pressure sensor, said sensor associated with a said valve, said sensor arranged to detect a period of inhalation by said user by detecting a condition of reduced pressure associated with said delivery apparatus for delivering supplemental oxygen to a user when said valve is in said second position;
a selector adapted to accept a target blood-oxygen saturation level;
a flow sensor, said flow sensor positioned along a flow path between said oxygen supply and said delivery apparatus, said flow sensor configured to generate information regarding a flow rate of oxygen delivered from said oxygen supply to said user; and
a processor arranged to calculate a time period which said valve should be maintained in its first position to cause a desired amount of oxygen to be delivered to said user when said oximeter indicates a blood-oxygen saturation level which is below said goal blood-oxygen saturation level and arranged to generate a signal for said time period, which signal applied to said valve moves said valve to said first position and causes oxygen to be delivered to said user when a condition of inhalation is detected by said pressure sensor, and said signal when removed from said valve causes said valve to be moved to said second position.
2. The apparatus in accordance with claim 1 including a memory associated with said processor, said memory configured to store flow rate information.
3. The apparatus in accordance with claim 1 wherein said processor, flow sensor, valve and pressure sensor are associated with said processor and said selector comprises a user-actuatable input.
4. The apparatus in accordance with claim 1 wherein said pressure sensor comprises a diaphragm exposed to the atmosphere on opposing sides so as to be altitude correcting.
5. A method of controlling a flow of supplemental oxygen from an oxygen supply to a user through a delivery apparatus in an open-loop breathing system, the delivery apparatus including a valve moveable between a first position permitting oxygen to flow from said supply to said user and a second position for preventing oxygen to flow from said supply to said user comprising the steps of:
receiving a goal blood-oxygen saturation level of a user;
determining an actual blood-oxygen saturation level of a user;
determining a length of time said valve should be moved to said first position in order to deliver a desired quantity of oxygen to achieve said goal blood-oxygen saturation level based upon said actual blood-oxygen saturation level;
detecting the initiation of inhalation by said user;
moving said valve from said second position to said first position for said determined length of time when said inhalation is detected;
returning said valve to said second position; and
generating information regarding an average flow rate of oxygen delivered from said supply to said user;
determining if a change in average flow rate exceeds a predetermined amount and, if so, triggering an alarm.
6. The method in accordance with claim 5 wherein said step of determining a blood-oxygen saturation level comprises measuring a blood-oxygen saturation level of said user with a pulse-oximeter.
7. The method in accordance with claim 5 wherein said step of determining the initiation of inhalation by a user comprises sensing a drop in pressure at said delivery apparatus.
8. The method in accordance with claim 5 wherein said predetermined amount comprises a predetermined percentage change in average flow rate.
9. The method in accordance with claim 5 wherein said step of triggering an alarm comprises illuminating a light.
10. The method in accordance with claim 5 wherein said step of triggering an alarm comprises emitting an audible noise.
11. The method in accordance with claim 5 including the step of storing flow rate information received from said output of said flow sensor and utilizing said stored information to generate said average flow rate.
12. The method in accordance with claim 5 wherein said step of generating information regarding an average flow rate comprises generating flow rate information with a flow sensor and utilizing said flow rate information to generate information regarding average flow rate.
13. A method of controlling a flow of oxygen from an oxygen supply to a user comprising the following steps:
providing an amount of oxygen to a user in a breathing system, said amount of oxygen determined by comparing a desired blood-oxygen content level with a measured blood-oxygen content level, said amount of oxygen delivered to said user when a period of inhalation of said user is detected, said amount of oxygen provided to said user continuously automatically adjusted based upon said desired and measured blood-oxygen content levels; and
determining an average dose time, said average dose time indicative of the average flow rate of oxygen delivered to said user and triggering an alarm if said average dose time changes by an amount exceeding a predetermined amount.
14. The method in accordance with claim 13 including the step of opening a valve to provide said amount of oxygen.
15. A method of controlling a flow of supplemental oxygen from an oxygen supply to a user through a delivery apparatus in an open-loop breathing system, the delivery apparatus including a valve moveable between a first position to flow from said supply to said user and a second position for preventing oxygen to flow from said supply to said user, comprising the steps of:
receiving a goal blood-oxygen saturation level of a user;
determining an actual blood-oxygen saturation level of a user;
determining a breath rate of said user;
sensing periods of inhalation by said user;
determining a length of time said valve should be moved to said first position in order to deliver a desired quantity of oxygen, said determining step comprising determining a maximum time said valve should be moved to said first position, determining a minimum time said valve should be moved to said first position, and determining a variable time said valve should be moved to said first position;
detecting the initiation of inhalation by said user; and
moving said valve from said second position to said first position for said determined length of time; and
returning said valve to said second position.
16. The method in accordance with claim 15 wherein said step of determining a blood oxygen saturation level comprises measuring a blood-oxygen saturation level of said user with a pulse-oximeter.
17. The method in accordance with claim 15 wherein said step of determining the initiation of inhalation by a user comprises sensing a drop in pressure at said delivery apparatus.
18. The method in accordance with claim 15 wherein said desired quantity of oxygen comprises a maximum quantity when said actual blood-oxygen saturation level is below said goal blood-oxygen saturation level.
19. The method in accordance with claim 15 wherein said desired quantity of oxygen comprises a linearly changing quantity between a minimum quantity corresponding to said minimum time and a maximum quantity corresponding to said maximum time.
20. The method in accordance with claim 15 wherein said step of moving said valve comprises applying a signal to said valve causing said valve to be retained in its first position for said determined length of time.
21. A portable oxygen delivery control apparatus for controlling a flow of oxygen to a user in an open-loop breathing system including an oxygen supply and a delivery apparatus for delivering supplemental oxygen to a user comprising:
an oximeter arranged to measure a blood-oxygen saturation level of a user and provide an output signal indicative of said blood-oxygen saturation level;
a valve, a first port of said valve adapted to be connected to said oxygen supply and a second port adapted to be connected to said delivery apparatus, said valve having a first position permitting oxygen to flow from said supply to said delivery apparatus, and a second position preventing oxygen from flowing from said supply to said delivery apparatus;
a pressure sensor, said sensor associated with a said valve, said sensor arranged to detect a period of inhalation by said user;
a selector adapted to accept a target blood-oxygen saturation level;
an average dose time calculator adapted to determine an amount of oxygen delivered to said user from said oxygen supply; and
a processor arranged to calculate a dose time period which said valve should be maintained in its first position to cause a desired amount of oxygen to be delivered to said user when said oximeter indicates a blood-oxygen saturation level which is below said goal blood-oxygen saturation level and arranged to generate a signal for said dose time period, which signal applied to said valve moves said valve to said first position and causes oxygen to be delivered to said user when a condition of inhalation is detected by said pressure sensor, and said signal when removed from said valve causes said valve to be moved to said second position, and said processor configured to utilize average dose time information generated by said average dose time calculator and trigger an alarm in the event said amount of oxygen delivered to said user from said oxygen supply meets a predetermined criteria.
22. The apparatus in accordance with claim 21 including a memory associated with said processor, said memory configured to store said average dose time information.
23. The apparatus in accordance with claim 21 wherein said alarm comprises an audible warning.
24. The apparatus in accordance with claim 21 wherein said alarm comprises a visual warning.
25. The apparatus in accordance with claim 21 wherein said processor, flow sensor, valve and pressure sensor are associated with a printed circuit board located within a housing and said selector comprises a user-actuatable input extending from said housing.
26. The apparatus in accordance with claim 21 wherein said pressure sensor comprises a diaphragm exposed to the atmosphere on opposing sides so as to be altitude correcting.
27. A method of controlling a flow of supplemental oxygen from an oxygen supply to a user through a delivery apparatus in an open-loop breathing system, the delivery apparatus including a valve moveable between a first position permitting oxygen to flow from said supply to said user and a second position for preventing oxygen to flow from said supply to said user comprising the steps of:
receiving a goal blood-oxygen saturation level of a user;
determining an actual blood-oxygen saturation level of a user;
determining a length of time said valve should be moved to said first position in order to deliver a desired quantity of oxygen to achieve said goal blood-oxygen saturation level based upon said actual blood-oxygen saturation level;
detecting the initiation of inhalation by said user;
moving said valve from said second position to said first position for said determined length of time when said inhalation is detected;
returning said valve to said second position;
generating information regarding an average dose time of oxygen delivered from said supply to said user; and
determining if a change in said average dose time exceeds a predetermined amount and, if so, triggering an alarm.
28. The method in accordance with claim 27 wherein said step of determining a blood-oxygen saturation level comprises measuring a blood-oxygen saturation level of said user with a pulse-oximeter.
29. The method in accordance with claim 27 wherein said step of determining the initiation of inhalation by a user comprises sensing a drop in pressure at said delivery apparatus.
30. The method in accordance with claim 27 wherein said step of triggering an alarm comprises illuminating a light.
31. The method in accordance with claim 27 wherein said step of triggering an alarm comprises emitting an audible noise.
32. The method in accordance with claim 27 including the step of storing current dose time information and utilizing said stored current does time information to generate said average dose time.
33. A portable oxygen delivery control apparatus for controlling a flow of oxygen to a user in an open-loop breathing system including an oxygen supply and a delivery apparatus for delivering supplemental oxygen to a user comprising:
an oximeter arranged to measure a blood-oxygen saturation level of a user and provide an output signal indicative of said blood-oxygen saturation level;
a valve, a first port of said valve adapted to be connected to said oxygen supply and a second port adapted to be connected to said delivery apparatus, said valve having a first position permitting oxygen to flow from said supply to said delivery apparatus, and a second position preventing oxygen from flowing from said supply to said delivery apparatus;
a pressure sensor, said sensor associated with a said valve, said sensor including a diaphragm exposed to the atmosphere on opposing sides so as to be altitude correcting and arranged to detect a period of inhalation by said user by detecting a condition of reduced pressure associated with said delivery apparatus for delivering supplemental oxygen to a user when said valve is in said second position;
a selector adapted to accept a target blood-oxygen saturation level;
a flow sensor, said flow sensor positioned along a flow path between said oxygen supply and said delivery apparatus, said flow sensor configured to generate information regarding a flow rate of oxygen delivered from said oxygen supply to said user; and
a processor arranged to calculate a time period which said valve should be maintained in its first position to cause a desired amount of oxygen to be delivered to said user when said oximeter indicates a blood-oxygen saturation level which is below said goal blood-oxygen saturation level and arranged to generate a signal for said time period, which signal applied to said valve moves said valve to said first position and causes oxygen to be delivered to said user when and a condition of inhalation is detected by said pressure sensor, and said signal when removed from said valve causes said valve to be moved to said second position, and said processor configured to utilize flow rate information generated by said flow sensor and trigger an alarm in the event said utilized flow rate information meets a predetermined criteria.
34. The apparatus in accordance with claim 33 including a memory associated with said processor, said memory configured to store flow rate information.
35. The apparatus in accordance with claim 33 wherein said alarm comprises an audible warning.
36. The apparatus in accordance with claim 33 wherein said alarm comprises a visual warning.
37. The apparatus in accordance with claim 33 wherein said processor, flow sensor, valve and pressure sensor are associated with a printed circuit board located within a housing and said selector comprises a user-actuatable input extending from said housing.
38. A method of controlling a flow of supplemental oxygen from an oxygen supply to a user through a delivery apparatus in an open-loop breathing system, the delivery apparatus including a valve moveable between a first position permitting oxygen to flow from said supply to said user and a second position for preventing oxygen to flow from said supply to said user comprising the steps of:
receiving a goal blood-oxygen saturation level of a user;
determining an actual blood-oxygen saturation level of a user;
determining a length of time said valve should be moved to said first position in order to deliver a desired quantity of oxygen to achieve said goal blood-oxygen saturation level based upon said actual blood-oxygen saturation level;
detecting the initiation of inhalation by said user;
moving said valve from said second position to said first position for said determined length of time when said inhalation is detected;
returning said valve to said first position; and
generating at two or more times information regarding an average flow rate of oxygen delivered from said supply to said user;
determining if a change in average flow rate exceeds a predetermined amount and, if so, triggering an alarm.
39. The method in accordance with claim 38 wherein said step of determining a blood-oxygen saturation level comprises measuring a blood-oxygen saturation level of said user with a pulse-oximeter.
40. The method in accordance with claim 38 wherein said step of determining the initiation of inhalation by a user comprises sensing a drop in pressure at said delivery apparatus.
41. The method in accordance with claim 38 wherein said predetermined amount comprises a predetermined percentage change in average flow rate.
42. The method in accordance with claim 38 wherein said step of triggering an alarm comprises illuminating a light.
43. The method in accordance with claim 38 wherein said step of triggering an alarm comprises emitting an audible noise.
44. The method in accordance with claim 38 including the step of storing flow rate information received from said output of said flow sensor and utilizing said stored information to generate said average flow rate.
45. The method in accordance with claim 38 wherein said step of generating information regarding an average flow rate comprises generating flow rate information with a flow sensor and utilizing said flow rate information to generate information regarding average flow rate.
46. A method of controlling a flow of oxygen from an oxygen supply to a user comprising the following steps:
providing an amount of oxygen to a user in a breathing system, said amount of oxygen determined by comparing a desired blood-oxygen content level with a measured blood-oxygen content level, said amount of oxygen delivered to said user when a period of inhalation of said user is detected, said amount of oxygen provided to said user continuously automatically adjusted based upon said desired and measured blood-oxygen content levels; and
determining an average flow rate of oxygen delivered to said user and triggering an alarm if said overage flow rate of oxygen changes by an amount exceeding a predetermined amount.
47. The method in accordance with claim 46 including the step of opening a valve to provide said amount of oxygen.
48. The method in accordance with claim 46 including the step of utilizing flow rate data received as an output of a flow sensor to calculate said average flow rate.
49. The method in accordance with claim 46 including the step of storing said flow rate data.
50. A method of controlling a flow of supplemental oxygen from an oxygen supply to a user through a delivery apparatus in an open-loop breathing system, the delivery apparatus including a valve moveable between a first position to flow from said supply to said user and a second position for preventing oxygen to flow from said supply to said user, comprising the steps of:
receiving a goal blood-oxygen saturation level of a user;
determining an actual blood-oxygen saturation level of a user;
determining a breath rate of said user;
sensing periods of inhalation by said user;
determining a length of time said valve should be moved to said first position in order to deliver a desired quantity of oxygen, said determining step comprising determining a first maximum time if said actual level has not reached said goal level or said actual level is below a minimum level, determining a second minimum time if said actual level is above said goal level, and determining a variable time if said actual level has at least once reached said goal level but said actual level is between said minimum level and said goal level, said step of determining a variable time including determining a breath rate of said user from said sensed periods of inhalation by said user, determining a delivery volume comprising a desired quantity of oxygen divided by said breath rate, and determining said variable time by dividing said delivery volume by a flow rate of supplemental oxygen available;
detecting the initiation of inhalation by said user; and
moving said valve from said second position to said first position for said determined length of time; and
returning said valve to said first position.
51. The method in accordance with claim 50 wherein said step of determining a blood oxygen saturation level comprises measuring a blood-oxygen saturation level of said user with a pulse-oximeter.
52. The method in accordance with claim 50 wherein said step of determining the initiation of inhalation by a user comprises sensing a drop in pressure at said delivery apparatus.
53. The method in accordance with claim 50 wherein said desired quantity of oxygen comprises a maximum quantity when said actual level is below said minimum level.
54. The method in accordance with claim 50 wherein said desired quantity of oxygen comprises a linearly changing quantity between a minimum quantity corresponding to said minimum time and a maximum quantity corresponding to said maximum time.
55. The method in accordance with claim 50 wherein said step of moving said valve comprises applying a signal to said valve causing said valve to be retained in its first position for said determined length of time.
56. The method in accordance with claim 50 wherein said determined length of time does not exceed one-half of an inhalation time of said user.
57. A portable oxygen delivery control apparatus for controlling a flow of oxygen to a user in an open-loop breathing system including an oxygen supply and a delivery apparatus for delivering supplemental oxygen to a user comprising:
an oximeter arranged to measure a blood-oxygen saturation level of a user and provide an output signal indicative of said blood-oxygen saturation level;
a valve, a first port of said valve adapted to be connected to said oxygen supply and a second port adapted to be connected to said delivery apparatus, said valve having a first position permitting oxygen to flow from said supply to said delivery apparatus, and a second position preventing oxygen from flowing from said supply to said delivery apparatus;
a pressure sensor, said sensor associated with a said valve, said sensor including a diaphragm exposed to the atmosphere on opposing sides so as to be altitude correcting and arranged to detect a period of inhalation by said user by detecting a condition of reduced pressure associated with said delivery apparatus for delivering supplemental oxygen to a user when said valve is in said second position;
a selector adapted to accept a target blood-oxygen saturation level;
a flow sensor, said flow sensor positioned along a flow path between said oxygen supply and said delivery apparatus, said flow sensor configured to generate information regarding a flow rate of oxygen delivered from said oxygen supply to said user; and
a processor arranged to calculate a time period which said valve should be maintained in its first position to cause a desired amount of oxygen to be delivered to said user when said oximeter indicates a blood-oxygen saturation level which is below said goal blood-oxygen saturation level and arranged to generate a signal for said time period, which signal applied to said valve moves said valve to said first position and causes oxygen to be delivered to said user when a condition of inhalation is detected by said pressure sensor, and said signal when removed from said valve causes said valve to be moved to said second position, and said processor configured to utilize flow rate information generated by said flow sensor and trigger an alarm in the event said utilized flow rate information meets a predetermined criteria.
58. The apparatus in accordance with claim 57 including a memory associated with said processor, said memory configured to store flow rate information.
59. The apparatus in accordance with claim 57 wherein said alarm comprises an audible warning.
60. The apparatus in accordance with claim 57 wherein said alarm comprises a visual warning.
61. The apparatus in accordance with claim 57 wherein said processor, flow sensor, valve and pressure sensor are associated with a printed circuit board located within a housing and said selector comprises a user-actuatable input extending from said housing.
62. A method of controlling a flow of supplemental oxygen from an oxygen supply to a user through a delivery apparatus in an open-loop breathing system, the delivery apparatus including a valve moveable between a first position permitting oxygen to flow from said supply to said user and a second position for preventing oxygen to flow from said supply to said user comprising the steps of:
receiving a goal blood-oxygen saturation level of a user;
determining an actual blood-oxygen saturation level of a user;
determining a length of time said valve should be moved to said first position in order to deliver a desired quantity of oxygen to achieve said goal blood-oxygen saturation level based upon said actual blood-oxygen saturation level;
detecting the initiation of inhalation by said user;
moving said valve from said second position to said first position for said determined length of time when said inhalation is detected;
returning said valve to said second position; and
generating at two or more times information regarding an average flow rate of oxygen delivered from said supply to said user;
determining if a change in average flow rate exceeds a predetermined amount and, if so, triggering an alarm.
63. The method in accordance with claim 62 wherein said step of determining a blood-oxygen saturation level comprises measuring a blood-oxygen saturation level of said user with a pulse-oximeter.
64. The method in accordance with claim 62 wherein said step of determining the initiation of inhalation by a user comprises sensing a drop in pressure at said delivery apparatus.
65. The method in accordance with claim 62 wherein said predetermined amount comprises a predetermined percentage change in average flow rate.
66. The method in accordance with claim 62 wherein said step of triggering an alarm comprises illuminating a light.
67. The method in accordance with claim 62 wherein said step of triggering an alarm comprises emitting an audible noise.
68. The method in accordance with claim 62 including the step of storing flow rate information received from said output of said flow sensor and utilizing said stored information to generate said average flow rate.
69. The method in accordance with claim 62 wherein said step of generating information regarding an average flow rate comprises generating flow rate information with a flow sensor and utilizing said flow rate information to generate information regarding average flow rate.
70. A method of controlling a flow of oxygen from an oxygen supply to a user comprising the following steps:
providing an amount of oxygen to a user in a breathing system, said amount of oxygen determined by comparing a desired blood-oxygen content level with a measured blood-oxygen content level, said amount of oxygen delivered to said user when a period of inhalation of said user is detected, said amount of oxygen provided to said user continuously automatically adjusted based upon said desired and measured blood-oxygen content levels; and
determining an average flow rate of oxygen delivered to said user and triggering an alarm if said average flow rate of oxygen changes by an amount exceeding a predetermined amount.
71. The method in accordance with claim 70 including the step of opening a valve to provide said amount of oxygen.
72. The method in accordance with claim 70 including the step of utilizing flow rate data received as an output of a flow sensor to calculate said average flow rate.
73. The method in accordance with claim 70 including the step of storing said flow rate data.
74. A method of controlling a flow of supplemental oxygen from an oxygen supply to a user through a delivery apparatus in an open-loop breathing system, the delivery apparatus including a valve moveable between a first position to flow from said supply to said user and a second position for preventing oxygen to flow from said supply to said user, comprising the steps of:
receiving a goal blood-oxygen saturation level of a user;
determining an actual blood-oxygen saturation level of a user;
determining a breath rate of said user;
sensing periods of inhalation by said user;
determining a length of time said valve should be moved to said first position in order to deliver a desired quantity of oxygen, said determining step comprising determining a first maximum time if said actual level has not reached said goal level or said actual level is below a minimum level, determining a second minimum time if said actual level is above said goal level, and determining a variable time if said actual level has at least once reached said goal level but said actual level is between said minimum level and said goal level, said step of determining a variable time including determining a breath rate of said user from said sensed periods of inhalation by said user, determining a delivery volume comprising a desired quantity of oxygen divided by said breath rate, and determining said variable time by dividing said delivery volume by a flow rate of supplemental oxygen available;
detecting the initiation of inhalation by said user; and
moving said valve from said second position to said first position for said determined length of time; and
returning said valve to said second position.
75. The method in accordance with claim 74 wherein said step of determining a blood oxygen saturation level comprises measuring a blood-oxygen saturation level of said user with a pulse-oximeter.
76. The method in accordance with claim 74 wherein said step of determining the initiation of inhalation by a user comprises sensing a drop in pressure at said delivery apparatus.
77. The method in accordance with claim 74 wherein said desired quantity of oxygen comprises a maximum quantity when said actual level is below said minimum level.
78. The method in accordance with claim 74 wherein said desired quantity of oxygen comprises a linearly changing quantity between a minimum quantity corresponding to said minimum time and a maximum quantity corresponding to said maximum time.
79. The method in accordance with claim 74 wherein said step of moving said valve comprises applying a signal to said valve causing said valve to be retained in its first position for said determined length of time.
80. The method in accordance with claim 74 wherein said determined length of time does not exceed one-half of an inhalation time of said user.
US10/695,436 1997-07-25 2003-10-28 Control of respiratory oxygen delivery Abandoned US20040159323A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/695,436 US20040159323A1 (en) 1997-07-25 2003-10-28 Control of respiratory oxygen delivery
US11/441,525 US20060213519A1 (en) 1997-07-25 2006-05-26 Control of respiratory oxygen delivery

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/900,686 US6532958B1 (en) 1997-07-25 1997-07-25 Automated control and conservation of supplemental respiratory oxygen
US6457897P 1997-11-04 1997-11-04
US09/463,614 US6371114B1 (en) 1998-07-24 1998-07-24 Control device for supplying supplemental respiratory oxygen
US10/076,001 US6561187B2 (en) 1997-07-25 2002-02-14 Control of supplemental respiratory oxygen
US10/370,799 US7331343B2 (en) 1997-07-25 2003-02-20 Control of supplemental respiratory oxygen
US10/695,436 US20040159323A1 (en) 1997-07-25 2003-10-28 Control of respiratory oxygen delivery

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/370,799 Continuation US7331343B2 (en) 1997-07-25 2003-02-20 Control of supplemental respiratory oxygen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/441,525 Continuation US20060213519A1 (en) 1997-07-25 2006-05-26 Control of respiratory oxygen delivery

Publications (1)

Publication Number Publication Date
US20040159323A1 true US20040159323A1 (en) 2004-08-19

Family

ID=23840713

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/463,614 Expired - Lifetime US6371114B1 (en) 1997-07-25 1998-07-24 Control device for supplying supplemental respiratory oxygen
US10/076,001 Expired - Lifetime US6561187B2 (en) 1997-07-25 2002-02-14 Control of supplemental respiratory oxygen
US10/370,799 Expired - Fee Related US7331343B2 (en) 1997-07-25 2003-02-20 Control of supplemental respiratory oxygen
US10/695,436 Abandoned US20040159323A1 (en) 1997-07-25 2003-10-28 Control of respiratory oxygen delivery
US11/441,525 Abandoned US20060213519A1 (en) 1997-07-25 2006-05-26 Control of respiratory oxygen delivery

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09/463,614 Expired - Lifetime US6371114B1 (en) 1997-07-25 1998-07-24 Control device for supplying supplemental respiratory oxygen
US10/076,001 Expired - Lifetime US6561187B2 (en) 1997-07-25 2002-02-14 Control of supplemental respiratory oxygen
US10/370,799 Expired - Fee Related US7331343B2 (en) 1997-07-25 2003-02-20 Control of supplemental respiratory oxygen

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/441,525 Abandoned US20060213519A1 (en) 1997-07-25 2006-05-26 Control of respiratory oxygen delivery

Country Status (1)

Country Link
US (5) US6371114B1 (en)

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020195105A1 (en) * 2000-01-13 2002-12-26 Brent Blue Method and apparatus for providing and controlling oxygen supply
US20050217668A1 (en) * 2003-10-24 2005-10-06 Pulmonox Technologies Corporation System and elements for managing therapeutic gas administration to a spontaneously breathing non-ventilated patient
US20050234364A1 (en) * 2003-03-28 2005-10-20 Ric Investments, Inc. Pressure support compliance monitoring system
WO2006026387A3 (en) * 2004-08-27 2006-07-13 Univ Johns Hopkins Disposable sleep and breathing monitor
US20060249151A1 (en) * 2005-05-03 2006-11-09 China Resource Group, Inc. Ventilator with rescuer and victim guidance
US20060283450A1 (en) * 2005-06-21 2006-12-21 Ric Investments, Llc. Respiratory device measurement system
US20070077200A1 (en) * 2005-09-30 2007-04-05 Baker Clark R Method and system for controlled maintenance of hypoxia for therapeutic or diagnostic purposes
US20090065007A1 (en) * 2007-09-06 2009-03-12 Wilkinson William R Oxygen concentrator apparatus and method
US20100083968A1 (en) * 2008-10-01 2010-04-08 Breathe Technologies Ventilator with biofeedback monitoring and control for improving patient activity and health
US20100224192A1 (en) * 2009-03-06 2010-09-09 Cardinal Health 207, Inc. Automated Oxygen Delivery Method
US20100224191A1 (en) * 2009-03-06 2010-09-09 Cardinal Health 207, Inc. Automated Oxygen Delivery System
US20110248856A1 (en) * 2010-04-13 2011-10-13 Obenchain Valerie A Gas flow and pressure error alarm
US8061353B2 (en) 2007-03-09 2011-11-22 Global Medical Holdings LLC Method and apparatus for delivering a dose of a gaseous drug to a patient
US20120055474A1 (en) * 2010-09-07 2012-03-08 Wilkinson William R Methods and systems for providing oxygen enriched gas
US8136527B2 (en) 2003-08-18 2012-03-20 Breathe Technologies, Inc. Method and device for non-invasive ventilation with nasal interface
US8381729B2 (en) 2003-06-18 2013-02-26 Breathe Technologies, Inc. Methods and devices for minimally invasive respiratory support
US8418694B2 (en) 2003-08-11 2013-04-16 Breathe Technologies, Inc. Systems, methods and apparatus for respiratory support of a patient
US8485183B2 (en) 2008-06-06 2013-07-16 Covidien Lp Systems and methods for triggering and cycling a ventilator based on reconstructed patient effort signal
US8567399B2 (en) 2007-09-26 2013-10-29 Breathe Technologies, Inc. Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
US8616207B2 (en) 2010-09-07 2013-12-31 Inova Labs, Inc. Oxygen concentrator heat management system and method
US8640699B2 (en) 2008-03-27 2014-02-04 Covidien Lp Breathing assistance systems with lung recruitment maneuvers
US8677999B2 (en) 2008-08-22 2014-03-25 Breathe Technologies, Inc. Methods and devices for providing mechanical ventilation with an open airway interface
US8714154B2 (en) 2011-03-30 2014-05-06 Covidien Lp Systems and methods for automatic adjustment of ventilator settings
US8770193B2 (en) 2008-04-18 2014-07-08 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8776793B2 (en) 2008-04-18 2014-07-15 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8783250B2 (en) 2011-02-27 2014-07-22 Covidien Lp Methods and systems for transitory ventilation support
US8925545B2 (en) 2004-02-04 2015-01-06 Breathe Technologies, Inc. Methods and devices for treating sleep apnea
US8939152B2 (en) 2010-09-30 2015-01-27 Breathe Technologies, Inc. Methods, systems and devices for humidifying a respiratory tract
US8955518B2 (en) 2003-06-18 2015-02-17 Breathe Technologies, Inc. Methods, systems and devices for improving ventilation in a lung area
US8985099B2 (en) 2006-05-18 2015-03-24 Breathe Technologies, Inc. Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer
US9132250B2 (en) 2009-09-03 2015-09-15 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US9180270B2 (en) 2009-04-02 2015-11-10 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within an outer tube
US9440180B2 (en) 2012-10-12 2016-09-13 Inova Labs, Llc Oxygen concentrator systems and methods
US9440179B2 (en) 2014-02-14 2016-09-13 InovaLabs, LLC Oxygen concentrator pump systems and methods
US9440036B2 (en) 2012-10-12 2016-09-13 InovaLabs, LLC Method and systems for the delivery of oxygen enriched gas
WO2017059530A1 (en) * 2015-10-05 2017-04-13 UNIVERSITé LAVAL Method for delivery of breathing gas to a patient and system for performing same
US9717876B2 (en) 2012-10-12 2017-08-01 Inova Labs, Inc. Dual oxygen concentrator systems and methods
US20170304576A1 (en) * 2014-11-19 2017-10-26 Koninklijke Philips N.V. Strap member for a patient interface
US9808591B2 (en) 2014-08-15 2017-11-07 Covidien Lp Methods and systems for breath delivery synchronization
US20170368295A1 (en) * 2016-06-22 2017-12-28 University Of Dammam Nebulizer tubing and a nebulizer system
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
US10058668B2 (en) 2007-05-18 2018-08-28 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
US10099028B2 (en) 2010-08-16 2018-10-16 Breathe Technologies, Inc. Methods, systems and devices using LOX to provide ventilatory support
US10136859B2 (en) 2014-12-23 2018-11-27 Michael Cutaia System and method for outpatient management of chronic disease
US10362967B2 (en) 2012-07-09 2019-07-30 Covidien Lp Systems and methods for missed breath detection and indication
US10821243B2 (en) 2010-04-13 2020-11-03 Advanced Interactive Response Systems, LLC Gas supply warning and communication system
US11458274B2 (en) 2016-05-03 2022-10-04 Inova Labs, Inc. Method and systems for the delivery of oxygen enriched gas
US11478594B2 (en) 2018-05-14 2022-10-25 Covidien Lp Systems and methods for respiratory effort detection utilizing signal distortion
US11511062B2 (en) 2010-04-13 2022-11-29 Advanced Interactive Response Systems LLC Gas supply warning and communication system
US20230007968A1 (en) * 2003-06-20 2023-01-12 ResMed Pty Ltd Device, system, and/or method for treating and monitoring a patient
US11752287B2 (en) 2018-10-03 2023-09-12 Covidien Lp Systems and methods for automatic cycling or cycling detection

Families Citing this family (536)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758503B2 (en) * 1997-01-27 2010-07-20 Lynn Lawrence A Microprocessor system for the analysis of physiologic and financial datasets
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US9468378B2 (en) * 1997-01-27 2016-10-18 Lawrence A. Lynn Airway instability detection system and method
US8932227B2 (en) * 2000-07-28 2015-01-13 Lawrence A. Lynn System and method for CO2 and oximetry integration
US20070191697A1 (en) * 2006-02-10 2007-08-16 Lynn Lawrence A System and method for SPO2 instability detection and quantification
US9521971B2 (en) 1997-07-14 2016-12-20 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US6371114B1 (en) * 1998-07-24 2002-04-16 Minnesota Innovative Technologies & Instruments Corporation Control device for supplying supplemental respiratory oxygen
ATE483490T1 (en) * 1999-06-30 2010-10-15 Univ Florida MONITORING SYSTEM FOR FAN
US20070000494A1 (en) * 1999-06-30 2007-01-04 Banner Michael J Ventilator monitor system and method of using same
US6644312B2 (en) * 2000-03-07 2003-11-11 Resmed Limited Determining suitable ventilator settings for patients with alveolar hypoventilation during sleep
US6938619B1 (en) * 2000-06-13 2005-09-06 Scott Laboratories, Inc. Mask free delivery of oxygen and ventilatory monitoring
US6814073B2 (en) 2000-08-29 2004-11-09 Resmed Limited Respiratory apparatus with improved flow-flattening detection
US6512938B2 (en) * 2000-12-12 2003-01-28 Nelson R. Claure System and method for closed loop controlled inspired oxygen concentration
IL140977A0 (en) * 2001-01-18 2002-02-10 Automed Automatic Dosage Syste Automatically regulating oxygen flow to a patient
US20060195041A1 (en) 2002-05-17 2006-08-31 Lynn Lawrence A Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
US9053222B2 (en) * 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US20030140924A1 (en) * 2001-11-06 2003-07-31 Aylsworth Alonzo C. Therapeutic gas conserver and control
US20070167853A1 (en) * 2002-01-22 2007-07-19 Melker Richard J System and method for monitoring health using exhaled breath
US20080200775A1 (en) 2007-02-20 2008-08-21 Lynn Lawrence A Maneuver-based plethysmographic pulse variation detection system and method
EP1513443B1 (en) 2002-06-20 2012-10-03 University of Florida Perfusion monitor and system, including specifically configured oximeter probes and covers for oximeter probes
US6909912B2 (en) * 2002-06-20 2005-06-21 University Of Florida Non-invasive perfusion monitor and system, specially configured oximeter probes, methods of using same, and covers for probes
DE10230165A1 (en) * 2002-07-04 2004-01-15 Ino Therapeutics Gmbh Method and device for the administration of carbon monoxide
WO2004030723A2 (en) * 2002-10-03 2004-04-15 Scott Laboratories, Inc. Bite block apparatus and method for use with a sedation an analgesia system
KR20040034358A (en) * 2002-10-18 2004-04-28 마츠시타 덴끼 산교 가부시키가이샤 Oxygen enrichment apparatus
US20050010125A1 (en) * 2002-11-26 2005-01-13 Joy James A. Systems and methods for respiration measurement
US20040206352A1 (en) * 2003-04-21 2004-10-21 Conroy John D. System and method for monitoring passenger oxygen saturation levels and estimating oxygen usage requirements
US7246620B2 (en) * 2003-04-21 2007-07-24 Conroy Jr John D System for monitoring pilot and/or passenger oxygen saturation levels and estimating oxygen usage requirements
US20070084897A1 (en) 2003-05-20 2007-04-19 Shelton Frederick E Iv Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism
US9060770B2 (en) 2003-05-20 2015-06-23 Ethicon Endo-Surgery, Inc. Robotically-driven surgical instrument with E-beam driver
DE10337138A1 (en) * 2003-08-11 2005-03-17 Freitag, Lutz, Dr. Method and arrangement for the respiratory assistance of a patient as well as tracheal prosthesis and catheter
JP2007508052A (en) * 2003-10-07 2007-04-05 アイノゲン、インコーポレイテッド Portable gas separation system
US7135059B2 (en) * 2003-10-07 2006-11-14 Inogen, Inc. Portable gas fractionalization system
US20050072423A1 (en) 2003-10-07 2005-04-07 Deane Geoffrey Frank Portable gas fractionalization system
US7066985B2 (en) * 2003-10-07 2006-06-27 Inogen, Inc. Portable gas fractionalization system
US20050072426A1 (en) * 2003-10-07 2005-04-07 Deane Geoffrey Frank Portable gas fractionalization system
US7383105B2 (en) * 2003-10-30 2008-06-03 Conroy Jr John D System and method for monitoring passenger oxygen saturation levels and estimating oxygen usage requirements
US7552731B2 (en) * 2003-11-14 2009-06-30 Remcore, Inc. Remote control gas regulation system
US7802571B2 (en) * 2003-11-21 2010-09-28 Tehrani Fleur T Method and apparatus for controlling a ventilator
EP3066978A1 (en) * 2003-12-30 2016-09-14 Beta Biomed Services, Inc. Method and system of monitoring respiration in an individual
US7222624B2 (en) * 2004-07-02 2007-05-29 Praxair Technology, Inc. Dual sensor oxygen therapy device
US7013898B2 (en) 2004-07-09 2006-03-21 Praxair Technology, Inc. Nasal pressure sensor oxygen therapy device
US8215531B2 (en) 2004-07-28 2012-07-10 Ethicon Endo-Surgery, Inc. Surgical stapling instrument having a medical substance dispenser
US11890012B2 (en) 2004-07-28 2024-02-06 Cilag Gmbh International Staple cartridge comprising cartridge body and attached support
US7455717B2 (en) * 2004-10-25 2008-11-25 Invacare Corporation Apparatus and method of providing concentrated product gas
US20060124128A1 (en) * 2004-11-12 2006-06-15 Deane Geoffrey F Portable intelligent controller for therapeutic gas systems
US20060211981A1 (en) * 2004-12-27 2006-09-21 Integrated Sensing Systems, Inc. Medical treatment procedure and system in which bidirectional fluid flow is sensed
DE102004063698B4 (en) * 2004-12-28 2010-02-04 Dae Systems Gmbh Emergency oxygen system for aircraft passengers
US20060225737A1 (en) * 2005-04-12 2006-10-12 Mr. Mario Iobbi Device and method for automatically regulating supplemental oxygen flow-rate
ITRM20050217A1 (en) * 2005-05-06 2006-11-07 Ginevri S R L PROCEDURE FOR NASAL VENTILATION AND ITS APPARATUS, IN PARTICULAR FOR NEONATAL FLOW-SYNCHRONIZED ASSISTED VENTILATION.
ITMI20050866A1 (en) 2005-05-13 2006-11-14 Marco Ranucci MONITORING SYSTEM FOR CARDIAC SURGERY INTERVENTIONS WITH CARDIOPOLMONARY BYPASS
US20070044799A1 (en) * 2005-07-08 2007-03-01 Hete Bernie F Modular oxygen regulator system and respiratory treatment system
US10159482B2 (en) 2005-08-31 2018-12-25 Ethicon Llc Fastener cartridge assembly comprising a fixed anvil and different staple heights
US7669746B2 (en) 2005-08-31 2010-03-02 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US7934630B2 (en) 2005-08-31 2011-05-03 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US9237891B2 (en) 2005-08-31 2016-01-19 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical stapling devices that produce formed staples having different lengths
US11246590B2 (en) 2005-08-31 2022-02-15 Cilag Gmbh International Staple cartridge including staple drivers having different unfired heights
US11484312B2 (en) 2005-08-31 2022-11-01 Cilag Gmbh International Staple cartridge comprising a staple driver arrangement
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
US8893717B2 (en) 2005-09-21 2014-11-25 Ino Therapeutics Llc Systems and methods of administering a pharmaceutical gas to a patient
US8545416B1 (en) * 2005-11-04 2013-10-01 Cleveland Medical Devices Inc. Integrated diagnostic and therapeutic system and method for improving treatment of subject with complex and central sleep apnea
US7942824B1 (en) * 2005-11-04 2011-05-17 Cleveland Medical Devices Inc. Integrated sleep diagnostic and therapeutic system and method
US20070106317A1 (en) 2005-11-09 2007-05-10 Shelton Frederick E Iv Hydraulically and electrically actuated articulation joints for surgical instruments
US7686870B1 (en) 2005-12-29 2010-03-30 Inogen, Inc. Expandable product rate portable gas fractionalization system
NZ552009A (en) * 2006-01-24 2007-10-26 Devx Tech Ip Ltd Hypoxic training apparatus with gas supply from primary, secondary and tertiary sources
US11224427B2 (en) 2006-01-31 2022-01-18 Cilag Gmbh International Surgical stapling system including a console and retraction assembly
US11793518B2 (en) 2006-01-31 2023-10-24 Cilag Gmbh International Powered surgical instruments with firing system lockout arrangements
US20120292367A1 (en) 2006-01-31 2012-11-22 Ethicon Endo-Surgery, Inc. Robotically-controlled end effector
US20110024477A1 (en) 2009-02-06 2011-02-03 Hall Steven G Driven Surgical Stapler Improvements
US8186555B2 (en) 2006-01-31 2012-05-29 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting and fastening instrument with mechanical closure system
US20110290856A1 (en) 2006-01-31 2011-12-01 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical instrument with force-feedback capabilities
US7845537B2 (en) 2006-01-31 2010-12-07 Ethicon Endo-Surgery, Inc. Surgical instrument having recording capabilities
US7753904B2 (en) 2006-01-31 2010-07-13 Ethicon Endo-Surgery, Inc. Endoscopic surgical instrument with a handle that can articulate with respect to the shaft
US11278279B2 (en) 2006-01-31 2022-03-22 Cilag Gmbh International Surgical instrument assembly
US8820603B2 (en) 2006-01-31 2014-09-02 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
US8708213B2 (en) 2006-01-31 2014-04-29 Ethicon Endo-Surgery, Inc. Surgical instrument having a feedback system
US7668579B2 (en) 2006-02-10 2010-02-23 Lynn Lawrence A System and method for the detection of physiologic response to stimulation
GB2436151B (en) * 2006-03-15 2009-09-30 Honeywell Normalair Garrett Method of controlling a gas separating apparatus
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
US20070283958A1 (en) * 2006-05-23 2007-12-13 Ray Naghavi Positive airway pressure device
US8322455B2 (en) 2006-06-27 2012-12-04 Ethicon Endo-Surgery, Inc. Manually driven surgical cutting and fastening instrument
US20080066752A1 (en) * 2006-09-20 2008-03-20 Nellcor Puritan Bennett Inc. Method and system for circulatory delay compensation in closed-loop control of a medical device
US7506791B2 (en) 2006-09-29 2009-03-24 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with mechanical mechanism for limiting maximum tissue compression
US10568652B2 (en) 2006-09-29 2020-02-25 Ethicon Llc Surgical staples having attached drivers of different heights and stapling instruments for deploying the same
US8728059B2 (en) 2006-09-29 2014-05-20 Covidien Lp System and method for assuring validity of monitoring parameter in combination with a therapeutic device
US11291441B2 (en) 2007-01-10 2022-04-05 Cilag Gmbh International Surgical instrument with wireless communication between control unit and remote sensor
US8652120B2 (en) 2007-01-10 2014-02-18 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and sensor transponders
US8684253B2 (en) 2007-01-10 2014-04-01 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor
US20080169332A1 (en) 2007-01-11 2008-07-17 Shelton Frederick E Surgical stapling device with a curved cutting member
US11039836B2 (en) 2007-01-11 2021-06-22 Cilag Gmbh International Staple cartridge for use with a surgical stapling instrument
US20080200819A1 (en) * 2007-02-20 2008-08-21 Lynn Lawrence A Orthostasis detection system and method
US20080202523A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20090001130A1 (en) 2007-03-15 2009-01-01 Hess Christopher J Surgical procedure using a cutting and stapling instrument having releasable staple-forming pockets
US20080230062A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of exhaled gas volumes
US8893946B2 (en) 2007-03-28 2014-11-25 Ethicon Endo-Surgery, Inc. Laparoscopic tissue thickness and clamp load measuring devices
US8695593B2 (en) * 2007-03-31 2014-04-15 Fleur T. Tehrani Weaning and decision support system for mechanical ventilation
NZ603120A (en) 2007-04-20 2014-01-31 Invacare Corp Product gas concentrator and method associated therewith
US11857181B2 (en) 2007-06-04 2024-01-02 Cilag Gmbh International Robotically-controlled shaft based rotary drive systems for surgical instruments
US8931682B2 (en) 2007-06-04 2015-01-13 Ethicon Endo-Surgery, Inc. Robotically-controlled shaft based rotary drive systems for surgical instruments
US7753245B2 (en) 2007-06-22 2010-07-13 Ethicon Endo-Surgery, Inc. Surgical stapling instruments
US11849941B2 (en) 2007-06-29 2023-12-26 Cilag Gmbh International Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis
US20090133695A1 (en) * 2007-11-27 2009-05-28 Rao Chamkurkishtiah P Mechanical ventilator system
US20090163774A1 (en) * 2007-12-20 2009-06-25 Sudeesh Thatha Managment and Diagnostic System for Patient Monitoring and Symptom Analysis
US8636736B2 (en) 2008-02-14 2014-01-28 Ethicon Endo-Surgery, Inc. Motorized surgical cutting and fastening instrument
US9179912B2 (en) 2008-02-14 2015-11-10 Ethicon Endo-Surgery, Inc. Robotically-controlled motorized surgical cutting and fastening instrument
JP5410110B2 (en) 2008-02-14 2014-02-05 エシコン・エンド−サージェリィ・インコーポレイテッド Surgical cutting / fixing instrument with RF electrode
US7819298B2 (en) 2008-02-14 2010-10-26 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with control features operable with one hand
US8758391B2 (en) 2008-02-14 2014-06-24 Ethicon Endo-Surgery, Inc. Interchangeable tools for surgical instruments
US7866527B2 (en) 2008-02-14 2011-01-11 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with interlockable firing system
US8573465B2 (en) 2008-02-14 2013-11-05 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical end effector system with rotary actuated closure systems
US11272927B2 (en) 2008-02-15 2022-03-15 Cilag Gmbh International Layer arrangements for surgical staple cartridges
US9770245B2 (en) 2008-02-15 2017-09-26 Ethicon Llc Layer arrangements for surgical staple cartridges
US7722698B2 (en) 2008-02-21 2010-05-25 Delphi Technologies, Inc. Method of determining the purity of oxygen present in an oxygen-enriched gas produced from an oxygen delivery system
US20090211443A1 (en) * 2008-02-21 2009-08-27 Youngblood James H Self-serviceable filter for an oxygen generating device
US20090214393A1 (en) * 2008-02-22 2009-08-27 Chekal Michael P Method of generating an oxygen-enriched gas for a user
US8075676B2 (en) 2008-02-22 2011-12-13 Oxus America, Inc. Damping apparatus for scroll compressors for oxygen-generating systems
EP2363163A1 (en) * 2008-03-27 2011-09-07 Nellcor Puritan Bennett LLC Device for controlled delivery of breathing gas to a patient using multiple ventilation parameters
US8267085B2 (en) 2009-03-20 2012-09-18 Nellcor Puritan Bennett Llc Leak-compensated proportional assist ventilation
US8746248B2 (en) 2008-03-31 2014-06-10 Covidien Lp Determination of patient circuit disconnect in leak-compensated ventilatory support
US10207069B2 (en) 2008-03-31 2019-02-19 Covidien Lp System and method for determining ventilator leakage during stable periods within a breath
US8272380B2 (en) * 2008-03-31 2012-09-25 Nellcor Puritan Bennett, Llc Leak-compensated pressure triggering in medical ventilators
US8689788B2 (en) * 2008-04-07 2014-04-08 Uti Limited Partnership Oxygenation procedures for newborns and devices for use therein
US9120050B2 (en) 2008-04-21 2015-09-01 Invacare Corporation Product gas concentrator utilizing vacuum swing adsorption and method associated therewith
US8457706B2 (en) * 2008-05-16 2013-06-04 Covidien Lp Estimation of a physiological parameter using a neural network
TW201000159A (en) * 2008-06-27 2010-01-01 chang-an Zhou Expandable type gas delivering system and gas delivering method thereof
US20090320836A1 (en) * 2008-06-30 2009-12-31 Baker Jr Clark R Method For Regulating Treatment Based On A Medical Device Under Closed-Loop Physiologic Control
US8862194B2 (en) * 2008-06-30 2014-10-14 Covidien Lp Method for improved oxygen saturation estimation in the presence of noise
EP2313136A2 (en) * 2008-07-23 2011-04-27 Chart SeQual Technologies Inc. Self-automated titration system and method
US8551006B2 (en) * 2008-09-17 2013-10-08 Covidien Lp Method for determining hemodynamic effects
US8210411B2 (en) 2008-09-23 2012-07-03 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting instrument
US8915249B2 (en) * 2008-09-23 2014-12-23 Chart Inc. Systems and methods for conserving oxygen in a breathing assistance device
US11648005B2 (en) 2008-09-23 2023-05-16 Cilag Gmbh International Robotically-controlled motorized surgical instrument with an end effector
US9005230B2 (en) 2008-09-23 2015-04-14 Ethicon Endo-Surgery, Inc. Motorized surgical instrument
US9386983B2 (en) 2008-09-23 2016-07-12 Ethicon Endo-Surgery, Llc Robotically-controlled motorized surgical instrument
US20100071696A1 (en) * 2008-09-25 2010-03-25 Nellcor Puritan Bennett Llc Model-predictive online identification of patient respiratory effort dynamics in medical ventilators
US8302602B2 (en) 2008-09-30 2012-11-06 Nellcor Puritan Bennett Llc Breathing assistance system with multiple pressure sensors
NL1036012C (en) * 2008-10-03 2010-04-06 Stephan Arend Hulsbergen MONITORING SYSTEM, RING FITTED WITH SUCH A SYSTEM, AND A SENSOR AND A PROCESSING UNIT AS PART OF THIS SYSTEM.
US8608045B2 (en) 2008-10-10 2013-12-17 Ethicon Endo-Sugery, Inc. Powered surgical cutting and stapling apparatus with manually retractable firing system
DE102009013396B3 (en) * 2009-03-16 2010-08-05 Dräger Medical AG & Co. KG Apparatus and method for controlling the oxygen dosage of a ventilator
US8082312B2 (en) * 2008-12-12 2011-12-20 Event Medical, Inc. System and method for communicating over a network with a medical device
US8517239B2 (en) 2009-02-05 2013-08-27 Ethicon Endo-Surgery, Inc. Surgical stapling instrument comprising a magnetic element driver
US8444036B2 (en) 2009-02-06 2013-05-21 Ethicon Endo-Surgery, Inc. Motor driven surgical fastener device with mechanisms for adjusting a tissue gap within the end effector
CN102341048A (en) 2009-02-06 2012-02-01 伊西康内外科公司 Driven surgical stapler improvements
US8434479B2 (en) * 2009-02-27 2013-05-07 Covidien Lp Flow rate compensation for transient thermal response of hot-wire anemometers
US8424521B2 (en) 2009-02-27 2013-04-23 Covidien Lp Leak-compensated respiratory mechanics estimation in medical ventilators
US8418691B2 (en) * 2009-03-20 2013-04-16 Covidien Lp Leak-compensated pressure regulated volume control ventilation
US20100313888A1 (en) * 2009-06-16 2010-12-16 Inspired Technologies, Inc. Spool valve assembly for delivery of a gaseous drug
US20100313885A1 (en) * 2009-06-16 2010-12-16 Inspired Technologies, Inc. Method of using a spool valve assembly for delivery of a gaseous drug
US9364623B2 (en) * 2009-07-15 2016-06-14 UNIVERSITé LAVAL Method and device for administering oxygen to a patient and monitoring the patient
US8789529B2 (en) 2009-08-20 2014-07-29 Covidien Lp Method for ventilation
US8596270B2 (en) * 2009-08-20 2013-12-03 Covidien Lp Systems and methods for controlling a ventilator
EP2473221B1 (en) 2009-09-03 2020-11-11 Breathe Technologies, Inc. Systems for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US8220688B2 (en) 2009-12-24 2012-07-17 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting instrument with electric actuator directional control assembly
US8851354B2 (en) 2009-12-24 2014-10-07 Ethicon Endo-Surgery, Inc. Surgical cutting instrument that analyzes tissue thickness
BR112012017172A2 (en) * 2010-01-12 2016-03-15 Teijin Pharma Ltd oxygen concentrator
US8171094B2 (en) * 2010-01-19 2012-05-01 Event Medical, Inc. System and method for communicating over a network with a medical device
WO2011127314A2 (en) * 2010-04-07 2011-10-13 Chart Sequal Technologies Inc. Portable oxygen delivery device
US8676285B2 (en) 2010-07-28 2014-03-18 Covidien Lp Methods for validating patient identity
US8783543B2 (en) 2010-07-30 2014-07-22 Ethicon Endo-Surgery, Inc. Tissue acquisition arrangements and methods for surgical stapling devices
WO2012021557A2 (en) * 2010-08-10 2012-02-16 The Regents Of The University Of California Automated fluid delivery system and method
US8554298B2 (en) 2010-09-21 2013-10-08 Cividien LP Medical ventilator with integrated oximeter data
US9320523B2 (en) 2012-03-28 2016-04-26 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprising tissue ingrowth features
US11298125B2 (en) 2010-09-30 2022-04-12 Cilag Gmbh International Tissue stapler having a thickness compensator
US9788834B2 (en) 2010-09-30 2017-10-17 Ethicon Llc Layer comprising deployable attachment members
US11812965B2 (en) 2010-09-30 2023-11-14 Cilag Gmbh International Layer of material for a surgical end effector
US9241714B2 (en) 2011-04-29 2016-01-26 Ethicon Endo-Surgery, Inc. Tissue thickness compensator and method for making the same
US10945731B2 (en) 2010-09-30 2021-03-16 Ethicon Llc Tissue thickness compensator comprising controlled release and expansion
US9364233B2 (en) 2010-09-30 2016-06-14 Ethicon Endo-Surgery, Llc Tissue thickness compensators for circular surgical staplers
US11925354B2 (en) 2010-09-30 2024-03-12 Cilag Gmbh International Staple cartridge comprising staples positioned within a compressible portion thereof
US8777004B2 (en) 2010-09-30 2014-07-15 Ethicon Endo-Surgery, Inc. Compressible staple cartridge comprising alignment members
US9232941B2 (en) 2010-09-30 2016-01-12 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising a reservoir
US9629814B2 (en) 2010-09-30 2017-04-25 Ethicon Endo-Surgery, Llc Tissue thickness compensator configured to redistribute compressive forces
US8695866B2 (en) 2010-10-01 2014-04-15 Ethicon Endo-Surgery, Inc. Surgical instrument having a power control circuit
CA2825128A1 (en) * 2011-03-24 2012-09-27 Oskar Franberg Gas dosing device
BR112013027794B1 (en) 2011-04-29 2020-12-15 Ethicon Endo-Surgery, Inc CLAMP CARTRIDGE SET
US11207064B2 (en) 2011-05-27 2021-12-28 Cilag Gmbh International Automated end effector component reloading system for use with a robotic system
US9072535B2 (en) 2011-05-27 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with rotatable staple deployment arrangements
US20140202455A1 (en) * 2011-08-25 2014-07-24 Koninklijke Philips N.V. Method and apparatus for controlling a ventilation therapy device
US9089657B2 (en) 2011-10-31 2015-07-28 Covidien Lp Methods and systems for gating user initiated increases in oxygen concentration during ventilation
US20130201316A1 (en) 2012-01-09 2013-08-08 May Patents Ltd. System and method for server based control
US9044230B2 (en) 2012-02-13 2015-06-02 Ethicon Endo-Surgery, Inc. Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status
WO2013134645A1 (en) 2012-03-09 2013-09-12 Invacare Corporation System and method for concentrating gas by adsorption
US9067174B2 (en) 2012-03-09 2015-06-30 Invacare Corporation System and method for concentrating gas
US9266053B2 (en) 2012-06-18 2016-02-23 Invacare Corporation System and method for concentrating gas
JP6245613B2 (en) 2012-03-15 2017-12-13 マリンクロット ホスピタル プロダクツ アイピー リミテッド Administration of high concentrations of nitric oxide
MX353040B (en) 2012-03-28 2017-12-18 Ethicon Endo Surgery Inc Retainer assembly including a tissue thickness compensator.
RU2014143258A (en) 2012-03-28 2016-05-20 Этикон Эндо-Серджери, Инк. FABRIC THICKNESS COMPENSATOR CONTAINING MANY LAYERS
CN104334098B (en) 2012-03-28 2017-03-22 伊西康内外科公司 Tissue thickness compensator comprising capsules defining a low pressure environment
US9993604B2 (en) 2012-04-27 2018-06-12 Covidien Lp Methods and systems for an optimized proportional assist ventilation
US9101358B2 (en) 2012-06-15 2015-08-11 Ethicon Endo-Surgery, Inc. Articulatable surgical instrument comprising a firing drive
US9289256B2 (en) 2012-06-28 2016-03-22 Ethicon Endo-Surgery, Llc Surgical end effectors having angled tissue-contacting surfaces
BR112014032776B1 (en) 2012-06-28 2021-09-08 Ethicon Endo-Surgery, Inc SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM
US9282974B2 (en) 2012-06-28 2016-03-15 Ethicon Endo-Surgery, Llc Empty clip cartridge lockout
US9408606B2 (en) 2012-06-28 2016-08-09 Ethicon Endo-Surgery, Llc Robotically powered surgical device with manually-actuatable reversing system
US11202631B2 (en) 2012-06-28 2021-12-21 Cilag Gmbh International Stapling assembly comprising a firing lockout
US20140005718A1 (en) 2012-06-28 2014-01-02 Ethicon Endo-Surgery, Inc. Multi-functional powered surgical device with external dissection features
US20140001231A1 (en) 2012-06-28 2014-01-02 Ethicon Endo-Surgery, Inc. Firing system lockout arrangements for surgical instruments
JP6290201B2 (en) 2012-06-28 2018-03-07 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Lockout for empty clip cartridge
US9700310B2 (en) 2013-08-23 2017-07-11 Ethicon Llc Firing member retraction devices for powered surgical instruments
US9375542B2 (en) 2012-11-08 2016-06-28 Covidien Lp Systems and methods for monitoring, managing, and/or preventing fatigue during ventilation
GB2508897B (en) * 2012-12-14 2016-02-10 Bahram Kandar Oxygen flow controller for medical use
WO2014118653A1 (en) * 2013-01-29 2014-08-07 Koninklijke Philips N.V. Control of neonatal oxygen supply
JP6382235B2 (en) 2013-03-01 2018-08-29 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Articulatable surgical instrument with a conductive path for signal communication
JP6345707B2 (en) 2013-03-01 2018-06-20 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Surgical instrument with soft stop
US9687230B2 (en) 2013-03-14 2017-06-27 Ethicon Llc Articulatable surgical instrument comprising a firing drive
US9629629B2 (en) 2013-03-14 2017-04-25 Ethicon Endo-Surgey, LLC Control systems for surgical instruments
BR112015026109B1 (en) 2013-04-16 2022-02-22 Ethicon Endo-Surgery, Inc surgical instrument
US9649110B2 (en) 2013-04-16 2017-05-16 Ethicon Llc Surgical instrument comprising a closing drive and a firing drive operated from the same rotatable output
MX369362B (en) 2013-08-23 2019-11-06 Ethicon Endo Surgery Llc Firing member retraction devices for powered surgical instruments.
US9675771B2 (en) 2013-10-18 2017-06-13 Covidien Lp Methods and systems for leak estimation
US10869987B2 (en) * 2013-12-20 2020-12-22 B/E Aerospace, Inc Pulse saturation oxygen delivery system and method
US11291868B2 (en) * 2013-12-20 2022-04-05 B/E Aerospace, Inc. Pulse saturation oxygen delivery system and method
EP2893948A1 (en) * 2014-01-10 2015-07-15 Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Methods and systems for providing oxygen to a patient
US9962161B2 (en) 2014-02-12 2018-05-08 Ethicon Llc Deliverable surgical instrument
JP6462004B2 (en) 2014-02-24 2019-01-30 エシコン エルエルシー Fastening system with launcher lockout
US20150272571A1 (en) 2014-03-26 2015-10-01 Ethicon Endo-Surgery, Inc. Surgical instrument utilizing sensor adaptation
US10013049B2 (en) 2014-03-26 2018-07-03 Ethicon Llc Power management through sleep options of segmented circuit and wake up control
BR112016021943B1 (en) 2014-03-26 2022-06-14 Ethicon Endo-Surgery, Llc SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE
US20150272557A1 (en) 2014-03-26 2015-10-01 Ethicon Endo-Surgery, Inc. Modular surgical instrument system
US10327764B2 (en) 2014-09-26 2019-06-25 Ethicon Llc Method for creating a flexible staple line
BR112016023807B1 (en) 2014-04-16 2022-07-12 Ethicon Endo-Surgery, Llc CARTRIDGE SET OF FASTENERS FOR USE WITH A SURGICAL INSTRUMENT
US20150297223A1 (en) 2014-04-16 2015-10-22 Ethicon Endo-Surgery, Inc. Fastener cartridges including extensions having different configurations
US10299792B2 (en) 2014-04-16 2019-05-28 Ethicon Llc Fastener cartridge comprising non-uniform fasteners
JP6636452B2 (en) 2014-04-16 2020-01-29 エシコン エルエルシーEthicon LLC Fastener cartridge including extension having different configurations
CN106456158B (en) 2014-04-16 2019-02-05 伊西康内外科有限责任公司 Fastener cartridge including non-uniform fastener
DE102014107980A1 (en) * 2014-06-05 2015-12-17 Hamilton Medical Ag Ventilation system with mechanical ventilation and extracorporeal blood gas exchange
US11311294B2 (en) 2014-09-05 2022-04-26 Cilag Gmbh International Powered medical device including measurement of closure state of jaws
US10111679B2 (en) 2014-09-05 2018-10-30 Ethicon Llc Circuitry and sensors for powered medical device
BR112017004361B1 (en) 2014-09-05 2023-04-11 Ethicon Llc ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT
US10105142B2 (en) 2014-09-18 2018-10-23 Ethicon Llc Surgical stapler with plurality of cutting elements
US11523821B2 (en) 2014-09-26 2022-12-13 Cilag Gmbh International Method for creating a flexible staple line
MX2017003960A (en) 2014-09-26 2017-12-04 Ethicon Llc Surgical stapling buttresses and adjunct materials.
US10076325B2 (en) 2014-10-13 2018-09-18 Ethicon Llc Surgical stapling apparatus comprising a tissue stop
US9924944B2 (en) 2014-10-16 2018-03-27 Ethicon Llc Staple cartridge comprising an adjunct material
US10517594B2 (en) 2014-10-29 2019-12-31 Ethicon Llc Cartridge assemblies for surgical staplers
US11141153B2 (en) 2014-10-29 2021-10-12 Cilag Gmbh International Staple cartridges comprising driver arrangements
US9844376B2 (en) 2014-11-06 2017-12-19 Ethicon Llc Staple cartridge comprising a releasable adjunct material
US10736636B2 (en) 2014-12-10 2020-08-11 Ethicon Llc Articulatable surgical instrument system
US9987000B2 (en) 2014-12-18 2018-06-05 Ethicon Llc Surgical instrument assembly comprising a flexible articulation system
US9844375B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Drive arrangements for articulatable surgical instruments
BR112017012996B1 (en) 2014-12-18 2022-11-08 Ethicon Llc SURGICAL INSTRUMENT WITH AN ANvil WHICH IS SELECTIVELY MOVABLE ABOUT AN IMMOVABLE GEOMETRIC AXIS DIFFERENT FROM A STAPLE CARTRIDGE
US9844374B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member
US10188385B2 (en) 2014-12-18 2019-01-29 Ethicon Llc Surgical instrument system comprising lockable systems
US10085748B2 (en) 2014-12-18 2018-10-02 Ethicon Llc Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors
US9943309B2 (en) 2014-12-18 2018-04-17 Ethicon Llc Surgical instruments with articulatable end effectors and movable firing beam support arrangements
US10786645B2 (en) * 2014-12-30 2020-09-29 Koninklijke Philips N.V. Capnometry system with supplemental oxygen detection and method of operation thereof
US10007238B1 (en) 2015-01-22 2018-06-26 John C. Taube Oxygen mixing and delivery
EP3242703A4 (en) * 2015-02-18 2018-10-03 Fisher & Paykel Healthcare Corporation Limited Flow therapy system
US20160249910A1 (en) 2015-02-27 2016-09-01 Ethicon Endo-Surgery, Llc Surgical charging system that charges and/or conditions one or more batteries
US10180463B2 (en) 2015-02-27 2019-01-15 Ethicon Llc Surgical apparatus configured to assess whether a performance parameter of the surgical apparatus is within an acceptable performance band
US11154301B2 (en) 2015-02-27 2021-10-26 Cilag Gmbh International Modular stapling assembly
US9993248B2 (en) 2015-03-06 2018-06-12 Ethicon Endo-Surgery, Llc Smart sensors with local signal processing
US10617412B2 (en) 2015-03-06 2020-04-14 Ethicon Llc System for detecting the mis-insertion of a staple cartridge into a surgical stapler
US9901342B2 (en) 2015-03-06 2018-02-27 Ethicon Endo-Surgery, Llc Signal and power communication system positioned on a rotatable shaft
US10548504B2 (en) 2015-03-06 2020-02-04 Ethicon Llc Overlaid multi sensor radio frequency (RF) electrode system to measure tissue compression
US10687806B2 (en) 2015-03-06 2020-06-23 Ethicon Llc Adaptive tissue compression techniques to adjust closure rates for multiple tissue types
JP2020121162A (en) 2015-03-06 2020-08-13 エシコン エルエルシーEthicon LLC Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement
US9924961B2 (en) 2015-03-06 2018-03-27 Ethicon Endo-Surgery, Llc Interactive feedback system for powered surgical instruments
US10441279B2 (en) 2015-03-06 2019-10-15 Ethicon Llc Multiple level thresholds to modify operation of powered surgical instruments
US10245033B2 (en) 2015-03-06 2019-04-02 Ethicon Llc Surgical instrument comprising a lockable battery housing
US9808246B2 (en) 2015-03-06 2017-11-07 Ethicon Endo-Surgery, Llc Method of operating a powered surgical instrument
ES2584915A1 (en) * 2015-03-30 2016-09-30 Universidad De Cádiz Automatic flow dosing device for oxygen therapy equipment (Machine-translation by Google Translate, not legally binding)
FI3259000T3 (en) 2015-03-31 2023-04-12 Apparatus for high gas flow
US10213201B2 (en) 2015-03-31 2019-02-26 Ethicon Llc Stapling end effector configured to compensate for an uneven gap between a first jaw and a second jaw
US20170007789A1 (en) * 2015-07-09 2017-01-12 Chang-An Chou Extendable air delivery system and air delivery method
US10835249B2 (en) 2015-08-17 2020-11-17 Ethicon Llc Implantable layers for a surgical instrument
US10105139B2 (en) 2015-09-23 2018-10-23 Ethicon Llc Surgical stapler having downstream current-based motor control
US10327769B2 (en) 2015-09-23 2019-06-25 Ethicon Llc Surgical stapler having motor control based on a drive system component
US10238386B2 (en) 2015-09-23 2019-03-26 Ethicon Llc Surgical stapler having motor control based on an electrical parameter related to a motor current
US10363036B2 (en) 2015-09-23 2019-07-30 Ethicon Llc Surgical stapler having force-based motor control
US10299878B2 (en) 2015-09-25 2019-05-28 Ethicon Llc Implantable adjunct systems for determining adjunct skew
US10736633B2 (en) 2015-09-30 2020-08-11 Ethicon Llc Compressible adjunct with looping members
US11890015B2 (en) 2015-09-30 2024-02-06 Cilag Gmbh International Compressible adjunct with crossing spacer fibers
US10980539B2 (en) 2015-09-30 2021-04-20 Ethicon Llc Implantable adjunct comprising bonded layers
US10478188B2 (en) 2015-09-30 2019-11-19 Ethicon Llc Implantable layer comprising a constricted configuration
JP6963819B2 (en) * 2015-11-10 2021-11-10 ユニバーシティ・オブ・タスマニアUniversity Of Tasmania How the device operates, the device and the system for automatically controlling inhaled oxygen distribution
WO2017106636A1 (en) * 2015-12-18 2017-06-22 Inova Labs, Inc. Use of an oxygen concentrator for cpap therapy
US10292704B2 (en) 2015-12-30 2019-05-21 Ethicon Llc Mechanisms for compensating for battery pack failure in powered surgical instruments
US10265068B2 (en) 2015-12-30 2019-04-23 Ethicon Llc Surgical instruments with separable motors and motor control circuits
US10368865B2 (en) 2015-12-30 2019-08-06 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10588625B2 (en) 2016-02-09 2020-03-17 Ethicon Llc Articulatable surgical instruments with off-axis firing beam arrangements
JP6911054B2 (en) 2016-02-09 2021-07-28 エシコン エルエルシーEthicon LLC Surgical instruments with asymmetric joint composition
US11213293B2 (en) 2016-02-09 2022-01-04 Cilag Gmbh International Articulatable surgical instruments with single articulation link arrangements
US10448948B2 (en) 2016-02-12 2019-10-22 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US11224426B2 (en) 2016-02-12 2022-01-18 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10258331B2 (en) 2016-02-12 2019-04-16 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
EP3432964B1 (en) 2016-03-25 2022-11-09 Separation Design Group, LLC Positive airway pressure system with integrated oxygen
US11064997B2 (en) 2016-04-01 2021-07-20 Cilag Gmbh International Surgical stapling instrument
US10617413B2 (en) 2016-04-01 2020-04-14 Ethicon Llc Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts
US10426467B2 (en) 2016-04-15 2019-10-01 Ethicon Llc Surgical instrument with detection sensors
US10492783B2 (en) 2016-04-15 2019-12-03 Ethicon, Llc Surgical instrument with improved stop/start control during a firing motion
US10335145B2 (en) 2016-04-15 2019-07-02 Ethicon Llc Modular surgical instrument with configurable operating mode
US11607239B2 (en) 2016-04-15 2023-03-21 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US10357247B2 (en) 2016-04-15 2019-07-23 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US10405859B2 (en) 2016-04-15 2019-09-10 Ethicon Llc Surgical instrument with adjustable stop/start control during a firing motion
US10828028B2 (en) 2016-04-15 2020-11-10 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US10456137B2 (en) 2016-04-15 2019-10-29 Ethicon Llc Staple formation detection mechanisms
US11179150B2 (en) 2016-04-15 2021-11-23 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US10433840B2 (en) 2016-04-18 2019-10-08 Ethicon Llc Surgical instrument comprising a replaceable cartridge jaw
US11317917B2 (en) 2016-04-18 2022-05-03 Cilag Gmbh International Surgical stapling system comprising a lockable firing assembly
US20170296173A1 (en) 2016-04-18 2017-10-19 Ethicon Endo-Surgery, Llc Method for operating a surgical instrument
CN105748069B (en) * 2016-04-21 2018-10-23 罗远明 A kind of centric sleep apnea carbon dioxide inhalation therapy device
WO2018007997A1 (en) 2016-07-08 2018-01-11 Trudell Medical International Smart oscillating positive expiratory pressure device
US10080521B2 (en) 2016-08-01 2018-09-25 Timothy Joshua Parrish Sleep apnea bi-level positive airway pressure machine with advanced diagnostics and self-cleaning capabilities
JP7093353B2 (en) 2016-12-09 2022-06-29 トゥルーデル メディカル インターナショナル Smart nebulizer
US10524789B2 (en) 2016-12-21 2020-01-07 Ethicon Llc Laterally actuatable articulation lock arrangements for locking an end effector of a surgical instrument in an articulated configuration
US20180168625A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Surgical stapling instruments with smart staple cartridges
US10485543B2 (en) 2016-12-21 2019-11-26 Ethicon Llc Anvil having a knife slot width
US10426471B2 (en) 2016-12-21 2019-10-01 Ethicon Llc Surgical instrument with multiple failure response modes
US11134942B2 (en) 2016-12-21 2021-10-05 Cilag Gmbh International Surgical stapling instruments and staple-forming anvils
US10588631B2 (en) 2016-12-21 2020-03-17 Ethicon Llc Surgical instruments with positive jaw opening features
US11419606B2 (en) 2016-12-21 2022-08-23 Cilag Gmbh International Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems
US20180168608A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Surgical instrument system comprising an end effector lockout and a firing assembly lockout
US10888322B2 (en) 2016-12-21 2021-01-12 Ethicon Llc Surgical instrument comprising a cutting member
US20180168598A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Staple forming pocket arrangements comprising zoned forming surface grooves
US10675026B2 (en) 2016-12-21 2020-06-09 Ethicon Llc Methods of stapling tissue
JP6983893B2 (en) 2016-12-21 2021-12-17 エシコン エルエルシーEthicon LLC Lockout configuration for surgical end effectors and replaceable tool assemblies
JP7010956B2 (en) 2016-12-21 2022-01-26 エシコン エルエルシー How to staple tissue
US20180168615A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument
US10588632B2 (en) 2016-12-21 2020-03-17 Ethicon Llc Surgical end effectors and firing members thereof
US10835246B2 (en) 2016-12-21 2020-11-17 Ethicon Llc Staple cartridges and arrangements of staples and staple cavities therein
US10980536B2 (en) 2016-12-21 2021-04-20 Ethicon Llc No-cartridge and spent cartridge lockout arrangements for surgical staplers
US10675025B2 (en) 2016-12-21 2020-06-09 Ethicon Llc Shaft assembly comprising separately actuatable and retractable systems
JP2020501779A (en) 2016-12-21 2020-01-23 エシコン エルエルシーEthicon LLC Surgical stapling system
US10532175B1 (en) * 2019-05-23 2020-01-14 Model Software Corporation Methods for minimizing delayed effects of exposure to reduced oxygen partial pressure via administration of supplemental oxygen
US11617847B2 (en) 2017-01-11 2023-04-04 Model Software Corporation Methods for minimizing delayed effects of exposure to reduced oxygen partial pressure via administration of supplemental oxygen
USD879808S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with graphical user interface
US10624633B2 (en) 2017-06-20 2020-04-21 Ethicon Llc Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument
US11517325B2 (en) 2017-06-20 2022-12-06 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval
US10881399B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument
US11071554B2 (en) 2017-06-20 2021-07-27 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements
US10327767B2 (en) 2017-06-20 2019-06-25 Ethicon Llc Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation
US11653914B2 (en) 2017-06-20 2023-05-23 Cilag Gmbh International Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector
US10881396B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Surgical instrument with variable duration trigger arrangement
US11382638B2 (en) 2017-06-20 2022-07-12 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance
US10888321B2 (en) 2017-06-20 2021-01-12 Ethicon Llc Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument
USD890784S1 (en) 2017-06-20 2020-07-21 Ethicon Llc Display panel with changeable graphical user interface
US10646220B2 (en) 2017-06-20 2020-05-12 Ethicon Llc Systems and methods for controlling displacement member velocity for a surgical instrument
USD879809S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with changeable graphical user interface
US10390841B2 (en) 2017-06-20 2019-08-27 Ethicon Llc Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation
US10779820B2 (en) 2017-06-20 2020-09-22 Ethicon Llc Systems and methods for controlling motor speed according to user input for a surgical instrument
US11090046B2 (en) 2017-06-20 2021-08-17 Cilag Gmbh International Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument
US10813639B2 (en) 2017-06-20 2020-10-27 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions
US10307170B2 (en) 2017-06-20 2019-06-04 Ethicon Llc Method for closed loop control of motor velocity of a surgical stapling and cutting instrument
US10368864B2 (en) 2017-06-20 2019-08-06 Ethicon Llc Systems and methods for controlling displaying motor velocity for a surgical instrument
US10980537B2 (en) 2017-06-20 2021-04-20 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations
US10993716B2 (en) 2017-06-27 2021-05-04 Ethicon Llc Surgical anvil arrangements
US11141154B2 (en) 2017-06-27 2021-10-12 Cilag Gmbh International Surgical end effectors and anvils
US10772629B2 (en) 2017-06-27 2020-09-15 Ethicon Llc Surgical anvil arrangements
US11324503B2 (en) 2017-06-27 2022-05-10 Cilag Gmbh International Surgical firing member arrangements
US11266405B2 (en) 2017-06-27 2022-03-08 Cilag Gmbh International Surgical anvil manufacturing methods
US10856869B2 (en) 2017-06-27 2020-12-08 Ethicon Llc Surgical anvil arrangements
USD854151S1 (en) 2017-06-28 2019-07-16 Ethicon Llc Surgical instrument shaft
US10903685B2 (en) 2017-06-28 2021-01-26 Ethicon Llc Surgical shaft assemblies with slip ring assemblies forming capacitive channels
US11259805B2 (en) 2017-06-28 2022-03-01 Cilag Gmbh International Surgical instrument comprising firing member supports
US10716614B2 (en) 2017-06-28 2020-07-21 Ethicon Llc Surgical shaft assemblies with slip ring assemblies with increased contact pressure
US10211586B2 (en) 2017-06-28 2019-02-19 Ethicon Llc Surgical shaft assemblies with watertight housings
USD906355S1 (en) 2017-06-28 2020-12-29 Ethicon Llc Display screen or portion thereof with a graphical user interface for a surgical instrument
EP4070740A1 (en) 2017-06-28 2022-10-12 Cilag GmbH International Surgical instrument comprising selectively actuatable rotatable couplers
US11246592B2 (en) 2017-06-28 2022-02-15 Cilag Gmbh International Surgical instrument comprising an articulation system lockable to a frame
US10765427B2 (en) 2017-06-28 2020-09-08 Ethicon Llc Method for articulating a surgical instrument
USD851762S1 (en) 2017-06-28 2019-06-18 Ethicon Llc Anvil
USD869655S1 (en) 2017-06-28 2019-12-10 Ethicon Llc Surgical fastener cartridge
US11058424B2 (en) 2017-06-28 2021-07-13 Cilag Gmbh International Surgical instrument comprising an offset articulation joint
US20190000461A1 (en) 2017-06-28 2019-01-03 Ethicon Llc Surgical cutting and fastening devices with pivotable anvil with a tissue locating arrangement in close proximity to an anvil pivot axis
US11564686B2 (en) 2017-06-28 2023-01-31 Cilag Gmbh International Surgical shaft assemblies with flexible interfaces
US11007022B2 (en) 2017-06-29 2021-05-18 Ethicon Llc Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument
US10258418B2 (en) 2017-06-29 2019-04-16 Ethicon Llc System for controlling articulation forces
US10932772B2 (en) 2017-06-29 2021-03-02 Ethicon Llc Methods for closed loop velocity control for robotic surgical instrument
US10898183B2 (en) 2017-06-29 2021-01-26 Ethicon Llc Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing
US10398434B2 (en) 2017-06-29 2019-09-03 Ethicon Llc Closed loop velocity control of closure member for robotic surgical instrument
US11471155B2 (en) 2017-08-03 2022-10-18 Cilag Gmbh International Surgical system bailout
US11304695B2 (en) 2017-08-03 2022-04-19 Cilag Gmbh International Surgical system shaft interconnection
US10796471B2 (en) 2017-09-29 2020-10-06 Ethicon Llc Systems and methods of displaying a knife position for a surgical instrument
USD907648S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
USD917500S1 (en) 2017-09-29 2021-04-27 Ethicon Llc Display screen or portion thereof with graphical user interface
USD907647S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
US11399829B2 (en) 2017-09-29 2022-08-02 Cilag Gmbh International Systems and methods of initiating a power shutdown mode for a surgical instrument
US10765429B2 (en) 2017-09-29 2020-09-08 Ethicon Llc Systems and methods for providing alerts according to the operational state of a surgical instrument
US10729501B2 (en) 2017-09-29 2020-08-04 Ethicon Llc Systems and methods for language selection of a surgical instrument
US10743872B2 (en) 2017-09-29 2020-08-18 Ethicon Llc System and methods for controlling a display of a surgical instrument
US10792449B2 (en) 2017-10-03 2020-10-06 Breathe Technologies, Inc. Patient interface with integrated jet pump
US11134944B2 (en) 2017-10-30 2021-10-05 Cilag Gmbh International Surgical stapler knife motion controls
US11090075B2 (en) 2017-10-30 2021-08-17 Cilag Gmbh International Articulation features for surgical end effector
US10779903B2 (en) 2017-10-31 2020-09-22 Ethicon Llc Positive shaft rotation lock activated by jaw closure
US10842490B2 (en) 2017-10-31 2020-11-24 Ethicon Llc Cartridge body design with force reduction based on firing completion
US11197670B2 (en) 2017-12-15 2021-12-14 Cilag Gmbh International Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed
US10779825B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments
US10687813B2 (en) 2017-12-15 2020-06-23 Ethicon Llc Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments
US10966718B2 (en) 2017-12-15 2021-04-06 Ethicon Llc Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments
US11006955B2 (en) 2017-12-15 2021-05-18 Ethicon Llc End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments
US10743875B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member
US10828033B2 (en) 2017-12-15 2020-11-10 Ethicon Llc Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto
US10779826B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Methods of operating surgical end effectors
US11033267B2 (en) 2017-12-15 2021-06-15 Ethicon Llc Systems and methods of controlling a clamping member firing rate of a surgical instrument
US10869666B2 (en) 2017-12-15 2020-12-22 Ethicon Llc Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument
US11071543B2 (en) 2017-12-15 2021-07-27 Cilag Gmbh International Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges
US10743874B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Sealed adapters for use with electromechanical surgical instruments
US10835330B2 (en) 2017-12-19 2020-11-17 Ethicon Llc Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly
US11020112B2 (en) 2017-12-19 2021-06-01 Ethicon Llc Surgical tools configured for interchangeable use with different controller interfaces
US10729509B2 (en) 2017-12-19 2020-08-04 Ethicon Llc Surgical instrument comprising closure and firing locking mechanism
US11045270B2 (en) 2017-12-19 2021-06-29 Cilag Gmbh International Robotic attachment comprising exterior drive actuator
US10716565B2 (en) 2017-12-19 2020-07-21 Ethicon Llc Surgical instruments with dual articulation drivers
USD910847S1 (en) 2017-12-19 2021-02-16 Ethicon Llc Surgical instrument assembly
US11311290B2 (en) 2017-12-21 2022-04-26 Cilag Gmbh International Surgical instrument comprising an end effector dampener
US11076853B2 (en) 2017-12-21 2021-08-03 Cilag Gmbh International Systems and methods of displaying a knife position during transection for a surgical instrument
US11129680B2 (en) 2017-12-21 2021-09-28 Cilag Gmbh International Surgical instrument comprising a projector
US10682134B2 (en) 2017-12-21 2020-06-16 Ethicon Llc Continuous use self-propelled stapling instrument
AU2019205865A1 (en) 2018-01-04 2020-07-16 Trudell Medical International Smart oscillating positive expiratory pressure device
EP3757960A4 (en) * 2018-02-21 2021-04-07 Teijin Pharma Limited Server, monitor system, terminal, monitor device, and method, for monitoring oxygen concentration device
US11141553B2 (en) * 2018-07-11 2021-10-12 General Electric Company Ventilation control system and method utilizing patient oxygen saturation
USD914878S1 (en) 2018-08-20 2021-03-30 Ethicon Llc Surgical instrument anvil
US10842492B2 (en) 2018-08-20 2020-11-24 Ethicon Llc Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system
US11253256B2 (en) 2018-08-20 2022-02-22 Cilag Gmbh International Articulatable motor powered surgical instruments with dedicated articulation motor arrangements
US11291440B2 (en) 2018-08-20 2022-04-05 Cilag Gmbh International Method for operating a powered articulatable surgical instrument
US11045192B2 (en) 2018-08-20 2021-06-29 Cilag Gmbh International Fabricating techniques for surgical stapler anvils
US10779821B2 (en) 2018-08-20 2020-09-22 Ethicon Llc Surgical stapler anvils with tissue stop features configured to avoid tissue pinch
US11324501B2 (en) 2018-08-20 2022-05-10 Cilag Gmbh International Surgical stapling devices with improved closure members
US10912559B2 (en) 2018-08-20 2021-02-09 Ethicon Llc Reinforced deformable anvil tip for surgical stapler anvil
US11207065B2 (en) 2018-08-20 2021-12-28 Cilag Gmbh International Method for fabricating surgical stapler anvils
US11039834B2 (en) 2018-08-20 2021-06-22 Cilag Gmbh International Surgical stapler anvils with staple directing protrusions and tissue stability features
US11083458B2 (en) 2018-08-20 2021-08-10 Cilag Gmbh International Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions
US10856870B2 (en) 2018-08-20 2020-12-08 Ethicon Llc Switching arrangements for motor powered articulatable surgical instruments
EP3938017A4 (en) * 2019-03-12 2022-12-14 Live Fully, Inc. Oxygen monitoring and control system
US11696761B2 (en) 2019-03-25 2023-07-11 Cilag Gmbh International Firing drive arrangements for surgical systems
US11172929B2 (en) 2019-03-25 2021-11-16 Cilag Gmbh International Articulation drive arrangements for surgical systems
US11147553B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11147551B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11471157B2 (en) 2019-04-30 2022-10-18 Cilag Gmbh International Articulation control mapping for a surgical instrument
US11452528B2 (en) 2019-04-30 2022-09-27 Cilag Gmbh International Articulation actuators for a surgical instrument
US11648009B2 (en) 2019-04-30 2023-05-16 Cilag Gmbh International Rotatable jaw tip for a surgical instrument
US11432816B2 (en) 2019-04-30 2022-09-06 Cilag Gmbh International Articulation pin for a surgical instrument
US11253254B2 (en) 2019-04-30 2022-02-22 Cilag Gmbh International Shaft rotation actuator on a surgical instrument
US11903581B2 (en) 2019-04-30 2024-02-20 Cilag Gmbh International Methods for stapling tissue using a surgical instrument
US11426251B2 (en) 2019-04-30 2022-08-30 Cilag Gmbh International Articulation directional lights on a surgical instrument
US11627959B2 (en) 2019-06-28 2023-04-18 Cilag Gmbh International Surgical instruments including manual and powered system lockouts
US11298132B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Inlernational Staple cartridge including a honeycomb extension
US11219455B2 (en) 2019-06-28 2022-01-11 Cilag Gmbh International Surgical instrument including a lockout key
US11259803B2 (en) 2019-06-28 2022-03-01 Cilag Gmbh International Surgical stapling system having an information encryption protocol
US11224497B2 (en) 2019-06-28 2022-01-18 Cilag Gmbh International Surgical systems with multiple RFID tags
US11426167B2 (en) 2019-06-28 2022-08-30 Cilag Gmbh International Mechanisms for proper anvil attachment surgical stapling head assembly
US11298127B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Interational Surgical stapling system having a lockout mechanism for an incompatible cartridge
US11399837B2 (en) 2019-06-28 2022-08-02 Cilag Gmbh International Mechanisms for motor control adjustments of a motorized surgical instrument
US11291451B2 (en) 2019-06-28 2022-04-05 Cilag Gmbh International Surgical instrument with battery compatibility verification functionality
US11246678B2 (en) 2019-06-28 2022-02-15 Cilag Gmbh International Surgical stapling system having a frangible RFID tag
US11684434B2 (en) 2019-06-28 2023-06-27 Cilag Gmbh International Surgical RFID assemblies for instrument operational setting control
US11497492B2 (en) 2019-06-28 2022-11-15 Cilag Gmbh International Surgical instrument including an articulation lock
US11464601B2 (en) 2019-06-28 2022-10-11 Cilag Gmbh International Surgical instrument comprising an RFID system for tracking a movable component
US11376098B2 (en) 2019-06-28 2022-07-05 Cilag Gmbh International Surgical instrument system comprising an RFID system
US11660163B2 (en) 2019-06-28 2023-05-30 Cilag Gmbh International Surgical system with RFID tags for updating motor assembly parameters
US11771419B2 (en) 2019-06-28 2023-10-03 Cilag Gmbh International Packaging for a replaceable component of a surgical stapling system
US11051807B2 (en) 2019-06-28 2021-07-06 Cilag Gmbh International Packaging assembly including a particulate trap
US11523822B2 (en) 2019-06-28 2022-12-13 Cilag Gmbh International Battery pack including a circuit interrupter
US11241235B2 (en) 2019-06-28 2022-02-08 Cilag Gmbh International Method of using multiple RFID chips with a surgical assembly
US11553971B2 (en) 2019-06-28 2023-01-17 Cilag Gmbh International Surgical RFID assemblies for display and communication
US11478241B2 (en) 2019-06-28 2022-10-25 Cilag Gmbh International Staple cartridge including projections
US11638587B2 (en) 2019-06-28 2023-05-02 Cilag Gmbh International RFID identification systems for surgical instruments
JP2022547826A (en) 2019-08-27 2022-11-16 トゥルーデル メディカル インターナショナル Vibrating positive expiratory pressure device
US11779720B2 (en) 2019-11-04 2023-10-10 Vapotherm, Inc. Methods, devices, and systems for improved oxygenation patient monitoring, mixing, and delivery
US11612706B2 (en) * 2019-11-25 2023-03-28 John C. Taube Methods, systems, and devices for controlling mechanical ventilation
US11464512B2 (en) 2019-12-19 2022-10-11 Cilag Gmbh International Staple cartridge comprising a curved deck surface
US11446029B2 (en) 2019-12-19 2022-09-20 Cilag Gmbh International Staple cartridge comprising projections extending from a curved deck surface
US11291447B2 (en) 2019-12-19 2022-04-05 Cilag Gmbh International Stapling instrument comprising independent jaw closing and staple firing systems
US11234698B2 (en) 2019-12-19 2022-02-01 Cilag Gmbh International Stapling system comprising a clamp lockout and a firing lockout
US11576672B2 (en) 2019-12-19 2023-02-14 Cilag Gmbh International Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw
US11911032B2 (en) 2019-12-19 2024-02-27 Cilag Gmbh International Staple cartridge comprising a seating cam
US11529137B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Staple cartridge comprising driver retention members
US11607219B2 (en) 2019-12-19 2023-03-21 Cilag Gmbh International Staple cartridge comprising a detachable tissue cutting knife
US11701111B2 (en) 2019-12-19 2023-07-18 Cilag Gmbh International Method for operating a surgical stapling instrument
US11504122B2 (en) 2019-12-19 2022-11-22 Cilag Gmbh International Surgical instrument comprising a nested firing member
US11304696B2 (en) 2019-12-19 2022-04-19 Cilag Gmbh International Surgical instrument comprising a powered articulation system
US11844520B2 (en) 2019-12-19 2023-12-19 Cilag Gmbh International Staple cartridge comprising driver retention members
US11559304B2 (en) 2019-12-19 2023-01-24 Cilag Gmbh International Surgical instrument comprising a rapid closure mechanism
US11529139B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Motor driven surgical instrument
USD975851S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
USD975278S1 (en) 2020-06-02 2023-01-10 Cilag Gmbh International Staple cartridge
USD975850S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
USD967421S1 (en) 2020-06-02 2022-10-18 Cilag Gmbh International Staple cartridge
USD966512S1 (en) 2020-06-02 2022-10-11 Cilag Gmbh International Staple cartridge
USD974560S1 (en) 2020-06-02 2023-01-03 Cilag Gmbh International Staple cartridge
USD976401S1 (en) 2020-06-02 2023-01-24 Cilag Gmbh International Staple cartridge
CA3189534A1 (en) 2020-07-16 2022-01-20 Invacare Corporation System and method for concentrating gas
US20220031351A1 (en) 2020-07-28 2022-02-03 Cilag Gmbh International Surgical instruments with differential articulation joint arrangements for accommodating flexible actuators
US11247008B1 (en) 2020-08-05 2022-02-15 Effortless Oxygen, Llc Flow triggered gas delivery
US11318276B2 (en) 2020-08-05 2022-05-03 Effortless Oxygen, Llc Flow triggered gas delivery
US11420007B2 (en) 2020-08-05 2022-08-23 Effortless Oxygen, Llc Flow triggered gas delivery
CN112245731B (en) * 2020-10-19 2022-10-11 湖南万脉医疗科技有限公司 Aerator for breathing machine and application thereof
US11896217B2 (en) 2020-10-29 2024-02-13 Cilag Gmbh International Surgical instrument comprising an articulation lock
US11452526B2 (en) 2020-10-29 2022-09-27 Cilag Gmbh International Surgical instrument comprising a staged voltage regulation start-up system
USD1013170S1 (en) 2020-10-29 2024-01-30 Cilag Gmbh International Surgical instrument assembly
US11617577B2 (en) 2020-10-29 2023-04-04 Cilag Gmbh International Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable
US11844518B2 (en) 2020-10-29 2023-12-19 Cilag Gmbh International Method for operating a surgical instrument
US11517390B2 (en) 2020-10-29 2022-12-06 Cilag Gmbh International Surgical instrument comprising a limited travel switch
USD980425S1 (en) 2020-10-29 2023-03-07 Cilag Gmbh International Surgical instrument assembly
US11779330B2 (en) 2020-10-29 2023-10-10 Cilag Gmbh International Surgical instrument comprising a jaw alignment system
US11534259B2 (en) 2020-10-29 2022-12-27 Cilag Gmbh International Surgical instrument comprising an articulation indicator
US11717289B2 (en) 2020-10-29 2023-08-08 Cilag Gmbh International Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable
US11653920B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Powered surgical instruments with communication interfaces through sterile barrier
US11678882B2 (en) 2020-12-02 2023-06-20 Cilag Gmbh International Surgical instruments with interactive features to remedy incidental sled movements
US11890010B2 (en) 2020-12-02 2024-02-06 Cllag GmbH International Dual-sided reinforced reload for surgical instruments
US11627960B2 (en) 2020-12-02 2023-04-18 Cilag Gmbh International Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections
US11737751B2 (en) 2020-12-02 2023-08-29 Cilag Gmbh International Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings
US11653915B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Surgical instruments with sled location detection and adjustment features
US11744581B2 (en) 2020-12-02 2023-09-05 Cilag Gmbh International Powered surgical instruments with multi-phase tissue treatment
US11849943B2 (en) 2020-12-02 2023-12-26 Cilag Gmbh International Surgical instrument with cartridge release mechanisms
US11696757B2 (en) 2021-02-26 2023-07-11 Cilag Gmbh International Monitoring of internal systems to detect and track cartridge motion status
US11925349B2 (en) 2021-02-26 2024-03-12 Cilag Gmbh International Adjustment to transfer parameters to improve available power
US11751869B2 (en) 2021-02-26 2023-09-12 Cilag Gmbh International Monitoring of multiple sensors over time to detect moving characteristics of tissue
US11723657B2 (en) 2021-02-26 2023-08-15 Cilag Gmbh International Adjustable communication based on available bandwidth and power capacity
US11744583B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Distal communication array to tune frequency of RF systems
US11701113B2 (en) 2021-02-26 2023-07-18 Cilag Gmbh International Stapling instrument comprising a separate power antenna and a data transfer antenna
US11812964B2 (en) 2021-02-26 2023-11-14 Cilag Gmbh International Staple cartridge comprising a power management circuit
US11793514B2 (en) 2021-02-26 2023-10-24 Cilag Gmbh International Staple cartridge comprising sensor array which may be embedded in cartridge body
US11730473B2 (en) 2021-02-26 2023-08-22 Cilag Gmbh International Monitoring of manufacturing life-cycle
US11749877B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Stapling instrument comprising a signal antenna
US11723658B2 (en) 2021-03-22 2023-08-15 Cilag Gmbh International Staple cartridge comprising a firing lockout
US11826012B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Stapling instrument comprising a pulsed motor-driven firing rack
US11826042B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Surgical instrument comprising a firing drive including a selectable leverage mechanism
US11717291B2 (en) 2021-03-22 2023-08-08 Cilag Gmbh International Staple cartridge comprising staples configured to apply different tissue compression
US11806011B2 (en) 2021-03-22 2023-11-07 Cilag Gmbh International Stapling instrument comprising tissue compression systems
US11737749B2 (en) 2021-03-22 2023-08-29 Cilag Gmbh International Surgical stapling instrument comprising a retraction system
US11759202B2 (en) 2021-03-22 2023-09-19 Cilag Gmbh International Staple cartridge comprising an implantable layer
US11744603B2 (en) 2021-03-24 2023-09-05 Cilag Gmbh International Multi-axis pivot joints for surgical instruments and methods for manufacturing same
US11849945B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Rotary-driven surgical stapling assembly comprising eccentrically driven firing member
US11793516B2 (en) 2021-03-24 2023-10-24 Cilag Gmbh International Surgical staple cartridge comprising longitudinal support beam
US11832816B2 (en) 2021-03-24 2023-12-05 Cilag Gmbh International Surgical stapling assembly comprising nonplanar staples and planar staples
US11896218B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Method of using a powered stapling device
US11786239B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Surgical instrument articulation joint arrangements comprising multiple moving linkage features
US11903582B2 (en) 2021-03-24 2024-02-20 Cilag Gmbh International Leveraging surfaces for cartridge installation
US11857183B2 (en) 2021-03-24 2024-01-02 Cilag Gmbh International Stapling assembly components having metal substrates and plastic bodies
US11849944B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Drivers for fastener cartridge assemblies having rotary drive screws
US11786243B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Firing members having flexible portions for adapting to a load during a surgical firing stroke
US11896219B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Mating features between drivers and underside of a cartridge deck
WO2022221177A1 (en) * 2021-04-11 2022-10-20 Khurana Vikas Diagnosis and treatment of congestive colon failure (ccf)
WO2022244004A1 (en) * 2021-05-20 2022-11-24 Ravit Barkama Systems and methods for supplemental oxygen delivery
US20220378424A1 (en) 2021-05-28 2022-12-01 Cilag Gmbh International Stapling instrument comprising a firing lockout
US11877745B2 (en) 2021-10-18 2024-01-23 Cilag Gmbh International Surgical stapling assembly having longitudinally-repeating staple leg clusters

Citations (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1932402A (en) * 1928-12-10 1933-10-31 Thermal Syndicate Ltd Process for and apparatus for use in molding articles of fused quartz
US2414747A (en) * 1942-07-02 1947-01-21 Harry M Kirschbaum Method and apparatus for controlling the oxygen content of the blood of living animals
US2912979A (en) * 1956-02-17 1959-11-17 Lieber Samuel Loewenstein Apparatus for administering and conserving gas
US3400712A (en) * 1965-08-12 1968-09-10 James E. Finan System for intermittently dispensing oxygen or other gas suitable for breathing
US3400713A (en) * 1966-10-12 1968-09-10 James E. Finan Apparatus for intermittently dispensing oxygen or other gas suitable for breathing
US3493703A (en) * 1968-08-02 1970-02-03 James E Finan Body motion sensitive electrical switch with lost motion means
US3734091A (en) * 1971-06-22 1973-05-22 Airco Inc Oxygen control system with blood oxygen saturation sensing means and method for closed system breathing
US3834383A (en) * 1972-12-11 1974-09-10 Puritan Bennett Corp Respiration apparatus with flow responsive control valve
US4054133A (en) * 1976-03-29 1977-10-18 The Bendix Corporation Control for a demand cannula
US4278110A (en) * 1979-11-13 1981-07-14 Price Ernest H Demand responsive flow controller
US4326513A (en) * 1979-07-02 1982-04-27 Dragerwerk Ag Patient data controlled respiration system
US4336590A (en) * 1979-05-02 1982-06-22 Intertechnique Devices for controlling gas flows
US4381002A (en) * 1980-12-18 1983-04-26 The United States Of America As Represented By The Secretary Of The Army Fluidic-controlled oxygen intermittent demand flow device
US4457303A (en) * 1980-11-26 1984-07-03 Tritec Industries, Inc. Respirating gas supply control method and apparatus therefor
US4461293A (en) * 1982-12-03 1984-07-24 Kircaldie, Randall, And Mcnab Respirating gas supply method and apparatus therefor
US4484578A (en) * 1980-11-26 1984-11-27 Kircaldie, Randall And Mcnab Respirator apparatus and method
US4567888A (en) * 1982-07-13 1986-02-04 Compagnie Francaise De Produits Oxygenes Device for treating respiratory deficiency of a patient
US4575042A (en) * 1984-08-17 1986-03-11 Associates Of Dallas Pneumatically amplified conservation valve
US4584996A (en) * 1984-03-12 1986-04-29 Blum Alvin S Apparatus for conservative supplemental oxygen therapy
US4612928A (en) * 1984-08-28 1986-09-23 Tiep Brian L Method and apparatus for supplying a gas to a body
US4648395A (en) * 1982-07-07 1987-03-10 Sanyo Densihkogyo Co. Ltd. Synchronized feed type oxygen concentrator for use in an open breathing system
US4665911A (en) * 1983-11-25 1987-05-19 Electro-Fluidics Intermittent supplemental oxygen apparatus and method
US4681099A (en) * 1984-11-30 1987-07-21 Tottori University Breath-synchronized concentrated-oxygen supplier
US4686974A (en) * 1985-10-18 1987-08-18 Tottori University Breath synchronized gas-insufflation device and method therefor
US4686975A (en) * 1985-05-03 1987-08-18 Applied Membrane Technology, Inc. Electronic respirable gas delivery device
US4705034A (en) * 1985-10-02 1987-11-10 Perkins Warren E Method and means for dispensing respirating gases by effecting a known displacement
US4706664A (en) * 1986-04-11 1987-11-17 Puritan-Bennett Corporation Inspiration oxygen saver
US4744356A (en) * 1986-03-03 1988-05-17 Greenwood Eugene C Demand oxygen supply device
US4745925A (en) * 1986-10-06 1988-05-24 Dietz Henry G Optoelectronic inhalation sensor for monitoring inhalation and for inhalation therapy
US4784130A (en) * 1986-12-04 1988-11-15 The John Bunn Company Flow controller
US4823788A (en) * 1988-04-18 1989-04-25 Smith Richard F M Demand oxygen controller and respiratory monitor
US4827922A (en) * 1987-03-05 1989-05-09 L'air Liquide Process and device for supplying respiratory oxygen
US4873971A (en) * 1985-10-02 1989-10-17 Perkins Warren E Method and means for dispensing respirating gases by effecting a known displacement
US4889116A (en) * 1987-11-17 1989-12-26 Phospho Energetics, Inc. Adaptive control of neonatal fractional inspired oxygen
US4971049A (en) * 1989-11-06 1990-11-20 Pulsair, Inc. Pressure sensor control device for supplying oxygen
US4972842A (en) * 1988-06-09 1990-11-27 Vital Signals, Inc. Method and apparatus for precision monitoring of infants on assisted ventilation
US5024219A (en) * 1987-01-12 1991-06-18 Dietz Henry G Apparatus for inhalation therapy using triggered dose oxygenator employing an optoelectronic inhalation sensor
US5038771A (en) * 1990-01-25 1991-08-13 Dietz Henry G Method and apparatus for respiratory therapy using intermittent flow having automatic adjustment of a dose of therapeutic gas to the rate of breathing
US5038770A (en) * 1989-02-03 1991-08-13 Perkins Warren E Fail-safe systems for respirating gas delivery devices
US5048515A (en) * 1988-11-15 1991-09-17 Sanso David W Respiratory gas supply apparatus and method
US5052400A (en) * 1986-02-20 1991-10-01 Dietz Henry G Method and apparatus for using an inhalation sensor for monitoring and for inhalation therapy
US5074299A (en) * 1988-05-02 1991-12-24 Dietz Henry G Monitor for controlling the flow of gases for breathing during inhalation
US5099837A (en) * 1990-09-28 1992-03-31 Russel Sr Larry L Inhalation-based control of medical gas
US5103814A (en) * 1988-04-28 1992-04-14 Timothy Maher Self-compensating patient respirator
US5137017A (en) * 1989-04-13 1992-08-11 Salter Labs Demand oxygen system
US5165397A (en) * 1988-12-15 1992-11-24 Arp Leon J Method and apparatus for demand oxygen system monitoring and control
US5251632A (en) * 1991-03-07 1993-10-12 Hamamatsu Photonics K.K. Tissue oxygen measuring system
US5280780A (en) * 1992-11-09 1994-01-25 Abel Elaine R Oxygen delivery and conserving device
US5315990A (en) * 1991-12-30 1994-05-31 Mondry Adolph J Method for delivering incremental doses of oxygen for maximizing blood oxygen saturation levels
US5323776A (en) * 1992-10-15 1994-06-28 Picker International, Inc. MRI compatible pulse oximetry system
US5360000A (en) * 1987-03-19 1994-11-01 Puritan-Bennett Corporation Pneumatic demand oxygen valve
US5365922A (en) * 1991-03-19 1994-11-22 Brigham And Women's Hospital, Inc. Closed-loop non-invasive oxygen saturation control system
US5388575A (en) * 1992-09-25 1995-02-14 Taube; John C. Adaptive controller for automatic ventilators
US5398676A (en) * 1993-09-30 1995-03-21 Press; Roman J. Portable emergency respirator
US5398682A (en) * 1992-08-19 1995-03-21 Lynn; Lawrence A. Method and apparatus for the diagnosis of sleep apnea utilizing a single interface with a human body part
US5429123A (en) * 1993-12-15 1995-07-04 Temple University - Of The Commonwealth System Of Higher Education Process control and apparatus for ventilation procedures with helium and oxygen mixtures
US5443062A (en) * 1993-11-23 1995-08-22 Hayes; Jeffrey P. Load activated oxygen delivery system
US5490502A (en) * 1992-05-07 1996-02-13 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
US5495848A (en) * 1994-11-25 1996-03-05 Nellcar Puritan Bennett Monitoring system for delivery of therapeutic gas
US5558086A (en) * 1992-12-16 1996-09-24 Freedom Air Services Method and apparatus for the intermittent delivery of oxygen therapy to a person
US5582164A (en) * 1995-03-14 1996-12-10 Stan A. Sanders Cassette size, pressurized O2 coil structure
US5603315A (en) * 1995-08-14 1997-02-18 Reliable Engineering Multiple mode oxygen delivery system
US5626131A (en) * 1995-06-07 1997-05-06 Salter Labs Method for intermittent gas-insufflation
US5664562A (en) * 1992-09-18 1997-09-09 Pierre Medical S.A. Breathing aid device
US5692497A (en) * 1996-05-16 1997-12-02 Children's Medical Center Corporation Microprocessor-controlled ventilator system and methods
US5697364A (en) * 1995-06-07 1997-12-16 Salter Labs Intermittent gas-insufflation apparatus
US5735268A (en) * 1995-06-07 1998-04-07 Salter Labs Intermitten gas-insufflation apparatus and method therefor
US5752509A (en) * 1995-07-10 1998-05-19 Burkhard Lachmann Artificial ventilation system
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
US5810759A (en) * 1997-03-27 1998-09-22 Michigan Critical Care Consultants, Inc. Control system for regulating gas exchange in extracoporeal circulation
US5813399A (en) * 1993-03-16 1998-09-29 Puritan Bennett Corporation System and method for closed loop airway pressure control during the inspiratory cycle of a breath in a patient ventilator using the exhalation valve as a microcomputer-controlled relief valve
US5848591A (en) * 1996-07-05 1998-12-15 Dragerwerk Ag Respirator with oxygen enrichment
US5865174A (en) * 1996-10-29 1999-02-02 The Scott Fetzer Company Supplemental oxygen delivery apparatus and method
US5915381A (en) * 1995-12-01 1999-06-29 Siemens Elema Ab Breathing apparatus and method for controlling same
US5925831A (en) * 1997-10-18 1999-07-20 Cardiopulmonary Technologies, Inc. Respiratory air flow sensor
US5927274A (en) * 1995-04-07 1999-07-27 Healthdyne Technologies, Inc. Pressure support ventilatory assist system
US5931162A (en) * 1996-06-03 1999-08-03 Siemens Aktiengesellschaft Ventilator which allows spontaneous inhalation and expiration within a controlled breathing mode
US5934277A (en) * 1991-09-03 1999-08-10 Datex-Ohmeda, Inc. System for pulse oximetry SpO2 determination
US5937853A (en) * 1995-11-16 1999-08-17 Siemens Elema Ab Ventilator for respiratory treatment
US5954050A (en) * 1997-10-20 1999-09-21 Christopher; Kent L. System for monitoring and treating sleep disorders using a transtracheal catheter
US6099481A (en) * 1997-11-03 2000-08-08 Ntc Technology, Inc. Respiratory profile parameter determination method and apparatus
US6142149A (en) * 1997-10-23 2000-11-07 Steen; Scot Kenneth Oximetry device, open oxygen delivery system oximetry device and method of controlling oxygen saturation
US6152134A (en) * 1996-10-18 2000-11-28 Invacare Corporation Oxygen conserving device
US6186142B1 (en) * 1997-07-25 2001-02-13 Minnesota Innovative Technologies & Instruments Corporation (Miti) Control of respiratory oxygen delivery
US6192883B1 (en) * 1999-08-03 2001-02-27 Richard L. Miller, Jr. Oxygen flow control system and method
US6220244B1 (en) * 1998-09-15 2001-04-24 Mclaughlin Patrick L. Conserving device for use in oxygen delivery and therapy
US6371114B1 (en) * 1998-07-24 2002-04-16 Minnesota Innovative Technologies & Instruments Corporation Control device for supplying supplemental respiratory oxygen
US6470885B1 (en) * 2000-01-13 2002-10-29 Brent Blue Method and apparatus for providing and controlling oxygen supply
US20020185126A1 (en) * 1997-01-17 2002-12-12 Christian Krebs Controlled gas-supply system
US6532958B1 (en) * 1997-07-25 2003-03-18 Minnesota Innovative Technologies & Instruments Corporation Automated control and conservation of supplemental respiratory oxygen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4932402A (en) 1986-04-11 1990-06-12 Puritan-Bennett Corporation Inspiration oxygen saver
US4883353A (en) * 1988-02-11 1989-11-28 Puritan-Bennett Corporation Pulse oximeter
GB9215455D0 (en) 1992-07-21 1992-09-02 Brain Archibald Ian Jeremy A laryngeal mask airway adapted to carry a reflecting-type oximeter
US5438980A (en) * 1993-01-12 1995-08-08 Puritan-Bennett Corporation Inhalation/exhalation respiratory phase detection circuit
SE470417B (en) * 1993-02-05 1994-02-21 Siemens Elema Ab Method for fresh gas supply for manual ventilation and a fan system for carrying out the method
DE4309923C2 (en) 1993-03-26 1995-02-16 Boesch Wilhelm Device for supplying breathing gas to a patient
FR2724564B1 (en) * 1994-09-16 1997-04-04 Boussignac Georges RESPIRATORY ASSISTANCE DEVICE
US5503148A (en) * 1994-11-01 1996-04-02 Ohmeda Inc. System for pulse oximetry SPO2 determination
US6041777A (en) * 1995-12-01 2000-03-28 Alliance Pharmaceutical Corp. Methods and apparatus for closed-circuit ventilation therapy
US6009481A (en) * 1996-09-30 1999-12-28 Emc Corporation Mass storage system using internal system-level mirroring

Patent Citations (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1932402A (en) * 1928-12-10 1933-10-31 Thermal Syndicate Ltd Process for and apparatus for use in molding articles of fused quartz
US2414747A (en) * 1942-07-02 1947-01-21 Harry M Kirschbaum Method and apparatus for controlling the oxygen content of the blood of living animals
US2912979A (en) * 1956-02-17 1959-11-17 Lieber Samuel Loewenstein Apparatus for administering and conserving gas
US3400712A (en) * 1965-08-12 1968-09-10 James E. Finan System for intermittently dispensing oxygen or other gas suitable for breathing
US3400713A (en) * 1966-10-12 1968-09-10 James E. Finan Apparatus for intermittently dispensing oxygen or other gas suitable for breathing
US3493703A (en) * 1968-08-02 1970-02-03 James E Finan Body motion sensitive electrical switch with lost motion means
US3734091A (en) * 1971-06-22 1973-05-22 Airco Inc Oxygen control system with blood oxygen saturation sensing means and method for closed system breathing
US3834383A (en) * 1972-12-11 1974-09-10 Puritan Bennett Corp Respiration apparatus with flow responsive control valve
US4054133A (en) * 1976-03-29 1977-10-18 The Bendix Corporation Control for a demand cannula
US4336590A (en) * 1979-05-02 1982-06-22 Intertechnique Devices for controlling gas flows
US4326513A (en) * 1979-07-02 1982-04-27 Dragerwerk Ag Patient data controlled respiration system
US4278110A (en) * 1979-11-13 1981-07-14 Price Ernest H Demand responsive flow controller
US4484578A (en) * 1980-11-26 1984-11-27 Kircaldie, Randall And Mcnab Respirator apparatus and method
US4457303A (en) * 1980-11-26 1984-07-03 Tritec Industries, Inc. Respirating gas supply control method and apparatus therefor
US4381002A (en) * 1980-12-18 1983-04-26 The United States Of America As Represented By The Secretary Of The Army Fluidic-controlled oxygen intermittent demand flow device
US4648395A (en) * 1982-07-07 1987-03-10 Sanyo Densihkogyo Co. Ltd. Synchronized feed type oxygen concentrator for use in an open breathing system
US4567888A (en) * 1982-07-13 1986-02-04 Compagnie Francaise De Produits Oxygenes Device for treating respiratory deficiency of a patient
US4462398A (en) * 1982-12-03 1984-07-31 Kircaldie, Randal and McNab, Trustee Respirating gas supply method and apparatus therefor
US4461293A (en) * 1982-12-03 1984-07-24 Kircaldie, Randall, And Mcnab Respirating gas supply method and apparatus therefor
US4506666A (en) * 1982-12-03 1985-03-26 Kircaldie, Randall And Mcnab Method and apparatus for rectifying obstructive apnea
US4519387A (en) * 1982-12-03 1985-05-28 Kircaldie, Randall And Mcnab, Trustee Respirating gas supply method and apparatus therefor
US4665911A (en) * 1983-11-25 1987-05-19 Electro-Fluidics Intermittent supplemental oxygen apparatus and method
US4584996A (en) * 1984-03-12 1986-04-29 Blum Alvin S Apparatus for conservative supplemental oxygen therapy
US4575042A (en) * 1984-08-17 1986-03-11 Associates Of Dallas Pneumatically amplified conservation valve
US4612928A (en) * 1984-08-28 1986-09-23 Tiep Brian L Method and apparatus for supplying a gas to a body
US4681099A (en) * 1984-11-30 1987-07-21 Tottori University Breath-synchronized concentrated-oxygen supplier
US4686975A (en) * 1985-05-03 1987-08-18 Applied Membrane Technology, Inc. Electronic respirable gas delivery device
US4873971A (en) * 1985-10-02 1989-10-17 Perkins Warren E Method and means for dispensing respirating gases by effecting a known displacement
US4705034A (en) * 1985-10-02 1987-11-10 Perkins Warren E Method and means for dispensing respirating gases by effecting a known displacement
US5005570A (en) * 1985-10-02 1991-04-09 Perkins Warren E Method and means for dispensing respirating gases by effecting a known displacement
US4686974A (en) * 1985-10-18 1987-08-18 Tottori University Breath synchronized gas-insufflation device and method therefor
US5052400A (en) * 1986-02-20 1991-10-01 Dietz Henry G Method and apparatus for using an inhalation sensor for monitoring and for inhalation therapy
US4744356A (en) * 1986-03-03 1988-05-17 Greenwood Eugene C Demand oxygen supply device
US4706664A (en) * 1986-04-11 1987-11-17 Puritan-Bennett Corporation Inspiration oxygen saver
US4745925A (en) * 1986-10-06 1988-05-24 Dietz Henry G Optoelectronic inhalation sensor for monitoring inhalation and for inhalation therapy
US4784130A (en) * 1986-12-04 1988-11-15 The John Bunn Company Flow controller
US5024219A (en) * 1987-01-12 1991-06-18 Dietz Henry G Apparatus for inhalation therapy using triggered dose oxygenator employing an optoelectronic inhalation sensor
US4827922A (en) * 1987-03-05 1989-05-09 L'air Liquide Process and device for supplying respiratory oxygen
US5360000A (en) * 1987-03-19 1994-11-01 Puritan-Bennett Corporation Pneumatic demand oxygen valve
US4889116A (en) * 1987-11-17 1989-12-26 Phospho Energetics, Inc. Adaptive control of neonatal fractional inspired oxygen
US4823788A (en) * 1988-04-18 1989-04-25 Smith Richard F M Demand oxygen controller and respiratory monitor
US5103814A (en) * 1988-04-28 1992-04-14 Timothy Maher Self-compensating patient respirator
US5074299A (en) * 1988-05-02 1991-12-24 Dietz Henry G Monitor for controlling the flow of gases for breathing during inhalation
US4972842A (en) * 1988-06-09 1990-11-27 Vital Signals, Inc. Method and apparatus for precision monitoring of infants on assisted ventilation
US5048515A (en) * 1988-11-15 1991-09-17 Sanso David W Respiratory gas supply apparatus and method
US5165397A (en) * 1988-12-15 1992-11-24 Arp Leon J Method and apparatus for demand oxygen system monitoring and control
US5038770A (en) * 1989-02-03 1991-08-13 Perkins Warren E Fail-safe systems for respirating gas delivery devices
US5137017A (en) * 1989-04-13 1992-08-11 Salter Labs Demand oxygen system
US4971049A (en) * 1989-11-06 1990-11-20 Pulsair, Inc. Pressure sensor control device for supplying oxygen
US5038771A (en) * 1990-01-25 1991-08-13 Dietz Henry G Method and apparatus for respiratory therapy using intermittent flow having automatic adjustment of a dose of therapeutic gas to the rate of breathing
US5099837A (en) * 1990-09-28 1992-03-31 Russel Sr Larry L Inhalation-based control of medical gas
US5251632A (en) * 1991-03-07 1993-10-12 Hamamatsu Photonics K.K. Tissue oxygen measuring system
US5365922A (en) * 1991-03-19 1994-11-22 Brigham And Women's Hospital, Inc. Closed-loop non-invasive oxygen saturation control system
US5934277A (en) * 1991-09-03 1999-08-10 Datex-Ohmeda, Inc. System for pulse oximetry SpO2 determination
US5315990A (en) * 1991-12-30 1994-05-31 Mondry Adolph J Method for delivering incremental doses of oxygen for maximizing blood oxygen saturation levels
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
US5546933A (en) * 1992-05-07 1996-08-20 New York University Method for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
US5490502A (en) * 1992-05-07 1996-02-13 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
US5398682A (en) * 1992-08-19 1995-03-21 Lynn; Lawrence A. Method and apparatus for the diagnosis of sleep apnea utilizing a single interface with a human body part
US5664562A (en) * 1992-09-18 1997-09-09 Pierre Medical S.A. Breathing aid device
US5388575A (en) * 1992-09-25 1995-02-14 Taube; John C. Adaptive controller for automatic ventilators
US5323776A (en) * 1992-10-15 1994-06-28 Picker International, Inc. MRI compatible pulse oximetry system
US5280780A (en) * 1992-11-09 1994-01-25 Abel Elaine R Oxygen delivery and conserving device
US5558086A (en) * 1992-12-16 1996-09-24 Freedom Air Services Method and apparatus for the intermittent delivery of oxygen therapy to a person
US5813399A (en) * 1993-03-16 1998-09-29 Puritan Bennett Corporation System and method for closed loop airway pressure control during the inspiratory cycle of a breath in a patient ventilator using the exhalation valve as a microcomputer-controlled relief valve
US5398676A (en) * 1993-09-30 1995-03-21 Press; Roman J. Portable emergency respirator
US5443062A (en) * 1993-11-23 1995-08-22 Hayes; Jeffrey P. Load activated oxygen delivery system
US5429123A (en) * 1993-12-15 1995-07-04 Temple University - Of The Commonwealth System Of Higher Education Process control and apparatus for ventilation procedures with helium and oxygen mixtures
US5495848A (en) * 1994-11-25 1996-03-05 Nellcar Puritan Bennett Monitoring system for delivery of therapeutic gas
US5582164A (en) * 1995-03-14 1996-12-10 Stan A. Sanders Cassette size, pressurized O2 coil structure
US5927274A (en) * 1995-04-07 1999-07-27 Healthdyne Technologies, Inc. Pressure support ventilatory assist system
US5735268A (en) * 1995-06-07 1998-04-07 Salter Labs Intermitten gas-insufflation apparatus and method therefor
US5626131A (en) * 1995-06-07 1997-05-06 Salter Labs Method for intermittent gas-insufflation
US5697364A (en) * 1995-06-07 1997-12-16 Salter Labs Intermittent gas-insufflation apparatus
US5752509A (en) * 1995-07-10 1998-05-19 Burkhard Lachmann Artificial ventilation system
US5603315A (en) * 1995-08-14 1997-02-18 Reliable Engineering Multiple mode oxygen delivery system
US5937853A (en) * 1995-11-16 1999-08-17 Siemens Elema Ab Ventilator for respiratory treatment
US5915381A (en) * 1995-12-01 1999-06-29 Siemens Elema Ab Breathing apparatus and method for controlling same
US5692497A (en) * 1996-05-16 1997-12-02 Children's Medical Center Corporation Microprocessor-controlled ventilator system and methods
US5931162A (en) * 1996-06-03 1999-08-03 Siemens Aktiengesellschaft Ventilator which allows spontaneous inhalation and expiration within a controlled breathing mode
US5848591A (en) * 1996-07-05 1998-12-15 Dragerwerk Ag Respirator with oxygen enrichment
US6152134A (en) * 1996-10-18 2000-11-28 Invacare Corporation Oxygen conserving device
US5865174A (en) * 1996-10-29 1999-02-02 The Scott Fetzer Company Supplemental oxygen delivery apparatus and method
US20020185126A1 (en) * 1997-01-17 2002-12-12 Christian Krebs Controlled gas-supply system
US5810759A (en) * 1997-03-27 1998-09-22 Michigan Critical Care Consultants, Inc. Control system for regulating gas exchange in extracoporeal circulation
US20030145852A1 (en) * 1997-07-25 2003-08-07 Minnesota Innovative Technologies And Instruments Control of supplemental respiratory Oxygen
US6561187B2 (en) * 1997-07-25 2003-05-13 Minnesota Innovative Technologies & Instruments Corporation Control of supplemental respiratory oxygen
US6186142B1 (en) * 1997-07-25 2001-02-13 Minnesota Innovative Technologies & Instruments Corporation (Miti) Control of respiratory oxygen delivery
US6532958B1 (en) * 1997-07-25 2003-03-18 Minnesota Innovative Technologies & Instruments Corporation Automated control and conservation of supplemental respiratory oxygen
US5925831A (en) * 1997-10-18 1999-07-20 Cardiopulmonary Technologies, Inc. Respiratory air flow sensor
US5954050A (en) * 1997-10-20 1999-09-21 Christopher; Kent L. System for monitoring and treating sleep disorders using a transtracheal catheter
US6142149A (en) * 1997-10-23 2000-11-07 Steen; Scot Kenneth Oximetry device, open oxygen delivery system oximetry device and method of controlling oxygen saturation
US6099481A (en) * 1997-11-03 2000-08-08 Ntc Technology, Inc. Respiratory profile parameter determination method and apparatus
US6371114B1 (en) * 1998-07-24 2002-04-16 Minnesota Innovative Technologies & Instruments Corporation Control device for supplying supplemental respiratory oxygen
US6220244B1 (en) * 1998-09-15 2001-04-24 Mclaughlin Patrick L. Conserving device for use in oxygen delivery and therapy
US6192883B1 (en) * 1999-08-03 2001-02-27 Richard L. Miller, Jr. Oxygen flow control system and method
US6470885B1 (en) * 2000-01-13 2002-10-29 Brent Blue Method and apparatus for providing and controlling oxygen supply

Cited By (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020195105A1 (en) * 2000-01-13 2002-12-26 Brent Blue Method and apparatus for providing and controlling oxygen supply
US7793660B2 (en) * 2003-03-28 2010-09-14 Ric Investments, Llc Method of treating obstructive sleep apnea
US20050234364A1 (en) * 2003-03-28 2005-10-20 Ric Investments, Inc. Pressure support compliance monitoring system
US8955518B2 (en) 2003-06-18 2015-02-17 Breathe Technologies, Inc. Methods, systems and devices for improving ventilation in a lung area
US8381729B2 (en) 2003-06-18 2013-02-26 Breathe Technologies, Inc. Methods and devices for minimally invasive respiratory support
US20230007968A1 (en) * 2003-06-20 2023-01-12 ResMed Pty Ltd Device, system, and/or method for treating and monitoring a patient
US8418694B2 (en) 2003-08-11 2013-04-16 Breathe Technologies, Inc. Systems, methods and apparatus for respiratory support of a patient
US8573219B2 (en) 2003-08-18 2013-11-05 Breathe Technologies, Inc. Method and device for non-invasive ventilation with nasal interface
US8136527B2 (en) 2003-08-18 2012-03-20 Breathe Technologies, Inc. Method and device for non-invasive ventilation with nasal interface
US20050217668A1 (en) * 2003-10-24 2005-10-06 Pulmonox Technologies Corporation System and elements for managing therapeutic gas administration to a spontaneously breathing non-ventilated patient
US8925545B2 (en) 2004-02-04 2015-01-06 Breathe Technologies, Inc. Methods and devices for treating sleep apnea
US20080092898A1 (en) * 2004-08-27 2008-04-24 John Hopkins University Disposable Sleep And Breathing Monitor
US9415182B2 (en) 2004-08-27 2016-08-16 The Johns Hopkins University Disposable sleep and breathing monitor
WO2006026387A3 (en) * 2004-08-27 2006-07-13 Univ Johns Hopkins Disposable sleep and breathing monitor
US20060249151A1 (en) * 2005-05-03 2006-11-09 China Resource Group, Inc. Ventilator with rescuer and victim guidance
US8561611B2 (en) 2005-06-21 2013-10-22 Ric Investments, Llc Respiratory device measurement system
WO2007001836A3 (en) * 2005-06-21 2007-03-15 Ric Investments Llc Respiratory device measurement system
US20060283450A1 (en) * 2005-06-21 2006-12-21 Ric Investments, Llc. Respiratory device measurement system
US20070077200A1 (en) * 2005-09-30 2007-04-05 Baker Clark R Method and system for controlled maintenance of hypoxia for therapeutic or diagnostic purposes
US8985099B2 (en) 2006-05-18 2015-03-24 Breathe Technologies, Inc. Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer
US8061353B2 (en) 2007-03-09 2011-11-22 Global Medical Holdings LLC Method and apparatus for delivering a dose of a gaseous drug to a patient
US10058668B2 (en) 2007-05-18 2018-08-28 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
US20090065007A1 (en) * 2007-09-06 2009-03-12 Wilkinson William R Oxygen concentrator apparatus and method
US8794237B2 (en) 2007-09-06 2014-08-05 Inova Labs, Inc. Oxygen concentrator apparatus and method having flow restricted coupling of the canisters
US9956370B2 (en) 2007-09-06 2018-05-01 Inova, Labs, LLC. Oxygen concentrator apparatus and method having flow restricted coupling of the canisters
US8915248B2 (en) 2007-09-06 2014-12-23 Inova Labs, Inc. Oxygen concentrator apparatus and method with an oxygen assisted venting system
US9649465B2 (en) 2007-09-06 2017-05-16 Inova Labs, Inc. Oxygen concentrator apparatus and method having variable operation modes
US9649464B2 (en) 2007-09-06 2017-05-16 Inova Labs, Inc. Oxygen concentrator apparatus and method having an ultrasonic detector
US8567399B2 (en) 2007-09-26 2013-10-29 Breathe Technologies, Inc. Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
US8640699B2 (en) 2008-03-27 2014-02-04 Covidien Lp Breathing assistance systems with lung recruitment maneuvers
US8640700B2 (en) 2008-03-27 2014-02-04 Covidien Lp Method for selecting target settings in a medical device
US8776793B2 (en) 2008-04-18 2014-07-15 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8770193B2 (en) 2008-04-18 2014-07-08 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US9925345B2 (en) 2008-06-06 2018-03-27 Covidien Lp Systems and methods for determining patient effort and/or respiratory parameters in a ventilation system
US8485183B2 (en) 2008-06-06 2013-07-16 Covidien Lp Systems and methods for triggering and cycling a ventilator based on reconstructed patient effort signal
US9956363B2 (en) 2008-06-06 2018-05-01 Covidien Lp Systems and methods for triggering and cycling a ventilator based on reconstructed patient effort signal
US9126001B2 (en) 2008-06-06 2015-09-08 Covidien Lp Systems and methods for ventilation in proportion to patient effort
US8485184B2 (en) 2008-06-06 2013-07-16 Covidien Lp Systems and methods for monitoring and displaying respiratory information
US8826907B2 (en) 2008-06-06 2014-09-09 Covidien Lp Systems and methods for determining patient effort and/or respiratory parameters in a ventilation system
US8485185B2 (en) 2008-06-06 2013-07-16 Covidien Lp Systems and methods for ventilation in proportion to patient effort
US9114220B2 (en) 2008-06-06 2015-08-25 Covidien Lp Systems and methods for triggering and cycling a ventilator based on reconstructed patient effort signal
US10828437B2 (en) 2008-06-06 2020-11-10 Covidien Lp Systems and methods for triggering and cycling a ventilator based on reconstructed patient effort signal
US8677999B2 (en) 2008-08-22 2014-03-25 Breathe Technologies, Inc. Methods and devices for providing mechanical ventilation with an open airway interface
US10252020B2 (en) * 2008-10-01 2019-04-09 Breathe Technologies, Inc. Ventilator with biofeedback monitoring and control for improving patient activity and health
WO2010039989A1 (en) 2008-10-01 2010-04-08 Breathe Technologies, Inc. Ventilator with biofeedback monitoring and control for improving patient activity and health
US20100083968A1 (en) * 2008-10-01 2010-04-08 Breathe Technologies Ventilator with biofeedback monitoring and control for improving patient activity and health
US20100224191A1 (en) * 2009-03-06 2010-09-09 Cardinal Health 207, Inc. Automated Oxygen Delivery System
US20100224192A1 (en) * 2009-03-06 2010-09-09 Cardinal Health 207, Inc. Automated Oxygen Delivery Method
US9180270B2 (en) 2009-04-02 2015-11-10 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within an outer tube
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
US9227034B2 (en) 2009-04-02 2016-01-05 Beathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation for treating airway obstructions
US10709864B2 (en) 2009-04-02 2020-07-14 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles with an outer tube
US10695519B2 (en) 2009-04-02 2020-06-30 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within nasal pillows
US11707591B2 (en) 2009-04-02 2023-07-25 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles with an outer tube
US10232136B2 (en) 2009-04-02 2019-03-19 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation for treating airway obstructions
US9675774B2 (en) 2009-04-02 2017-06-13 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles in free space
US10046133B2 (en) 2009-04-02 2018-08-14 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation for providing ventilation support
US10265486B2 (en) 2009-09-03 2019-04-23 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US9132250B2 (en) 2009-09-03 2015-09-15 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US11511062B2 (en) 2010-04-13 2022-11-29 Advanced Interactive Response Systems LLC Gas supply warning and communication system
US8653979B2 (en) * 2010-04-13 2014-02-18 Valerie A. Obenchain Gas flow and pressure error alarm
US10821243B2 (en) 2010-04-13 2020-11-03 Advanced Interactive Response Systems, LLC Gas supply warning and communication system
US20110248856A1 (en) * 2010-04-13 2011-10-13 Obenchain Valerie A Gas flow and pressure error alarm
US10099028B2 (en) 2010-08-16 2018-10-16 Breathe Technologies, Inc. Methods, systems and devices using LOX to provide ventilatory support
US8603228B2 (en) 2010-09-07 2013-12-10 Inova Labs, Inc. Power management systems and methods for use in an oxygen concentrator
US8616207B2 (en) 2010-09-07 2013-12-31 Inova Labs, Inc. Oxygen concentrator heat management system and method
US20120055474A1 (en) * 2010-09-07 2012-03-08 Wilkinson William R Methods and systems for providing oxygen enriched gas
US8939152B2 (en) 2010-09-30 2015-01-27 Breathe Technologies, Inc. Methods, systems and devices for humidifying a respiratory tract
US9358358B2 (en) 2010-09-30 2016-06-07 Breathe Technologies, Inc. Methods, systems and devices for humidifying a respiratory tract
US8783250B2 (en) 2011-02-27 2014-07-22 Covidien Lp Methods and systems for transitory ventilation support
US8714154B2 (en) 2011-03-30 2014-05-06 Covidien Lp Systems and methods for automatic adjustment of ventilator settings
US10362967B2 (en) 2012-07-09 2019-07-30 Covidien Lp Systems and methods for missed breath detection and indication
US11642042B2 (en) 2012-07-09 2023-05-09 Covidien Lp Systems and methods for missed breath detection and indication
US9717876B2 (en) 2012-10-12 2017-08-01 Inova Labs, Inc. Dual oxygen concentrator systems and methods
US11364359B2 (en) 2012-10-12 2022-06-21 Inova Labs, Inc. Method and systems for the delivery of oxygen enriched gas
US9440036B2 (en) 2012-10-12 2016-09-13 InovaLabs, LLC Method and systems for the delivery of oxygen enriched gas
US9440180B2 (en) 2012-10-12 2016-09-13 Inova Labs, Llc Oxygen concentrator systems and methods
US11684744B2 (en) 2012-10-12 2023-06-27 Inova Labs, Inc. Method and systems for the delivery of oxygen enriched gas
US9440179B2 (en) 2014-02-14 2016-09-13 InovaLabs, LLC Oxygen concentrator pump systems and methods
US9808591B2 (en) 2014-08-15 2017-11-07 Covidien Lp Methods and systems for breath delivery synchronization
US10864336B2 (en) 2014-08-15 2020-12-15 Covidien Lp Methods and systems for breath delivery synchronization
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
US11712174B2 (en) 2014-10-27 2023-08-01 Covidien Lp Ventilation triggering
US10940281B2 (en) 2014-10-27 2021-03-09 Covidien Lp Ventilation triggering
US20170304576A1 (en) * 2014-11-19 2017-10-26 Koninklijke Philips N.V. Strap member for a patient interface
US10136859B2 (en) 2014-12-23 2018-11-27 Michael Cutaia System and method for outpatient management of chronic disease
WO2017059530A1 (en) * 2015-10-05 2017-04-13 UNIVERSITé LAVAL Method for delivery of breathing gas to a patient and system for performing same
US11065408B2 (en) 2015-10-05 2021-07-20 UNIVERSITé LAVAL Method for delivery of breathing gas to a patient and system for performing same
US11458274B2 (en) 2016-05-03 2022-10-04 Inova Labs, Inc. Method and systems for the delivery of oxygen enriched gas
US20170368295A1 (en) * 2016-06-22 2017-12-28 University Of Dammam Nebulizer tubing and a nebulizer system
US11160948B2 (en) * 2016-06-22 2021-11-02 Imam Abdulrahman Bin Faisal University Nebulizer tubing with a port to minimize medicament loss
US11478594B2 (en) 2018-05-14 2022-10-25 Covidien Lp Systems and methods for respiratory effort detection utilizing signal distortion
US11752287B2 (en) 2018-10-03 2023-09-12 Covidien Lp Systems and methods for automatic cycling or cycling detection

Also Published As

Publication number Publication date
US6561187B2 (en) 2003-05-13
US20030145852A1 (en) 2003-08-07
US20020112726A1 (en) 2002-08-22
US20060213519A1 (en) 2006-09-28
US6371114B1 (en) 2002-04-16
US7331343B2 (en) 2008-02-19

Similar Documents

Publication Publication Date Title
US6186142B1 (en) Control of respiratory oxygen delivery
US6371114B1 (en) Control device for supplying supplemental respiratory oxygen
US6532958B1 (en) Automated control and conservation of supplemental respiratory oxygen
US7013898B2 (en) Nasal pressure sensor oxygen therapy device
EP2121092B1 (en) Apparatus for delivering a dose of a gaseous drug to a patient
US7222624B2 (en) Dual sensor oxygen therapy device
US9707366B2 (en) Flow triggered pulsed oxygen delivery for medical applications
US20190125999A1 (en) System and method for delivering oxygen and preventing hypercapnia
CN111921050A (en) Method for controlling oxygen delivery
US11247008B1 (en) Flow triggered gas delivery
US11318276B2 (en) Flow triggered gas delivery
US11420007B2 (en) Flow triggered gas delivery
AU2021221922B2 (en) Flow triggered gas delivery
US20220040426A1 (en) Flow Triggered Gas Delivery

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION